Section 55

EurekaMag PDF full texts Chapter 54,590


Allain, B.; Jarray, R.; Borriello, L.; Leforban, B.; Dufour, S.; Liu, W.-q.; Pamonsinlapatham, P.; Bianco, S.; Larghero, J.ér.ôm.; Hadj-Slimane, R.éd.; Garbay, C.; Raynaud, F.ço.; Lepelletier, Y. 2012: Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cells. Cellular Signalling 24(1): 214-223
Ball, S.G.; Bayley, C.; Shuttleworth, C.A.; Kielty, C.M. 2010: Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells. Biochemical Journal 427(1): 29-40
Evans, I.M.; Yamaji, M.; Britton, G.; Pellet-Many, C.; Lockie, C.; Zachary, I.C.; Frankel, P. 2011: Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells. Molecular and Cellular Biology 31(6): 1174-1185
Yaqoob, U.; Cao, S.; Shergill, U.; Jagavelu, K.; Geng, Z.; Yin, M.; de Assuncao, T.M.; Cao, Y.; Szabolcs, A.; Thorgeirsson, S.; Schwartz, M.; Yang, J.D.; Ehman, R.; Roberts, L.; Mukhopadhyay, D.; Shah, V.H. 2012: Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment. Cancer Research 72(16): 4047-4059
Bechet, D.; Tirand, L.; Faivre, B.éa.; Plénat, F.ço.; Bonnet, C.; Bastogne, T.; Frochot, C.él.; Guillemin, F.ço.; Barberi-Heyob, M. 2010: Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release. Pharmaceutical Research 27(3): 468-479
Cao, Y.; Wang, L.; Nandy, D.; Zhang, Y.; Basu, A.; Radisky, D.; Mukhopadhyay, D. 2008: Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Research 68(21): 8667-8672
Matsushita, A.; Sasajima, K.; Yokoyama, T.; Nakamura, Y.; Aimoto, T.; Uchida, E. 2010: Neuropilin-1, as a new therapeutic target in human pancreatic cancer. Journal of Nippon Medical School 77(1): 53-55
Prahst, C.; Héroult, M.él.; Lanahan, A.A.; Uziel, N.; Kessler, O.; Shraga-Heled, N.; Simons, M.; Neufeld, G.; Augustin, H.G. 2008: Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1. Journal of Biological Chemistry 283(37): 25110-25114
Rizzolio, S.; Rabinowicz, N.; Rainero, E.; Lanzetti, L.; Serini, G.; Norman, J.; Neufeld, G.; Tamagnone, L. 2012: Neuropilin-1-dependent regulation of EGF-receptor signaling. Cancer Research 72(22): 5801-5811
Kumar, A.; Huo, S.; Zhang, X.; Liu, J.; Tan, A.; Li, S.; Jin, S.; Xue, X.; Zhao, Y.; Ji, T.; Han, L.; Liu, H.; Zhang, X.; Zhang, J.; Zou, G.; Wang, T.; Tang, S.; Liang, X-Jie. 2014: Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment. Acs Nano 8(5): 4205-4220
Valdembri, D.; Caswell, P.T.; Anderson, K.I.; Schwarz, J.P.; König, I.; Astanina, E.; Caccavari, F.; Norman, J.C.; Humphries, M.J.; Bussolino, F.; Serini, G. 2009: Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. Plos Biology 7(1): E25
Nasarre, P.; Gemmill, R.M.; Potiron, V.A.; Roche, J.ël.; Lu, X.; Barón, A.E.; Korch, C.; Garrett-Mayer, E.; Lagana, A.; Howe, P.H.; Drabkin, H.A. 2013: Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition. Cancer Research 73(23): 7111-7121
Nasarre, C.éc.; Koncina, E.; Labourdette, G.ér.; Cremel, G.ér.; Roussel, G.; Aunis, D.; Bagnard, D. 2009: Neuropilin-2 acts as a modulator of Sema3A-dependent glioma cell migration. Cell Adhesion and Migration 3(4): 383-389
Keck, B.; Wach, S.; Taubert, H.; Zeiler, S.; Ott, O.J.; Kunath, F.; Hartmann, A.; Bertz, S.; Weiss, C.; Hönscheid, P.; Schellenburg, S.; Rödel, C.; Baretton, G.B.; Sauer, R.; Fietkau, R.; Wullich, B.; Krause, F.S.; Datta, K.; Muders, M.H. 2015: Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients. International Journal of Cancer 136(2): 443-451
Hayden Gephart, M.G.; Su, Y.Sophie.; Bandara, S.; Tsai, F-Chiao.; Hong, J.; Conley, N.; Rayburn, H.; Milenkovic, L.; Meyer, T.; Scott, M.P. 2013: Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma. Journal of Neuro-Oncology 115(2): 161-168
Yasuoka, H.; Kodama, R.; Tsujimoto, M.; Yoshidome, K.; Akamatsu, H.; Nakahara, M.; Inagaki, M.; Sanke, T.; Nakamura, Y. 2009: Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression. Bmc Cancer 9: 220
Grandclement, C.; Pallandre, J.R.é; Valmary Degano, S.év.; Viel, E.; Bouard, A.; Balland, J.ér.ém.; Rémy-Martin, J.-P.; Simon, B.; Rouleau, A.; Boireau, W.; Klagsbrun, M.; Ferrand, C.; Borg, C. 2011: Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells. Plos one 6(7): E20444
Rossi, M.; Tuck, J.; Kim, O.-J.; Panova, I.; Symanowski, J.T.; Mahalingam, M.; Riker, A.I.; Alani, R.M.; Ryu, B. 2014: Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma. British Journal of Dermatology 171(2): 403-408
Takahashi, H.; Yoshihara, S.-i.; Nishizumi, H.; Tsuboi, A. 2010: Neuropilin-2 is required for the proper targeting of ventral glomeruli in the mouse olfactory bulb. Molecular and Cellular Neurosciences 44(3): 233-245
Samuel, S.; Gaur, P.; Fan, F.; Xia, L.; Gray, M.J.; Dallas, N.A.; Bose, D.; Rodriguez-Aguayo, C.; Lopez-Berestein, G.; Plowman, G.; Bagri, A.; Sood, A.K.; Ellis, L.M. 2011: Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell lines. Plos one 6(10): E23208
Xu, Y.; Yuan, L.; Mak, J.; Pardanaud, L.; Caunt, M.; Kasman, I.; Larrivée, B.; Del Toro, R.; Suchting, S.; Medvinsky, A.; Silva, J.; Yang, J.; Thomas, J.-L.éo.; Koch, A.W.; Alitalo, K.; Eichmann, A.; Bagri, A. 2010: Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. Journal of Cell Biology 188(1): 115-130
Goel, H.L.; Bae, D.; Pursell, B.; Gouvin, L.M.; Lu, S.; Mercurio, A.M. 2011: Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland. Development 138(14): 2969-2976
Cao, Y.; Hoeppner, L.H.; Bach, S.; E, G.; Guo, Y.; Wang, E.; Wu, J.; Cowley, M.J.; Chang, D.K.; Waddell, N.; Grimmond, S.M.; Biankin, A.V.; Daly, R.J.; Zhang, X.; Mukhopadhyay, D. 2013: Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial α5 integrin. Cancer Research 73(14): 4579-4590
Goel, H.L.; Pursell, B.; Standley, C.; Fogarty, K.; Mercurio, A.M. 2012: Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling. Journal of Cell Science 125(Part 2): 497-506
Dallas, N.A.; Gray, M.J.; Xia, L.; Fan, F.; van Buren, G.; Gaur, P.; Samuel, S.; Lim, S.J.; Arumugam, T.; Ramachandran, V.; Wang, H.; Ellis, L.M. 2008: Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(24): 8052-8060
Narazaki, M.; Segarra, M.; Tosato, G. 2008: Neuropilin-2: a new molecular target for antiangiogenic and antitumor strategies. Journal of the National Cancer Institute 100(2): 81-83
Saban, M.R.; Sferra, T.J.; Davis, C.A.; Simpson, C.; Allen, A.; Maier, J.; Fowler, B.; Knowlton, N.; Birder, L.; Wu, X.-R.; Saban, R. 2010: Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment. American Journal of Physiology. Renal Physiology 299(6): F1245-F1256
Schwarz, Q.; Maden, C.H.; Davidson, K.; Ruhrberg, C. 2009: Neuropilin-mediated neural crest cell guidance is essential to organise sensory neurons into segmented dorsal root ganglia. Development 136(11): 1785-1789
Kim, W.H.; Lee, S.H.; Jung, M.H.; Seo, J.H.; Kim, J.; Kim, M.A.; Lee, Y.M. 2009: Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF. Experimental Cell Research 315(13): 2154-2164
Vadasz, Z.; Attias, D.; Kessel, A.; Toubi, E. 2010: Neuropilins and semaphorins - from angiogenesis to autoimmunity. Autoimmunity Reviews 9(12): 825-829
Prud'homme, G.ér.J.; Glinka, Y. 2012: Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity. Oncotarget 3(9): 921-939
Lumb, R.; Wiszniak, S.; Kabbara, S.; Scherer, M.; Harvey, N.; Schwarz, Q. 2014: Neuropilins define distinct populations of neural crest cells. Neural Development 9: 24
Bagri, A.; Tessier-Lavigne, M.; Watts, R.J. 2009: Neuropilins in tumor biology. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(6): 1860-1864
Grandclement, C.; Borg, C. 2011: Neuropilins: a new target for cancer therapy. Cancers 3(2): 1899-1928
Geretti, E.; Klagsbrun, M. 2007: Neuropilins: novel targets for anti-angiogenesis therapies. Cell Adhesion and Migration 1(2): 56-61
Zachary, I. 2014: Neuropilins: role in signalling, angiogenesis and disease. Chemical Immunology and Allergy 99: 37-70
Chen, J.; Gong, Z.-H.; Yan, H.; Qiao, Z.; Qin, B.-Y. 2012: Neuroplastic alteration of TTX-resistant sodium channel with visceral pain and morphine-induced hyperalgesia. Journal of Pain Research 5: 491-502
Stuber, G.D.; Hopf, F.W.; Tye, K.M.; Chen, B.T.; Bonci, A. 2010: Neuroplastic alterations in the limbic system following cocaine or alcohol exposure. Current Topics in Behavioral Neurosciences 3: 3-27
Kotsyuba, E.P.; Vaschenko, M.A. 2010: Neuroplastic and neuropathological changes in the central nervous system of the Gray mussel Crenomytilus grayanus (Dunker) under environmental stress. Invertebrate Neuroscience: in 10(1): 35-46
Rácz, I.ó 2014: Neuroplastic changes in addiction. Frontiers in Molecular Neuroscience 6: 56
Eyre, H.; Baune, B.T. 2012: Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 37(9): 1397-1416
Raz, E.; Tinelli, E.; Guidetti, G.; Totaro, P.; Bozzao, L.; Pantano, P. 2010: Neuroplastic changes in the brain: a case of two successive adaptive changes within the motor cortex. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging 20(3): 297-301
Stopczynski, R.E.; Normolle, D.P.; Hartman, D.J.; Ying, H.; DeBerry, J.J.; Bielefeldt, K.; Rhim, A.D.; DePinho, R.A.; Albers, K.M.; Davis, B.M. 2014: Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. Cancer Research 74(6): 1718-1727
Chang, Y.; Song, H.-J.; Lee, J.-J.; Seo, J.-H.; Kim, J.-H.; Lee, H.J.; Kim, H.J.; Kim, Y.; Ahn, J.-H.; Park, S.-J.; Kwon, J.H.; Jeong, K.S.; Jung, D.-K. 2010: Neuroplastic changes within the brains of manganese-exposed welders: recruiting additional neural resources for successful motor performance. Occupational and Environmental Medicine 67(12): 809-815
Zendel, B.Rich.; Willoughby, K.A.; Rovet, J.F. 2013: Neuroplastic effects of music lessons on hippocampal volume in children with congenital hypothyroidism. Neuroreport 24(17): 947-950
Knaepen, K.; Goekint, M.; Heyman, E.M.; Meeusen, R. 2010: Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Medicine 40(9): 765-801
Rodríguez-González, R.; Hurtado, O.; Sobrino, T.ás.; Castillo, J.é 2007: Neuroplasticity and cellular therapy in cerebral infarction. Cerebrovascular Diseases 24(Suppl 1): 167-180
Goh, J.O.; Park, D.C. 2009: Neuroplasticity and cognitive aging: the scaffolding theory of aging and cognition. Restorative Neurology and Neuroscience 27(5): 391-403
Harasym, P.H. 2008: Neuroplasticity and critical thinking. Kaohsiung Journal of Medical Sciences 24(7): 339-340
Young, J.A.; Tolentino, M. 2011: Neuroplasticity and its applications for rehabilitation. American Journal of Therapeutics 18(1): 70-80
Serafini, G. 2012: Neuroplasticity and major depression, the role of modern antidepressant drugs. World Journal of Psychiatry 2(3): 49-57
Kuhn, M.; Popovic, A.; Pezawas, L. 2014: Neuroplasticity and memory formation in major depressive disorder: an imaging genetics perspective on serotonin and BDNF. Restorative Neurology and Neuroscience 32(1): 25-49
Siddall, P.J. 2013: Neuroplasticity and pain: what does it all mean?. Medical Journal of Australia 198(4): 177-178
Greene, C.S. 2009: Neuroplasticity and sensitization. Journal of the American Dental Association 140(6): 676-678
Vance, D.E.; Kaur, J.; Fazeli, P.L.; Talley, M.H.; Yuen, H.K.; Kitchin, B.; Lin, F. 2012: Neuroplasticity and successful cognitive aging: a brief overview for nursing. Journal of Neuroscience Nursing: Journal of the American Association of Neuroscience Nurses 44(4): 218-227
Martin, R.E. 2009: Neuroplasticity and swallowing. Dysphagia 24(2): 218-229
Hayley, S.; Litteljohn, D. 2013: Neuroplasticity and the next wave of antidepressant strategies. Frontiers in Cellular Neuroscience 7: 218
Putilina, M.V. 2011: Neuroplasticity as a basis for early rehabilitation of stroke patients. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(12 Part 2): 64-69
Peschanski, M.; Le Forestier, N.; Rapisardi, S. 1993: Neuroplasticity as a basis for therapeutics in spinal cord injuries and diseases. Restorative Neurology and Neuroscience 5(1): 87-97
Li, P.; Legault, J.; Litcofsky, K.A. 2014: Neuroplasticity as a function of second language learning: anatomical changes in the human brain. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 58: 301-324
Krystal, J.H.; Tolin, D.F.; Sanacora, G.; Castner, S.A.; Williams, G.V.; Aikins, D.E.; Hoffman, R.E.; D'Souza, D.C. 2009: Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia. Drug Discovery Today 14(13-14): 690-697
Obretenova, S.; Halko, M.A.; Plow, E.B.; Pascual-Leone, A.; Merabet, L.B. 2010: Neuroplasticity associated with tactile language communication in a deaf-blind subject. Frontiers in Human Neuroscience 3: 60
Madsen, H.B.; Brown, R.M.; Lawrence, A.J. 2012: Neuroplasticity in addiction: cellular and transcriptional perspectives. Frontiers in Molecular Neuroscience 5: 99
O'Brien, C.P. 2009: Neuroplasticity in addictive disorders. Dialogues in Clinical Neuroscience 11(3): 350-353
Grundey, J.; Thirugnanasambandam, N.; Kaminsky, K.; Drees, A.; Skwirba, A.C.; Lang, N.; Paulus, W.; Nitsche, M.A. 2012: Neuroplasticity in cigarette smokers is altered under withdrawal and partially restituted by nicotine exposition. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(12): 4156-4162
Krishnan, S.Sundar.; Panigrahi, M.; Jayalakshmi, S.; Varma, D.R. 2011: Neuroplasticity in hemispheric syndrome: an interesting case report. Neurology India 59(4): 601-604
Seidler, R.D. 2012: Neuroplasticity in middle age: an ecologically valid approach. Frontiers in Human Neuroscience 6: 324
Drevets, W.C. 2004: Neuroplasticity in mood disorders. Dialogues in Clinical Neuroscience 6(2): 199-216
Chen, Y.; Lin, Y.; Li, K.; Li, J.-h.; Di, P.; Jin, Z. 2009: Neuroplasticity in patients with implant supported full dentures. Zhonghua Kou Qiang Yi Xue Za Zhi 44(4): 193-197
Luraschi, J.; Korgaonkar, M.S.; Whittle, T.; Schimmel, M.; Müller, F.; Klineberg, I. 2013: Neuroplasticity in the adaptation to prosthodontic treatment. Journal of Orofacial Pain 27(3): 206-216
Pitchers, K.K.; Balfour, M.E.; Lehman, M.N.; Richtand, N.M.; Yu, L.; Coolen, L.M. 2010: Neuroplasticity in the mesolimbic system induced by natural reward and subsequent reward abstinence. Biological Psychiatry 67(9): 872-879
Chandrasekaran, B.; Gandour, J.T.; Krishnan, A. 2007: Neuroplasticity in the processing of pitch dimensions: a multidimensional scaling analysis of the mismatch negativity. Restorative Neurology and Neuroscience 25(3-4): 195-210
Kusiak, A.N.; Selzer, M.E. 2013: Neuroplasticity in the spinal cord. Handbook of Clinical Neurology 110: 23-42
Lieu, T.; Undem, B.J. 2011: Neuroplasticity in vagal afferent neurons involved in cough. Pulmonary Pharmacology and Therapeutics 24(3): 276-279
Zheng, Z.; Xu, F. 2012: Neuroplasticity may play a role in inter-individual difference among neuropsychiatric disease treatment efficacy. Developmental Psychobiology 54(4): 369-371
Puretić, M.B.; Demarin, V. 2012: Neuroplasticity mechanisms in the pathophysiology of chronic pain. Acta Clinica Croatica 51(3): 425-429
Chen, C.-Y. 2014: Neuroplasticity of central corticotropin-releasing factor and serotonergic systems in anxiety-related behavior. Neuropeptides 48(4): 187-188
Yan, C.; Ye, L.; Zhen, J.; Ke, L.; Gang, L. 2008: Neuroplasticity of edentulous patients with implant-supported full dentures. European Journal of Oral Sciences 116(5): 387-393
Lewis, D.A. 2009: Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia. Dialogues in Clinical Neuroscience 11(3): 269-280
Di Rienzo, F.; Guillot, A.; Mateo, S.éb.; Daligault, S.éb.; Delpuech, C.; Rode, G.; Collet, C. 2015: Neuroplasticity of imagined wrist actions after spinal cord injury: a pilot study. Experimental Brain Research 233(1): 291-302
Di Rienzo, F.; Guillot, A.; Mateo, S.; Daligault, S.; Delpuech, C.; Rode, G.; Collet, C. 2014: Neuroplasticity of prehensile neural networks after quadriplegia. Neuroscience 274: 82-92
Hoenig, K.; Müller, C.; Herrnberger, Bärbel.; Sim, E-Jin.; Spitzer, M.; Ehret, Günter.; Kiefer, M. 2011: Neuroplasticity of semantic representations for musical instruments in professional musicians. Neuroimage 56(3): 1714-1725
Ghilardi, J.R.; Freeman, K.T.; Jimenez-Andrade, J.M.; Coughlin, K.A.; Kaczmarska, M.J.; Castaneda-Corral, G.; Bloom, A.P.; Kuskowski, M.A.; Mantyh, P.W. 2012: Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint. Arthritis and Rheumatism 64(7): 2223-2232
Meyer, M.; Toepel, U.; Keller, J.; Nussbaumer, D.; Zysset, S.; Friederici, A.D. 2007: Neuroplasticity of sign language: implications from structural and functional brain imaging. Restorative Neurology and Neuroscience 25(3-4): 335-351
Brundage, C.M.; Taylor, B.E. 2010: Neuroplasticity of the central hypercapnic ventilatory response: teratogen-induced impairment and subsequent recovery during development. Developmental Neurobiology 70(10): 726-735
Francis, J.T.; Song, W. 2011: Neuroplasticity of the sensorimotor cortex during learning. Neural Plasticity 2011: 310737
Gout, O. 2010: Neuroplasticity predicts outcome of optic neuritis independent of tissue damage. Annals of Neurology 68(6): 970
Balu, D.T.; Coyle, J.T. 2011: Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neuroscience and Biobehavioral Reviews 35(3): 848-870
Liang, Z.; King, J.; Zhang, N. 2014: Neuroplasticity to a single-episode traumatic stress revealed by resting-state fMRi in awake rats. Neuroimage 103: 485-491
Högberg, A.; Linander, I. 2013: Neuroplasticity, epigenetics--and new perspectives for gender studies. Lakartidningen 110(8): 424-426
Garland, E.L.; Howard, M.O. 2009: Neuroplasticity, psychosocial genomics, and the biopsychosocial paradigm in the 21st century. Health and Social Work 34(3): 191-199
Chakraborty, R.; Chatterjee, A.; Choudhary, S.; Chakraborty, P.K. 2007: Neuroplasticity--a paradigm shift in neurosciences. Journal of the Indian Medical Association 105(9): 513
Fisher, M.; Loewy, R.; Carter, C.; Lee, A.; Ragland, J.D.; Niendam, T.; Schlosser, D.; Pham, L.; Miskovich, T.; Vinogradov, S. 2015: Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophrenia Bulletin 41(1): 250-258
Rajji, T.K.; Rogasch, N.C.; Daskalakis, Z.J.; Fitzgerald, P.B. 2013: Neuroplasticity-based brain stimulation interventions in the study and treatment of schizophrenia: a review. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 58(2): 93-98
Rogowsky, B.A.; Papamichalis, P.; Villa, L.; Heim, S.; Tallal, P. 2013: Neuroplasticity-based cognitive and linguistic skills training improves reading and writing skills in college students. Frontiers in psychology 4: 137
Fisher, M.; Holland, C.; Subramaniam, K.; Vinogradov, S. 2010: Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophrenia Bulletin 36(4): 869-879
Hutchinson, E. 2011: Neuroplasticity: Functional recovery after stroke. Nature reviews. Neuroscience 12(1): 4
Gillick, B.T.; Zirpel, L. 2012: Neuroplasticity: an appreciation from synapse to system. Archives of Physical Medicine and Rehabilitation 93(10): 1846-1855
Onténiente, B. 2009: Neuroplasticity: from physiological adaptation to the concept of therapeutic plasticity. Journal de la Societe de Biologie 203(1): 107-111
Merzenich, M.M.; Nahum, M.; Van Vleet, T.M. 2013: Neuroplasticity: introduction. Progress in Brain Research 207: Xxi-Xxvi
Damulin, I.V. 2009: Neuroplasticity: main mechanisms and their clinical significance. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(4): 4-8
Owczarek, S.; Kiryushko, D.; Larsen, M.Hald.; Kastrup, J.Sandholm.; Gajhede, M.; Sandi, C.; Berezin, V.; Bock, E.; Soroka, V. 2010: Neuroplastin-55 binds to and signals through the fibroblast growth factor receptor. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 24(4): 1139-1150
Jo, D.H. 2012: Neuroplasty. Korean Journal of Pain 25(2): 73-74
White, U.A.; Stephens, J.M. 2010: Neuropoietin activates STAT3 independent of LIFR activation in adipocytes. Biochemical and Biophysical Research Communications 395(1): 48-50
White, U.A.; Stewart, W.C.; Mynatt, R.L.; Stephens, J.M. 2008: Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes. Journal of Biological Chemistry 283(33): 22505-22512
Vecchiato, G.; Toppi, J.; Cincotti, F.; Astolfi, L.; De Vico Fallani, F.; Aloise, F.; Mattia, D.; Bocale, S.; Vernucci, F.; Babiloni, F. 2010: Neuropolitics: EEG spectral maps related to a political vote based on the first impression of the candidate's face. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2010: 2902-2905
Hawkes, C.H. 2009: Neuropoppycockology. Practical Neurology 9(6): 347-352
Somoza, R.; Conget, P.; Rubio, F.J. 2008: Neuropotency of human mesenchymal stem cell cultures: clonal studies reveal the contribution of cell plasticity and cell contamination. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(5): 546-555
Onorati, M.; Camnasio, S.; Binetti, M.; Jung, C.B.; Moretti, A.; Cattaneo, E. 2010: Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells. Molecular and Cellular Neurosciences 43(3): 287-295
Nadelhoffer, T.; Bibas, S.; Grafton, S.; Kiehl, K.A.; Mansfield, A.; Sinnott-Armstrong, W.; Gazzaniga, M. 2012: Neuroprediction, Violence, and the Law: Setting the Stage. Neuroethics 5(1): 67-99
Alkan, T. 2009: Neuroproctective effects of ischemic tolerance (preconditioning) and postconditioning. Turkish Neurosurgery 19(4): 406-412
Micevych, P.; Soma, K.K.; Sinchak, K. 2008: Neuroprogesterone: key to estrogen positive feedback?. Brain Research Reviews 57(2): 470-480
Kirschen, M.P.; Topjian, A.A.; Hammond, R.; Illes, J.; Abend, N.S. 2014: Neuroprognostication after pediatric cardiac arrest. Pediatric Neurology 51(5): 663-668.E2
Kapczinski, F.; Streb, L.G. 2014: Neuroprogression and staging in psychiatry: historical considerations. Revista Brasileira de Psiquiatria 36(3): 187-188
Schneider, M.R.; DelBello, M.P.; McNamara, R.K.; Strakowski, S.M.; Adler, C.M. 2012: Neuroprogression in bipolar disorder. Bipolar Disorders 14(4): 356-374
Davis, J.; Moylan, S.; Harvey, B.H.; Maes, M.; Berk, M. 2014: Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries. Australian and New Zealand Journal of Psychiatry 48(6): 512-529
Stein, K.; Broome, M.R. 2015: Neuroprogression in schizophrenia: pathways and underpinning clinical staging and therapeutic corollaries. Australian and New Zealand Journal of Psychiatry 49(2): 183-184
Gildengers, A.G.; Chung, K.-H.; Huang, S.-H.; Begley, A.; Aizenstein, H.J.; Tsai, S.-Y. 2014: Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder. Bipolar Disorders 16(6): 617-623
Mikołajewska, E.; Mikołajewski, D. 2012: Neuroprostheses for increasing disabled patients' mobility and control. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 21(2): 263-272
Tyler, D.J. 2007: Neuroprostheses for management of dysphagia resulting from cerebrovascular disorders. Acta Neurochirurgica. Suppl 97(Part 1): 293-304
Ring, H.; Treger, I.; Gruendlinger, L.; Hausdorff, J.M. 2009: Neuroprosthesis for footdrop compared with an ankle-foot orthosis: effects on postural control during walking. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 18(1): 41-47
Popovic, M.R.; Thrasher, T.A.; Zivanovic, V.; Takaki, J.; Hajek, V. 2005: Neuroprosthesis for retraining reaching and grasping functions in severe hemiplegic patients. Neuromodulation: Journal of the International Neuromodulation Society 8(1): 58-72
Dunning, K.; Black, K.; Harrison, A.; McBride, K.; Israel, S. 2009: Neuroprosthesis peroneal functional electrical stimulation in the acute inpatient rehabilitation setting: a case series. Physical Therapy 89(5): 499-506
Stone, J.; Landau, W. 2013: Neuroprosthetic control and tetraplegia. Lancet 381(9881): 1900
Pancrazio, J.J.; Peckham, P.Hunter. 2009: Neuroprosthetic devices: how far are we from recovering movement in paralyzed patients?. Expert Review of Neurotherapeutics 9(4): 427-430
Sheffler, L.R.; Hennessey, M.T.; Knutson, J.S.; Chae, J. 2009: Neuroprosthetic effect of peroneal nerve stimulation in multiple sclerosis: a preliminary study. Archives of Physical Medicine and Rehabilitation 90(2): 362-365
Monaco, E.A.; Friedlander, R.M. 2012: Neuroprosthetic learning utilizes the same neural circuitry required for motor learning. Neurosurgery 70(6): N10
Collinger, J.L.; Foldes, S.; Bruns, T.M.; Wodlinger, B.; Gaunt, R.; Weber, D.J. 2013: Neuroprosthetic technology for individuals with spinal cord injury. Journal of Spinal Cord Medicine 36(4): 258-272
Pappas, K.M.; DeVoll, J.R. 2012: Neuroprosthetics. Aviation Space and Environmental Medicine 83(5): 537-538
Rosahl, S.K. 2007: Neuroprosthetics and neuroenhancement: can we draw a line?. Virtual Mentor: Vm 9(2): 132-139
Rupp, R.; Gerner, H.J. 2007: Neuroprosthetics of the upper extremity--clinical application in spinal cord injury and challenges for the future. Acta Neurochirurgica. Suppl 97(Part 1): 419-426
Cortinovis, D.; Alberti, P.; Frigeni, B.; Bidoli, P.; Cavaletti, G. 2013: Neuroprotectant agents against oxaliplatin induced neurotoxicity: lackings, facts and future prospective. Annals of Oncology: Official Journal of the European Society for Medical Oncology 24(5): 1418-1419
Munson, T.; Amin-Hanjani, S. 2013: Neuroprotectant drug shows promise in human ischemic stroke. World Neurosurgery 79(3-4): 408-409
Jeyaseelan, K.; Lim, K.Y.; Armugam, A. 2008: Neuroprotectants in stroke therapy. Expert Opinion on PharmacoTherapy 9(6): 887-900
Wahlgren, N.G.; Lyden, P. 2000: Neuroprotectants in the treatment of stroke--an overview. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 9(6 Part 2): 32-35
Yao, C.; Zhang, J.; Chen, F.; Lin, Y. 2013: Neuroprotectin D1 attenuates brain damage induced by transient middle cerebral artery occlusion in rats through TRPC6/CREB pathways. Molecular Medicine Reports 8(2): 543-550
Sheets, K.G.; Zhou, Y.; Ertel, M.K.; Knott, E.J.; Regan, C.E.; Elison, J.R.; Gordon, W.C.; Gjorstrup, P.; Bazan, N.G. 2010: Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse. Molecular Vision 16: 320-329
Antony, R.; Lukiw, W.J.; Bazan, N.G. 2010: Neuroprotectin D1 induces dephosphorylation of Bcl-xL in a PP2A-dependent manner during oxidative stress and promotes retinal pigment epithelial cell survival. Journal of Biological Chemistry 285(24): 18301-18308
Stark, D.T.; Bazan, N.G. 2011: Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models. Molecular Neurobiology 43(2): 131-138
Kanan, Y.; Gordon, W.C.; Mukherjee, P.K.; Bazan, N.G.; Al-Ubaidi, M.R. 2015: Neuroprotectin D1 is synthesized in the cone photoreceptor cell line 661W and elicits protection against light-induced stress. Cellular and Molecular Neurobiology 35(2): 197-204
Calandria, J.M.; Bazan, N.G. 2010: Neuroprotectin D1 modulates the induction of pro-inflammatory signaling and promotes retinal pigment epithelial cell survival during oxidative stress. Advances in Experimental Medicine and Biology 664: 663-670
Rajasagi, N.K.; Reddy, P.B.J.; Mulik, S.; Gjorstrup, P.; Rouse, B.T. 2013: Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Investigative Ophthalmology and Visual Science 54(9): 6269-6279
Cortina, M.S.; He, J.; Russ, T.; Bazan, N.G.; Bazan, H.E.P. 2013: Neuroprotectin D1 restores corneal nerve integrity and function after damage from experimental surgery. Investigative Ophthalmology and Visual Science 54(6): 4109-4116
Bazan, N.G. 2009: Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. Journal of Lipid Research 50 Suppl: S400-S405
Marcheselli, V.L.; Mukherjee, P.K.; Arita, M.; Hong, S.; Antony, R.; Sheets, K.; Winkler, J.W.; Petasis, N.A.; Serhan, C.N.; Bazan, N.G. 2010: Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukotrienes and Essential Fatty Acids 82(1): 27-34
Xu, Z.-Z.; Liu, X.-J.; Berta, T.; Park, C.-K.; Lü, N.; Serhan, C.N.; Ji, R.-R. 2013: Neuroprotectin/protectin D1 protects against neuropathic pain in mice after nerve trauma. Annals of Neurology 74(3): 490-495
Hong, S.; Tian, H.; Lu, Y.; Laborde, J.M.; Muhale, F.A.; Wang, Q.; Alapure, B.V.; Serhan, C.N.; Bazan, N.G. 2014: Neuroprotectin/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes. American Journal of Physiology. Cell Physiology 307(11): C1058-C1067
Jawad, N.; Rizvi, M.; Gu, J.; Adeyi, O.; Tao, G.; Maze, M.; Ma, D. 2009: Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neuroscience Letters 460(3): 232-236
Yousuf, S.; Atif, F.; Ahmad, M.; Ishrat, T.; Khan, B.; Islam, F. 2011: Neuroprotection Offered by Majun Khadar, a Traditional Unani Medicine, during Cerebral Ischemic Damage in Rats. Evidence-BasedComplementaryandAlternativeMedicine:Ecam 2011: 754025
Valadas, J.S.; Batalha, V.ân.L.; Ferreira, D.G.; Gomes, R.; Coelho, J.E.; Sebastião, A.M.; Diógenes, M.J.é; Lopes, L.ís.V. 2012: Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin-releasing factor (CRF) in glutamate injured cortical neurons. Journal of Neurochemistry 123(6): 1030-1040
Moldes, O.; Sobrino, T.ás.; Blanco, M.; Agulla, J.ús.; Barral, D.; Ramos-Cabrer, P.; Castillo, J.é 2012: Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke. Neuropharmacology 63(8): 1279-1285
Dykstra, C.M.; Ratnam, M.; Gurd, J.W. 2009: Neuroprotection after status epilepticus by targeting protein interactions with postsynaptic density protein 95. Journal of Neuropathology and Experimental Neurology 68(7): 823-831
Radermacher, K.A.; Wingler, K.; Langhauser, F.; Altenhöfer, S.; Kleikers, P.; Hermans, J.J.R.; Hrabě de Angelis, M.; Kleinschnitz, C.; Schmidt, H.H.H.W. 2013: Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. Antioxidants and Redox Signaling 18(12): 1418-1427
Yu, H.; Yao, L.; Zhou, H.; Qu, S.; Zeng, X.; Zhou, D.; Zhou, Y.; Li, X.; Liu, Z. 2014: Neuroprotection against Aβ25-35-induced apoptosis by Salvia miltiorrhiza extract in SH-SY5Y cells. Neurochemistry International 75: 89-95
Zhang, S.; Chen, X.; Yang, Y.; Zhou, X.; Liu, J.; Ding, F. 2011: Neuroprotection against cobalt chloride-induced cell apoptosis of primary cultured cortical neurons by salidroside. Molecular and Cellular Biochemistry 354(1-2): 161-170
Kuo, Y-Chih.; Chou, P-Ru. 2014: Neuroprotection against degeneration of sk-N-mc cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin. Journal of Pharmaceutical Sciences 103(8): 2484-2497
Schauwecker, P.E.; Wood, R.I.; Lorenzana, A. 2009: Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion. Brain Research 1265: 37-46
Gao, Y.; Liang, W.; Hu, X.; Zhang, W.; Stetler, R.A.; Vosler, P.; Cao, G.; Chen, J. 2010: Neuroprotection against hypoxic-ischemic brain injury by inhibiting the apoptotic protease activating factor-1 pathway. Stroke 41(1): 166-172
Suttkus, A.; Rohn, S.; Jäger, C.; Arendt, T.; Morawski, M. 2012: Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress. American Journal of Neurodegenerative Disease 1(2): 122-129
Zhou, M.; Xu, W.; Liao, G.; Bi, X.; Baudry, M. 2009: Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation. Experimental Neurology 218(1): 75-82
Lam, P.Y.; Chen, N.; Chiu, P.Y.; Leung, H.Y.; Ko, K.M. 2012: Neuroprotection against oxidative injury by a nucleic acid-based health product (Squina DNA) through enhancing mitochondrial antioxidant status and functional capacity. Journal of Medicinal Food 15(7): 629-638
Wang, X.; Jiang, C.-M.; Wan, H.-Y.; Wu, J.-L.; Quan, W.-Q.; Wu, K.-Y.; Li, D. 2014: Neuroprotection against permanent focal cerebral ischemia by ginkgolides a and B is associated with obstruction of the mitochondrial apoptotic pathway via inhibition of c-Jun N-terminal kinase in rats. Journal of Neuroscience Research 92(2): 232-242
Fukuda, K.; Hirooka, K.; Mizote, M.; Nakamura, T.; Itano, T.; Shiraga, F. 2010: Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin Ii type 1 receptor. Investigative Ophthalmology and Visual Science 51(7): 3629-3638
Jiang, X.; Ai, C.; Shi, E.; Nakajima, Y.; Ma, H. 2009: Neuroprotection against spinal cord ischemia-reperfusion injury induced by different ischemic postconditioning methods: roles of phosphatidylinositol 3-kinase-Akt and extracellular signal-regulated kinase. Anesthesiology 111(6): 1197-1205
Tauskela, J.S.; Brunette, E. 2009: Neuroprotection against staurosporine by metalloporphyrins independent of antioxidant capability. Neuroscience Letters 466(1): 41-46
Leak, R.K.; Chen, J. 2013: Neuroprotection against stroke and CNS injury: new mechanisms, targets, and controversies. Cns and Neurological Disorders Drug Targets 12(3): 300-301
Kanamori, A.; Catrinescu, M.-M.; Mahammed, A.; Gross, Z.; Levin, L.A. 2010: Neuroprotection against superoxide anion radical by metallocorroles in cellular and murine models of optic neuropathy. Journal of Neurochemistry 114(2): 488-498
Yu, C.-Z.; Li, C.; Pei, D.-S.; Zong, Y.-Y.; Shi, Q.; Wen, X.-R.; Guan, Q.-H.; Hang, D.; Hou, X.-Y.; Zhang, G.-Y. 2009: Neuroprotection against transient focal cerebral ischemia and oxygen-glucose deprivation by interference with GluR6-PSD95 protein interaction. Neurochemical Research 34(11): 2008-2021
Brittain, J.M.; Chen, L.; Wilson, S.M.; Brustovetsky, T.; Gao, X.; Ashpole, N.M.; Molosh, A.I.; You, H.; Hudmon, A.; Shekhar, A.; White, F.A.; Zamponi, G.W.; Brustovetsky, N.; Chen, J.; Khanna, R. 2011: Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). Journal of Biological Chemistry 286(43): 37778-37792
Harris, K.; Armstrong, S.P.; Campos-Pires, R.; Kiru, L.; Franks, N.P.; Dickinson, R. 2013: Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site. Anesthesiology 119(5): 1137-1148
Chan, H.; Paur, H.; Vernon, A.C.; Zabarsky, V.; Datla, K.P.; Croucher, M.J.; Dexter, D.T. 2010: Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease. Parkinson's Disease 2010
Valenza, M.; Cattaneo, E. 2010: Neuroprotection and brain cholesterol biosynthesis in Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America 107(37): E143; Author Reply 144
Xiao, X.; Liu, Y.; Qi, C.; Qiu, F.; Chen, X.; Zhang, J.; Yang, P. 2010: Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia. Neurological Research 32(5): 547-555
Simpkins, J.W.; Singh, M.; Brock, C.; Etgen, A.M. 2012: Neuroprotection and estrogen receptors. Neuroendocrinology 96(2): 119-130
Charron, C.; Messier, C.; Plamondon, Hélène. 2008: Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia. Physiology and Behavior 93(3): 502-511
Pavese, N.; Kiferle, L.; Piccini, P. 2009: Neuroprotection and imaging studies in Parkinson's disease. Parkinsonism and Related Disorders 15(Suppl 4): S33-S37
Kocsis, J.D. 2009: Neuroprotection and immunomodulation by cell transplantation are becoming central themes in potential therapeutic approaches for cell-based therapies. Neuroscience Letters 456(3): 99
Obisesan, T.O.; Gillum, R.F.; Johnson, S.; Umar, N.; Williams, D.; Bond, V.; Kwagyan, J. 2012: Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans. International Journal of Alzheimer's Disease 2012: 568382
de Freitas, P.; Zanoni, J.Nelisis.; Alves, A.Maria.Pereira.; de Miranda Neto, M.Hubner. 2012: Neuroprotection and neurodegeneration in submucosal VIP-IR neurons in the jejunum of ascorbic acid supplemented aging Wistar rats. Nutritional Neuroscience 15(6): 283-288
Arnon, R.; Aharoni, R. 2009: Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate. Journal of Neural Transmission 116(11): 1443-1449
Sugaya, K.; Youdim, M.B.H.; Nordberg, A.; Rao, K.S.J. 2012: Neuroprotection and neuroregeneration in Alzheimer's disease. International Journal of Alzheimer's Disease 2012: 864138
Stangel, M. 2008: Neuroprotection and neuroregeneration in multiple sclerosis. Journal of Neurology 255(Suppl 6): 77-81
Brandner, S.; Kleindienst, A. 2011: Neuroprotection and neuroregeneration: what to expect from a stem cell-based therapy of acute brain injury. Critical Care Medicine 39(11): 2577-2578
Yang, Y.; Bian, G.-X.; Lu, Q.-J. 2008: Neuroprotection and neurotrophism effects of liquiritin on primary cultured hippocampal cells. Zhongguo Zhong Yao Za Zhi 33(8): 931-935
Nucci, C.; Strouthidis, N.G.; Khaw, P.T. 2013: Neuroprotection and other novel therapies for glaucoma. Current Opinion in Pharmacology 13(1): 1-4
London, A.; Itskovich, E.; Benhar, I.; Kalchenko, V.; Mack, M.; Jung, S.; Schwartz, M. 2011: Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. Journal of Experimental Medicine 208(1): 23-39
Hurtado, O.; Lizasoain, I.; Moro, Mía.Ángeles. 2011: Neuroprotection and recovery: recent data at the bench on citicoline. Stroke 42(1 Suppl): S33-S35
Perez, M.; Benitez, S.U.; Cartarozzi, L.P.; Del Bel, E.; Guimarães, F.S.; Oliveira, A.L.R. 2013: Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats. European Journal of Neuroscience 38(10): 3424-3434
West, A.K.; Leung, J.Y.K.; Chung, R.S. 2011: Neuroprotection and regeneration by extracellular metallothionein via lipoprotein-receptor-related proteins. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 16(7): 1115-1122
Omari, K.M.; Lutz, S.E.; Santambrogio, L.; Lira, S.A.; Raine, C.S. 2009: Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. American Journal of Pathology 174(1): 164-176
Guo, D.; Dexheimer, T.S.; Pommier, Y.; Nash, H.A. 2014: Neuroprotection and repair of 3'-blocking DNA ends by glaikit (gkt) encoding Drosophila tyrosyl-DNA phosphodiesterase 1 (TDP1). Proceedings of the National Academy of Sciences of the United States of America 111(44): 15816-15820
Sun, Y.; Dai, M.; Wang, Y.; Wang, W.; Sun, Q.; Yang, G.-Y.; Bian, L. 2011: Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice. Journal of Neurotrauma 28(12): 2513-2521
De Nicola, A.F.; Brocca, M.E.; Pietranera, L.; Garcia-Segura, L.M. 2012: Neuroprotection and sex steroid hormones: evidence of estradiol-mediated protection in hypertensive encephalopathy. Mini Reviews in Medicinal Chemistry 12(11): 1081-1089
Evrard, P.; Gaultier, C. 2006: Neuroprotection and sudden infant death. a robust Brussels--Paris collaboration and future perspectives. Revue Medicale de Bruxelles 27(Special Issue): Sp13-Sp17
Felberg, R.A.; Burgin, W.S.; Grotta, J.C. 2000: Neuroprotection and the ischemic cascade. Cns Spectrums 5(3): 52-58
Cui, L.; Zhang, X.; Yang, R.; Wang, L.; Liu, L.; Li, M.; Du, W. 2011: Neuroprotection and underlying mechanisms of oxymatrine in cerebral ischemia of rats. Neurological Research 33(3): 319-324
Andrews, R.J. 2007: Neuroprotection at the nanolevel--Part I: Introduction to nanoneurosurgery. Annals of the New York Academy of Sciences 1122: 169-184
Andrews, R.J. 2007: Neuroprotection at the nanolevel--Part II: Nanodevices for neuromodulation--deep brain stimulation and spinal cord injury. Annals of the new York Academy of Sciences 1122: 185-196
Yao, C.; Zhang, J.; Liu, G.; Chen, F.; Lin, Y. 2014: Neuroprotection by (-)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress. Molecular Medicine Reports 9(1): 69-76
Morroni, F.; Sita, G.; Tarozzi, A.; Cantelli-Forti, G.; Hrelia, P. 2014: Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease. Brain Research 1589: 93-104
Duarte, E.íl.P.; Curcio, M.; Canzoniero, L.M.; Duarte, C.B. 2012: Neuroprotection by GDNF in the ischemic brain. Growth Factors 30(4): 242-257
Nguyen, N.; Lee, S.B.; Lee, Y.S.; Lee, Y.S.; Lee, K.-H.; Ahn, J.-Y. 2009: Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochemical Research 34(5): 942-951
Feng, Y.; Liu, T.; Li, X.-Q.; Liu, Y.; Zhu, X.-Y.; Jankovic, J.; Pan, T.-H.; Wu, Y.-C. 2014: Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's disease. Neuroscience Letters 579: 35-40
Molnar, M.; Lennmyr, F. 2010: Neuroprotection by S-PBN in hyperglycemic ischemic brain injury in rats. Upsala Journal of Medical Sciences 115(3): 163-168
Bermejo-Bescós, P.; Piñero-Estrada, E.; Villar del Fresno, A.Ma. 2008: Neuroprotection by Spirulina platensis protean extract and phycocyanin against iron-induced toxicity in SH-SY5Y neuroblastoma cells. Toxicology in vitro: an international journal published in association with BIBRA 22(6): 1496-1502
Ghosh, A.; Chandran, K.; Kalivendi, S.V.; Joseph, J.; Antholine, W.E.; Hillard, C.J.; Kanthasamy, A.; Kanthasamy, A.; Kalyanaraman, B. 2010: Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free Radical Biology and Medicine 49(11): 1674-1684
Stanton, P.K.; Potter, P.E.; Aguilar, J.; Decandia, M.; Moskal, J.R. 2009: Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13. Neuroreport 20(13): 1193-1197
Thaler, S.; Choragiewicz, T.J.; Rejdak, R.; Fiedorowicz, M.; Turski, W.A.; Tulidowicz-Bielak, M.; Zrenner, E.; Schuettauf, F.; Zarnowski, T. 2010: Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid. Graefe's Archive for Clinical and Experimental Ophthalmology 248(12): 1729-1735
Scafidi, S.; Racz, J.; Hazelton, J.; McKenna, M.C.; Fiskum, G. 2010: Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain. Developmental Neuroscience 32(5-6): 480-487
Cunha, R.A. 2005: Neuroprotection by adenosine in the brain: from A(1) receptor activation to a (2A) receptor blockade. Purinergic Signalling 1(2): 111-134
Anderson, C. 2008: Neuroprotection by angiotensin receptor blockers?. Journal of Hypertension 26(5): 853
Paterniti, I.; Cordaro, M.; Campolo, M.; Siracusa, R.; Cornelius, C.; Navarra, M.; Cuzzocrea, S.; Esposito, E. 2014: Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation. Cns and Neurological Disorders Drug Targets 13(9): 1530-1541
Ouyang, Y.-B.; Xu, L.; Yue, S.; Liu, S.; Giffard, R.G. 2014: Neuroprotection by astrocytes in brain ischemia: importance of microRNAs. Neuroscience Letters 565: 53-58
Schwarzkopf, T.M.; Hagl, S.; Eckert, G.P.; Klein, J. 2013: Neuroprotection by bilobalide in ischemia: improvement of mitochondrial function. Die Pharmazie 68(7): 584-589
Kim, I.-D.; Lim, C.-M.; Kim, J.-B.; Nam, H.Y.; Nam, K.; Kim, S.-W.; Park, J.-S.; Lee, J.-K. 2010: Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain. Journal of Controlled Release: Official Journal of the Controlled Release Society 142(3): 422-430
Yeste-Velasco, M.; Folch, J.; Casadesús, G.; Smith, M.A.; Pallàs, M.; Camins, A. 2009: Neuroprotection by c-Jun NH2-terminal kinase inhibitor SP600125 against potassium deprivation-induced apoptosis involves the Akt pathway and inhibition of cell cycle reentry. Neuroscience 159(3): 1135-1147
Xu, K.; Xu, Y.-H.; Chen, J.-F.; Schwarzschild, M.A. 2010: Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease. Neuroscience 167(2): 475-481
Wei Xu; Miou Zhou; Baudry, M. 2008: Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences. Neuroscientist: a Review Journal Bringing Neurobiology Neurology and Psychiatry 14(5): 409-414
Gaspard, V.; Viellevoye, R.; Rigo, J. 2012: Neuroprotection by controlled hypothermia in neonatal hypoxic-ischemic encephalopathy. Revue Medicale de Liege 67(4): 186-190
Wu, J.; Li, Q.; Wang, X.; Yu, S.; Li, L.; Wu, X.; Chen, Y.; Zhao, J.; Zhao, Y. 2013: Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. Plos one 8(3): E59843
Kim, H.-Y. 2014: Neuroprotection by docosahexaenoic acid in brain injury. Military Medicine 179(11 Suppl): 106-111
Shen, H.; Kihara, T.; Hongo, H.; Wu, X.; Kem, W.R.; Shimohama, S.; Akaike, A.; Niidome, T.; Sugimoto, H. 2010: Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors. British Journal of Pharmacology 161(1): 127-139
Zheng, Z.; Schwab, S.; Grau, A.; Berger, C. 2007: Neuroprotection by early and delayed treatment of acute stroke with high dose aspirin. Brain Research 1186: 275-280
Barreto, G.E. 2011: Neuroprotection by estradiol: some important considerations. Human and Experimental Toxicology 30(10): 1737-1739
Arnold, S.; Beyer, C. 2009: Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. Journal of Neurochemistry 110(1): 1-11
Bråtane, B.T.; Cui, H.; Cook, D.J.; Bouley, J.; Tymianski, M.; Fisher, M. 2011: Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor. Stroke 42(11): 3265-3270
Hughes, R.H.; Silva, V.A.; Ahmed, I.; Shreiber, D.I.; Morrison, B. 2014: Neuroprotection by genipin against reactive oxygen and reactive nitrogen species-mediated injury in organotypic hippocampal slice cultures. Brain Research 1543: 308-314
Fanne, R.A.; Nassar, T.; Mazuz, A.; Waked, O.; Heyman, S.N.; Hijazi, N.; Goelman, G.; Higazi, A.A.-R. 2011: Neuroprotection by glucagon: role of gluconeogenesis. Journal of Neurosurgery 114(1): 85-91
Schauwecker, P.E. 2010: Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain. Experimental Neurology 224(1): 207-218
Johann, S.; Beyer, C. 2013: Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. Journal of Steroid Biochemistry and Molecular Biology 137: 71-81
Scartabelli, T.; Gerace, E.; Landucci, E.; Moroni, F.; Pellegrini-Giampietro, D.E. 2008: Neuroprotection by group i mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K-Akt signaling pathway: a novel postconditioning strategy?. Neuropharmacology 55(4): 509-516
Ma, C.; D'Mello, S.R. 2011: Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism. Journal of Biological Chemistry 286(6): 4819-4828
Arien-Zakay, H.; Lecht, S.; Nagler, A.; Lazarovici, P. 2011: Neuroprotection by human umbilical cord blood-derived progenitors in ischemic brain injuries. Archives Italiennes de Biologie 149(2): 233-245
Galoyan, A.A.; Sarkissian, J.S.; Chavushyan, V.A.; Meliksetyan, I.B.; Avagyan, Z.E.; Poghosyan, M.V.; Vahradyan, H.G.; Mkrtchian, H.H.; Abrahamyan, D.O. 2008: Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Abeta25-35 model of Alzheimer's disease. Alzheimer's and Dementia: the Journal of the Alzheimer's Association 4(5): 332-344
Kuffler, D.P. 2010: Neuroprotection by hypothermia plus alkalinization of dorsal root ganglia neurons through ischemia. Annals of the new York Academy of Sciences 1199: 158-163
Giusti, S.án.; Fiszer de Plazas, S. 2012: Neuroprotection by hypoxic preconditioning involves upregulation of hypoxia-inducible factor-1 in a prenatal model of acute hypoxia. Journal of Neuroscience Research 90(2): 468-478
Jung, J.E.; Kim, G.S.; Chan, P.H. 2011: Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke 42(12): 3574-3579
Hudetz, J.A.; Pagel, P.S. 2010: Neuroprotection by ketamine: a review of the experimental and clinical evidence. Journal of Cardiothoracic and Vascular Anesthesia 24(1): 131-142
Papazisis, G.; Kallaras, K.; Kaiki-Astara, A.; Pourzitaki, C.; Tzachanis, D.; Dagklis, T.; Kouvelas, D. 2008: Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy. International Journal of Neuropsychopharmacology 11(3): 321-329
Dang, S.; Liu, X.; Fu, P.; Gong, W.; Yan, F.; Han, P.; Ding, Y.; Ji, X.; Luo, Y. 2011: Neuroprotection by local intra-arterial infusion of erythropoietin after focal cerebral ischemia in rats. Neurological Research 33(5): 520-528
Ishii, M.; Iizuka, R.; Kiuchi, Y.; Mori, Y.; Shimizu, S. 2011: Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity. Molecular and Cellular Biochemistry 358(1-2): 1-11
Armagan, G.; Turunc, E.; Kanit, L.; Yalcin, A. 2012: Neuroprotection by mefenamic acid against D-serine: involvement of oxidative stress, inflammation and apoptosis. Free Radical Research 46(6): 726-739
Lekic, T.; Manaenko, A.; Rolland, W.; Virbel, K.; Hartman, R.; Tang, J.; Zhang, J.H. 2011: Neuroprotection by melatonin after germinal matrix hemorrhage in neonatal rats. Acta Neurochirurgica. Suppl 111: 201-206
Radogna, F.; Nuccitelli, S.; Mengoni, F.; Ghibelli, L. 2009: Neuroprotection by melatonin on astrocytoma cell death. Annals of the new York Academy of Sciences 1171: 509-513
Schildknecht, S.; Pape, R.; Müller, N.; Robotta, M.; Marquardt, A.; Bürkle, A.; Drescher, M.; Leist, M. 2011: Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite. Journal of Biological Chemistry 286(7): 4991-5002
Duan, W.; Guo, Y.; Xiao, J.; Chen, X.; Li, Z.; Han, H.; Li, C. 2014: Neuroprotection by monocarbonyl dimethoxycurcumin C: ameliorating the toxicity of mutant TDP-43 via HO-1. Molecular Neurobiology 49(1): 368-379
Campos-Esparza, M.d.R.; Torres-Ramos, M.ón.A. 2010: Neuroprotection by natural polyphenols: molecular mechanisms. Central Nervous System Agents in Medicinal Chemistry 10(4): 269-277
Huang, X.; Cheng, Z.; Su, Q.; Zhu, X.; Wang, Q.; Chen, R.; Wang, X. 2012: Neuroprotection by nicotine against colchicine-induced apoptosis is mediated by PI3-kinase--Akt pathways. International Journal of Neuroscience 122(6): 324-332
Haelewyn, B.; David, H.él.èn.N.; Rouillon, C.; Chazalviel, L.; Lecocq, M.; Risso, J.-J.; Lemaire, M.; Abraini, J.H. 2008: Neuroprotection by nitrous oxide: facts and evidence. Critical Care Medicine 36(9): 2651-2659
Eschenfelder, C.C.; Krug, R.; Yusofi, A.F.; Meyne, J.K.; Herdegen, T.; Koch, A.; Zhao, Y.; Carl, U.M.; Deuschl, G. 2008: Neuroprotection by oxygen in acute transient focal cerebral ischemia is dose dependent and shows superiority of hyperbaric oxygenation. Cerebrovascular Diseases 25(3): 193-201
Wu, Y.; Wang, L.; Dai, C.; Ma, G.; Zhang, Y.; Zhang, X.; Wu, Z. 2014: Neuroprotection by platelet-activating factor acetylhydrolase in a mouse model of transient cerebral ischemia. Neuroscience Letters 558: 26-30
Berger, C.; Xia, F.; Maurer, M.H.; Schwab, S. 2008: Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Research Reviews 58(1): 48-56
Heinonen, A.-M.; Rahman, M.; Dogbevia, G.; Jakobi, H.; Wölfl, S.; Sprengel, R.; Schwaninger, M. 2014: Neuroprotection by rAAV-mediated gene transfer of bone morphogenic protein 7. Bmc Neuroscience 15: 38
Hardeland, R.üd. 2009: Neuroprotection by radical avoidance: search for suitable agents. Molecules 14(12): 5054-5102
Eliash, S.; Dror, V.; Cohen, S.; Rehavi, M. 2009: Neuroprotection by rasagiline in thiamine deficient rats. Brain Research 1256: 138-148
Matteucci, A.; Gaddini, L.; Villa, M.; Varano, M.; Parravano, M.; Monteleone, V.; Cavallo, F.; Leo, L.; Mallozzi, C.; Malchiodi-Albedi, F.; Pricci, F. 2014: Neuroprotection by rat Müller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation. Experimental Eye Research 125: 20-29
Kumar, A.; Negi, G.; Sharma, S.S. 2013: Neuroprotection by resveratrol in diabetic neuropathy: concepts and mechanisms. Current Medicinal Chemistry 20(36): 4640-4645
Verma, R.; Mishra, V.; Gupta, K.; Sasmal, D.; Raghubir, R. 2011: Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter-1. Journal of Neuroscience Research 89(11): 1849-1858
Sun, A.; Xu, X.; Lin, J.; Cui, X.; Xu, R. 2015: Neuroprotection by saponins. PhytoTherapy Research: Ptr 29(2): 187-200
Jiang, J.; Ganesh, T.; Du, Y.; Thepchatri, P.; Rojas, A.; Lewis, I.; Kurtkaya, S.; Li, L.; Qui, M.; Serrano, G.; Shaw, R.; Sun, A.; Dingledine, R. 2010: Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. Proceedings of the National Academy of Sciences of the United States of America 107(5): 2307-2312
Chen, X.-M.; Wang, N.-N.; Zhang, T.-Y.; Wang, F.; Wu, C.-F.; Yang, J.-Y. 2014: Neuroprotection by sildenafil: neuronal networks potentiation in acute experimental stroke. Cns Neuroscience and Therapeutics 20(1): 40-49
Li, M.; Dai, F.-r.; Du, X.-p.; Yang, Q.-d.; Chen, Y. 2012: Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson's disease. Journal of Molecular Neuroscience: Mn 48(1): 225-233
Kannappan, R.; Gupta, S.C.; Kim, J.H.; Reuter, S.; Aggarwal, B.B. 2011: Neuroprotection by spice-derived nutraceuticals: you are what you eat!. Molecular Neurobiology 44(2): 142-159
Taranukhin, A.G.; Taranukhina, E.Y.; Saransaari, P.; Podkletnova, I.M.; Pelto-Huikko, M.; Oja, S.S. 2010: Neuroprotection by taurine in ethanol-induced apoptosis in the developing cerebellum. Journal of Biomedical Science 17(Suppl 1): S12
Nakanishi, N.; Tu, S.; Shin, Y.; Cui, J.; Kurokawa, T.; Zhang, D.; Chen, H.-S.V.; Tong, G.; Lipton, S.A. 2009: Neuroprotection by the NR3A subunit of the NMDA receptor. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 29(16): 5260-5265
Wu, C-Jen.; Chen, J-Tai.; Yen, T-Lin.; Jayakumar, T.; Chou, D-Suey.; Hsiao, G.; Sheu, J-Rong. 2011: Neuroprotection by the Traditional Chinese Medicine, Tao-Hong-Si-Wu-Tang, against Middle Cerebral Artery Occlusion-Induced Cerebral Ischemia in Rats. Evidence-Based Complementary and Alternative Medicine: Ecam 2011: 803015
Fleiss, B.; Nilsson, M.K.L.; Blomgren, K.; Mallard, C. 2012: Neuroprotection by the histone deacetylase inhibitor trichostatin a in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury. Journal of Neuroinflammation 9: 70
Fang, S.; Xu, H.; Lu, J.; Zhu, Y.; Jiang, H. 2013: Neuroprotection by the kappa-opioid receptor agonist, BRL52537, is mediated via up-regulating phosphorylated signal transducer and activator of transcription-3 in cerebral ischemia/reperfusion injury in rats. Neurochemical Research 38(11): 2305-2312
Broom, L.; Marinova-Mutafchieva, L.; Sadeghian, M.; Davis, J.B.; Medhurst, A.D.; Dexter, D.T. 2011: Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease. Free Radical Biology and Medicine 50(5): 633-640
Qian, Y.; Guan, T.; Huang, M.; Cao, L.; Li, Y.; Cheng, H.; Jin, H.; Yu, D. 2012: Neuroprotection by the soy isoflavone, genistein, via inhibition of mitochondria-dependent apoptosis pathways and reactive oxygen induced-NF-κB activation in a cerebral ischemia mouse model. Neurochemistry International 60(8): 759-767
El Bitar, F.; Meunier, J.; Villard, V.; Alméras, M.; Krishnan, K.; Covey, D.F.; Maurice, T.; Akwa, Y. 2014: Neuroprotection by the synthetic neurosteroid enantiomers ent-PREGS and ent-DHEAS against Aβ₂₅₋₃₅ peptide-induced toxicity in vitro and in vivo in mice. Psychopharmacology 231(17): 3293-3312
Masuko, T.; Namiki, R.; Nemoto, Y.; Miyake, M.; Kizawa, Y.; Suzuki, T.; Kashiwagi, K.; Igarashi, K.; Kusama, T. 2009: Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors. Journal of Pharmacology and Experimental Therapeutics 331(2): 522-530
Qian, Y.R.; Lee, M.-J.; Hwang, S.; Kook, J.H.; Kim, J.-K.; Bae, C.S. 2010: Neuroprotection by valproic Acid in mouse models of permanent and transient focal cerebral ischemia. Korean Journal of Physiology and Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology 14(6): 435-440
Carriere, C.H.; Kang, N.H.; Niles, L.P. 2014: Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease. Neuroscience 267: 114-121
Bigdeli, M.R. 2011: Neuroprotection caused by hyperoxia preconditioning in animal stroke models. Thescientificworldjournal 11: 403-421
Röther, J. 2008: Neuroprotection does not work!. Stroke 39(2): 523-524
Conlon, N.; Grocott, H.P.; Mackensen, G.B. 2008: Neuroprotection during cardiac surgery. Expert Review of Cardiovascular Therapy 6(4): 503-520
Clair, D.G.; Hopkins, L.N.; Mehta, M.; Kasirajan, K.; Schermerhorn, M.; Schönholz, C.; Kwolek, C.J.; Eskandari, M.K.; Powell, R.J.; Ansel, G.M.; Bajwa, T.; Dattilo, J.B.; Dave, R.; Gray, B.H.; Gray, W.A.; Jordan, W.D.; Katzen, B.T.; Krajcer, Z.; Lurnsden, A.B.; Maldonado, T.; Myla, S.; Patel, A.; Ramee, S.; Rappard, G.; Rhee, R.Y.; Rubin, B.G.; Timaran, C.H.; Wheatley, G.H.; Woo, E.Y. 2011: Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 77(3): 420-429
Hu, M.H.; Zheng, Q.F.; Jia, X.Z.; Li, Y.; Dong, Y.C.; Wang, C.Y.; Lin, Q.Y.; Zhang, F.Y.; Zhao, R.B.; Xu, H.W.; Zhou, J.H.; Yuan, H.P.; Zhang, W.H.; Ren, H. 2014: Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation. Clinical and Experimental Immunology 175(2): 268-284
Morente, Vónica.; Pérez-Sen, R.; Ortega, F.; Huerta-Cepas, J.; Delicado, E.G.; Miras-Portugal, M.Teresa. 2014: Neuroprotection elicited by P2Y13 receptors against genotoxic stress by inducing DUSP2 expression and MAPK signaling recovery. Biochimica et Biophysica Acta 1843(9): 1886-1898
Ding, D. 2015: Neuroprotection following acute ischemic stroke: efficacy of preconditioning and antioxidants. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 36(4): 631-632
Belohlávek, J.; Smíd, O. 2009: Neuroprotection following cardiac arrest and early post-resuscitation care. Vnitrni Lekarstvi 55(11): 1011-1013
Hersch, S.M.; Rosas, H.D. 2008: Neuroprotection for Huntington's disease: ready, set, slow. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 5(2): 226-236
Pandya, R.S.; Mao, L.L.J.; Zhou, E.W.; Bowser, R.; Zhu, Z.; Zhu, Y.; Wang, X. 2012: Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy. Central Nervous System Agents in Medicinal Chemistry 12(1): 15-27
Imai, H.; Singh, R.S.J.; Fort, P.E.; Gardner, T.W. 2009: Neuroprotection for diabetic retinopathy. Developments in Ophthalmology 44: 56-68
Moretti, A.; Ferrari, F.; Villa, R.F. 2015: Neuroprotection for ischaemic stroke: current status and challenges. Pharmacology and Therapeutics 146: 23-34
Turner, R.C.; Lucke-Wold, B.; Lucke-Wold, N.; Elliott, A.S.; Logsdon, A.F.; Rosen, C.L.; Huber, J.D. 2013: Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions. International Journal of Molecular Sciences 14(1): 1890-1917
Ginsberg, M.D. 2008: Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55(3): 363-389
Bessero, A.-C.; Clarke, P.G.H. 2010: Neuroprotection for optic nerve disorders. Current Opinion in Neurology 23(1): 10-15
Park, S.B.; Goldstein, D.; Lin, C.S.-Y.; Krishnan, A.V.; Friedlander, M.L.; Kiernan, M.C. 2011: Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29(18): E553
Maitre, N.L.; Stark, A.R. 2012: Neuroprotection for premature infants?: another perspective on caffeine. JAMA 307(3): 304-305
Huckfeldt, R.M.; Vavvas, D.G. 2013: Neuroprotection for retinal detachment. International Ophthalmology Clinics 53(4): 105-117
Minnerup, J.; Sutherland, B.A.; Buchan, A.M.; Kleinschnitz, C. 2012: Neuroprotection for stroke: current status and future perspectives. International Journal of Molecular Sciences 13(9): 11753-11772
Lewis, M.D.; Bailes, J. 2011: Neuroprotection for the warrior: dietary supplementation with omega-3 fatty acids. Military Medicine 176(10): 1120-1127
Loane, D.J.; Faden, A.I. 2010: Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends in Pharmacological Sciences 31(12): 596-604
Sena, D.F.; Lindsley, K. 2013: Neuroprotection for treatment of glaucoma in adults. Cochrane Database of Systematic Reviews 2: Cd006539
Harris, W.; Sachana, M.; Flaskos, J.; Hargreaves, A.J. 2009: Neuroprotection from diazinon-induced toxicity in differentiating murine N2a neuroblastoma cells. Neurotoxicology 30(6): 958-964
Yokota, H.; Narayanan, S.P.; Zhang, W.; Liu, H.; Rojas, M.; Xu, Z.; Lemtalsi, T.; Nagaoka, T.; Yoshida, A.; Brooks, S.E.; Caldwell, R.W.; Caldwell, R.B. 2011: Neuroprotection from retinal ischemia/reperfusion injury by NOX2 NADPH oxidase deletion. Investigative Ophthalmology and Visual Science 52(11): 8123-8131
Adelson, J.D.; Barreto, G.E.; Xu, L.; Kim, T.; Brott, B.K.; Ouyang, Y.-B.; Naserke, T.; Djurisic, M.; Xiong, X.; Shatz, C.J.; Giffard, R.G. 2012: Neuroprotection from stroke in the absence of MHCi or PirB. Neuron 73(6): 1100-1107
Chaturvedi, M.; Figiel, I.; Sreedhar, B.; Kaczmarek, L. 2012: Neuroprotection from tissue inhibitor of metalloproteinase-1 and its nanoparticles. Neurochemistry International 61(7): 1065-1071
Schapira, A.H.V. 2009: Neuroprotection in Parkinson's disease. Parkinsonism and Related Disorders 15(Suppl 4): S41-S43
Rákóczi, K.ár.; Klivényi, P.ét.; Vécsei, L.ás.á 2009: Neuroprotection in Parkinson's disease and other neurodegenerative disorders: preclinical and clinical findings. Ideggyogyaszati Szemle 62(1-2): 25-34
Galati, S.; Di Giovanni, G. 2010: Neuroprotection in Parkinson's disease: a realistic goal?. Cns Neuroscience and Therapeutics 16(6): 327-329
Linazasoro, G.; Sesar, A.; Valldeoriola, F.; Compta, Y.; Herrero, M.T.; Martínez Castrillo, J.C.; López Lozano, J.J.; Bergaretxe, A.; Vela, L.; Fernández, J.M.; Castro, A.; Kulisevski, J.; Lezcano, E.; Vaamonde, J.; López Del Val, J.; Chacón, J.; Vivancos, F.; Luquin, R.; Aguilar, M.; Burguera, J.A.; Salvador, C.; Menéndez Guisasola, L.; Catalán, M.J.; Mir, P.; Campos, V.; Grandas, F.; Mínguez, A.; Balaguer, E.; Yáñez, R.; Leiva, C.; García Ruiz, P.; Cubo, E. 2009: Neuroprotection in Parkinson's disease: analysis though group of experts' methodology. Neurologia 24(2): 113-124
Stocchi, F. 2007: Neuroprotection in Parkinson's disease: clinical trials. Handbook of Clinical Neurology 84: 17-29
Linazasoro, G.J. 2002: Neuroprotection in Parkinson's disease: love story or mission impossible?. Expert Review of Neurotherapeutics 2(3): 403-416
Voss, T.; Ravina, B. 2008: Neuroprotection in Parkinson's disease: myth or reality?. Current Neurology and Neuroscience Reports 8(4): 304-309
Andropoulos, D.B.; Brady, K.M.; Easley, R.B.; Fraser, C.D. 2010: Neuroprotection in Pediatric Cardiac Surgery: what is on the Horizon?. Progress in Pediatric Cardiology 29(2): 113-122
Huang, R.; Han, L.; Li, J.; Ren, F.; Ke, W.; Jiang, C.; Pei, Y. 2009: Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles. Journal of Gene Medicine 11(9): 754-763
Lidster, K.; Jackson, S.J.; Ahmed, Z.; Munro, P.; Coffey, P.; Giovannoni, G.; Baker, M.D.; Baker, D. 2013: Neuroprotection in a novel mouse model of multiple sclerosis. Plos one 8(11): E79188
Vinukonda, G.; Csiszar, A.; Hu, F.; Dummula, K.; Pandey, N.K.; Zia, M.T.; Ferreri, N.R.; Ungvari, Z.; LaGamma, E.F.; Ballabh, P. 2010: Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition. Brain: a Journal of Neurology 133(Part 8): 2264-2280
Werner, C. 2010: Neuroprotection in acute cerebral ischemia: can we improve clinical outcomes?. Best Practice and Research. Clinical Anaesthesiology 24(4): Vii-Vix
Auriel, E.; Bornstein, N.M. 2010: Neuroprotection in acute ischemic stroke--current status. Journal of Cellular and Molecular Medicine 14(9): 2200-2202
Shuaib, A. 2006: Neuroprotection in acute ischemic stroke: are we there yet?. International Journal of Stroke: Official Journal of the International Stroke Society 1(2): 100-101
Murri, L. 2010: Neuroprotection in amyotrophic lateral sclerosis: from pathology to treatment. Cns and Neurological Disorders Drug Targets 9(3): 258
Pérez de la Ossa, N.; Dávalos, A. 2007: Neuroprotection in cerebral infarction: the opportunity of new studies. Cerebrovascular Diseases 24(Suppl 1): 153-156
Chacon, M.R.; Jensen, M.B.; Sattin, J.A.; Zivin, J.A. 2008: Neuroprotection in cerebral ischemia: emphasis on the SAINT trial. Current Cardiology Reports 10(1): 37-42
Fazeli, S.A. 2009: Neuroprotection in diabetic encephalopathy. Neuro-Degenerative Diseases 6(5-6): 213-218
Walker, M. 2007: Neuroprotection in epilepsy. Epilepsia 48 Suppl. 8: 66-68
Fu, A.; Hui, E.K.-W.; Lu, J.Z.; Boado, R.J.; Pardridge, W.M. 2010: Neuroprotection in experimental stroke in the rat with an IgG-erythropoietin fusion protein. Brain Research 1360: 193-197
Vasudevan, S.K.; Gupta, V.; Crowston, J.G. 2011: Neuroprotection in glaucoma. Indian Journal of Ophthalmology 59 Suppl: S102-S113
Tamm, E.R.; Grehn, F.; Pfeiffer, N. 2013: Neuroprotection in glaucoma. Cell and Tissue Research 353(2): 201-203
Baltmr, A.; Duggan, J.; Nizari, S.; Salt, T.E.; Cordeiro, M.F. 2010: Neuroprotection in glaucoma - Is there a future role?. Experimental Eye Research 91(5): 554-566
Govindarajan, B.; Laird, J.; Sherman, R.; Salomon, R.G.; Bhattacharya, S.K. 2008: Neuroprotection in glaucoma using calpain-1 inhibitors: regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics. Cns and Neurological Disorders Drug Targets 7(3): 295-304
Dimovska-Jordanova, A. 2012: Neuroprotection in glaucoma--delusion, reality or hope?. Prilozi 33(2): 163-173
Cheung, W.; Guo, L.; Cordeiro, M.F. 2008: Neuroprotection in glaucoma: drug-based approaches. Optometry and Vision Science: Official Publication of the American Academy of Optometry 85(6): 406-416
Kountouras, J.; Zavos, C.; Deretzi, G.; Polyzos, S.A.; Gavalas, E.; Tsiaousi, E.; Giartza-Taxidou, E.; Chatzopoulos, D.; Michael, S.; Tsarouchas, G. 2011: Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication?. Experimental Eye Research 92(5): 436-438
Chen, S.-d.; Wang, L.; Zhang, X.-l. 2013: Neuroprotection in glaucoma: present and future. Chinese Medical Journal 126(8): 1567-1577
Danesh-Meyer, H.V. 2011: Neuroprotection in glaucoma: recent and future directions. Current Opinion in Ophthalmology 22(2): 78-86
Shishkova, V.N. 2014: Neuroprotection in hypertensive patients: minimization of poor prognosis. Terapevticheskii Arkhiv 86(8): 113-118
Clancy, R.R. 2008: Neuroprotection in infant heart surgery. Clinics in Perinatology 35(4): 809
Padmanabhan, A.; Haldar, S.M. 2014: Neuroprotection in ischemic stroke: AhR we making progress?. Circulation 130(23): 2002-2004
Maghzi, A.-H.; Minagar, A.; Waubant, E. 2013: Neuroprotection in multiple sclerosis: a therapeutic approach. Cns Drugs 27(10): 799-815
Van der Walt, A.; Butzkueven, H.; Kolbe, S.; Marriott, M.; Alexandrou, E.; Gresle, M.; Egan, G.; Kilpatrick, T. 2010: Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade. Pharmacology and Therapeutics 126(1): 82-93
Legido, A.ín.; Valencia, I.; Katsetos, C.D.; Delivoria-Papadopoulos, M.ía. 2007: Neuroprotection in perinatal hypoxic-ischemic encephalopathy. Effective treatment and future perspectives. Medicina 67(6 Part 1): 543-555
Belcastro, V. 2011: Neuroprotection in post-stroke epilepsy: a realistic goal?. Seizure 20(8): 665
So, K.F.; Tang, S.W.; Lee, T.M.C. 2012: Neuroprotection in steroid therapy: a rodent model. Hong Kong Medical Journal 18(Suppl 3): 20-23
Khurana, D.; Bal, S. 2009: Neuroprotection in stroke. Journal of the Indian Medical Association 107(6): 378-82 391
Arumugam, T.V.; Woodruff, T.M.; Lathia, J.D.; Selvaraj, P.K.; Mattson, M.P.; Taylor, S.M. 2009: Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience 158(3): 1074-1089
Fu, A.; Hui, E.K.-W.; Lu, J.Z.; Boado, R.J.; Pardridge, W.M. 2011: Neuroprotection in stroke in the mouse with intravenous erythropoietin-Trojan horse fusion protein. Brain Research 1369: 203-207
Majid, A. 2014: Neuroprotection in stroke: past, present, and future. Isrn Neurology 2014: 515716
Laskowitz, D.T.; Kolls, B.J. 2010: Neuroprotection in subarachnoid hemorrhage. Stroke 41(10 Suppl): S79-S84
Witt, C.L. 2013: Neuroprotection in the NICU. Advances in Neonatal Care: Official Journal of the National Association of Neonatal Nurses 13(Suppl 5): S1
Hermann, D.M.; Bassetti, C.L. 2007: Neuroprotection in the SAINT-II aftermath. Annals of neurology 62(6): 677-8; author reply 678
Gonzalez, F.F.; Ferriero, D.M. 2009: Neuroprotection in the newborn infant. Clinics in Perinatology 36(4): 859
Zipp, F.; Gold, R. 2011: Neuroprotection in the treatment of multiple sclerosis. Der Nervenarzt 82(8): 973-977
Kaptigau, W.M. 2007: Neuroprotection in traumatic brain injury: practical implications for Papua new Guinea and some research developments. Papua and new Guinea Medical Journal 50(1-2): 67-71
Nazıroğlu, M.; Ciğ, B.; Ozgül, C. 2013: Neuroprotection induced by N-acetylcysteine against cytosolic glutathione depletion-induced Ca2+ influx in dorsal root ganglion neurons of mice: role of TRPV1 channels. Neuroscience 242: 151-160
Nazıroğlu, M.; Senol, N.ün.; Ghazizadeh, V.; Yürüker, V. 2014: Neuroprotection induced by N-acetylcysteine and selenium against traumatic brain injury-induced apoptosis and calcium entry in hippocampus of rat. Cellular and Molecular Neurobiology 34(6): 895-903
Crouzin, N.; Ferreira, M.-C.él.d.J.; Cohen-Solal, C.; Barbanel, G.ér.; Guiramand, J.; Vignes, M. 2010: Neuroprotection induced by vitamin e against oxidative stress in hippocampal neurons: involvement of TRPV1 channels. Molecular Nutrition and Food Research 54(4): 496-505
Prasad, S.S.; Russell, M.; Nowakowska, M. 2011: Neuroprotection induced in vitro by ischemic preconditioning and postconditioning: modulation of apoptosis and PI3K-Akt pathways. Journal of Molecular Neuroscience: Mn 43(3): 428-442
Akram, A.; Gibson, C.L.; Grubb, B.D. 2013: Neuroprotection mediated by the EP₄ receptor avoids the detrimental side effects of COX-2 inhibitors following ischaemic injury. Neuropharmacology 65: 165-172
Li, H.; Park, J.H.; Yan, B.; Yoo, K.-Y.; Lee, C.H.; Choi, J.H.; Hwang, I.K.; Won, M.-H. 2011: Neuroprotection of Alpinia katsumadai Seed Extract against Neuronal Damage in the Ischemic Gerbil Hippocampus is Linked to Altered Brain-Derived Neurotrophic Factor. Laboratory Animal Research 27(1): 67-71
Sun, Y.-F.; Pei, D.-S.; Zhang, Q.-X.; Zhang, G.-Y. 2008: Neuroprotection of GST, an extract of traditional Chinese herb, against ischemic brain injury induced by transient brain ischemia and reperfusion in rat hippocampus. Neurological Research 30(5): 471-475
Lv, Q.; Liu, Y.; Han, D.; Xu, J.; Zong, Y.-Y.; Wang, Y.; Zhang, G.-Y. 2012: Neuroprotection of GluK1 kainate receptor agonist ATPA against ischemic neuronal injury through inhibiting GluK2 kainate receptor-JNK3 pathway via GABA(A) receptors. Brain Research 1456: 1-13
Xu, J.; Liu, Y.; Zhang, G-Yi. 2008: Neuroprotection of GluR5-containing kainate receptor activation against ischemic brain injury through decreasing tyrosine phosphorylation of N-methyl-D-aspartate receptors mediated by Src kinase. Journal of Biological Chemistry 283(43): 29355-29366
Wei, G.; Lu, X.-C.M.; Shear, D.A.; Yang, X.; Tortella, F.C. 2011: Neuroprotection of Selective Brain Cooling After Penetrating Ballistic-like Brain Injury in Rats. Therapeutic Hypothermia and Temperature Management 1(1): 33-42
Zheng, X-Rong.; Zhang, S-Shan.; Yin, F.; Tang, J-Lu.; Yang, Y-Jia.; Wang, X.; Zhong, L. 2012: Neuroprotection of VEGF-expression neural stem cells in neonatal cerebral palsy rats. Behavioural Brain Research 230(1): 108-115
Jiang, H.; Jin, W.-L.; Jin, D.-D.; Chen, J.-T. 2011: Neuroprotection of a neotype transactivating-brain-derived neurotrophic factor fusion protein with penetrating activity of blood-brain barrier. Zhonghua Yi Xue Za Zhi 91(25): 1786-1790
Cheng, H.; Ding, Y.; Yu, R.; Chen, J.; Wu, C. 2014: Neuroprotection of a novel cyclopeptide C*HSDGIC* from the cyclization of PACAP (1-5) in cellular and rodent models of retinal ganglion cell apoptosis. Plos one 9(10): E108090
Lee, J.-C.; Won, M.-H. 2014: Neuroprotection of antioxidant enzymes against transient global cerebral ischemia in gerbils. Anatomy and Cell Biology 47(3): 149-156
Liu, C.; Zhao, H.; Ji, Z.-H.; Yu, X.-Y. 2014: Neuroprotection of atractylenolide IIi from Atractylodis macrocephalae against glutamate-induced neuronal apoptosis via inhibiting caspase signaling pathway. Neurochemical Research 39(9): 1753-1758
Wei, X-Wen.; Yan, H.; Xu, B.; Wu, Y-Ping.; Li, C.; Zhang, G-Yi. 2012: Neuroprotection of co-activation of GABA receptors by preventing caspase-3 denitrosylation in KA-induced seizures. Brain Research Bulletin 88(6): 617-623
Guizar-Sahagun, G.; Grijalva, I.; Madrazo, I.; Franco-Bourland, R.; Salgado-Ceballos, H.; Ibarra, A.; Larriva-Sahd, J. 1994: Neuroprotection of completely lacerated spinal cord of adult rats by homotopic and heterotopic transplantation. Restorative Neurology and Neuroscience 7(2): 61-70
Wu, Y.; Li, X.; Xie, W.; Jankovic, J.; Le, W.; Pan, T. 2010: Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochemistry International 57(3): 198-205
Zhang, Z.; Zhang, K.; Du, X.; Li, Y. 2012: Neuroprotection of desferrioxamine in lipopolysaccharide-induced nigrostriatal dopamine neuron degeneration. Molecular Medicine Reports 5(2): 562-566
Rabiei, Z.; Bigdeli, M.R.; Rasoulian, B. 2013: Neuroprotection of dietary virgin olive oil on brain lipidomics during stroke. Current Neurovascular Research 10(3): 231-237
Cui, L.; Zhang, X.; Yang, R.; Wang, L.; Liu, L.; Li, M.; Du, W. 2010: Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Brain Research 1325: 164-173
Zhang, X.; Zhang, X.; Wang, C.; Li, Y.; Dong, L.; Cui, L.; Wang, L.; Liu, Z.; Qiao, H.; Zhu, C.; Xing, Y.; Cao, X.; Ji, Y.; Zhao, K. 2012: Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability. Brain Research 1459: 61-70
Seo, J.Y.; Lee, C.H.; Cho, J.H.; Choi, J.H.; Yoo, K.-Y.; Kim, D.W.; Park, O.K.; Li, H.; Choi, S.Y.; Hwang, I.K.; Won, M.-H. 2009: Neuroprotection of ebselen against ischemia/reperfusion injury involves GABA shunt enzymes. Journal of the Neurological Sciences 285(1-2): 88-94
Qi, S.-H.; Liu, Y.; Wang, W.-W.; Wang, M.; Zhang, G.-Y. 2009: Neuroprotection of ethanol against cerebral ischemia/reperfusion induced brain injury through GABA receptor activation. Brain Research 1276: 151-158
Qi, S.-H.; Liu, Y.; Hao, L.-Y.; Guan, Q.-H.; Gu, Y.-H.; Zhang, J.; Yan, H.; Wang, M.; Zhang, G.-Y. 2010: Neuroprotection of ethanol against ischemia/reperfusion-induced brain injury through decreasing c-Jun N-terminal kinase 3 (JNK3) activation by enhancing GABA release. Neuroscience 167(4): 1125-1137
Zhou, C.; Li, C.; Yu, H.-M.; Zhang, F.; Han, D.; Zhang, G.-Y. 2008: Neuroprotection of gamma-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia. Journal of Neuroscience Research 86(13): 2973-2983
Lu, F.; Nakamura, T.; Toyoshima, T.; Liu, Y.; Shinomiya, A.; Hirooka, K.; Okabe, N.; Miyamoto, O.; Tamiya, T.; Keep, R.F.; Itano, T. 2014: Neuroprotection of granulocyte colony-stimulating factor during the acute phase of transient forebrain ischemia in gerbils. Brain Research 1548: 49-55
Juan, Y.-S.; Chuang, S.-M.; Long, C.-Y.; Chen, C.-H.; Levin, R.M.; Liu, K.-M.; Huang, C.-H. 2012: Neuroprotection of green tea catechins on surgical menopause-induced overactive bladder in a rat model. Menopause 19(3): 346-354
Tamaki, S.J.; Jacobs, Y.; Dohse, M.; Capela, A.; Cooper, J.D.; Reitsma, M.; He, D.; Tushinski, R.; Belichenko, P.V.; Salehi, A.; Mobley, W.; Gage, F.H.; Huhn, S.; Tsukamoto, A.S.; Weissman, I.L.; Uchida, N. 2009: Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell 5(3): 310-319
Sun, L.; Yang, L.; Xu, Y.-W.; Liang, H.; Han, J.; Zhao, R.-J.; Cheng, Y. 2012: Neuroprotection of hydroxysafflor yellow a in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption. Brain Research 1473: 227-235
Liu, Z.; Qiu, Y.-H.; Li, B.; Ma, S.-H.; Peng, Y.-P. 2011: Neuroprotection of interleukin-6 against NMDA-induced apoptosis and its signal-transduction mechanisms. Neurotoxicity Research 19(3): 484-495
Liu, J.; Xu, Q.; Wang, H.; Wang, R.; Hou, X.-Y. 2013: Neuroprotection of ischemic postconditioning by downregulating the postsynaptic signaling mediated by kainate receptors. Stroke 44(7): 2031-2035
Filomeni, G.; Graziani, I.; De Zio, D.; Dini, L.; Centonze, D.; Rotilio, G.; Ciriolo, M.R. 2012: Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease. Neurobiology of Aging 33(4): 767-785
Yi, Y.-H.; Guo, W.-C.; Sun, W.-W.; Su, T.; Lin, H.; Chen, S.-Q.; Deng, W.-Y.; Zhou, W.; Liao, W.-P. 2008: Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses. Biologics: Targets and Therapy 2(2): 339-344
Margaryan, G.; Mattioli, C.; Mladinic, M.; Nistri, A. 2010: Neuroprotection of locomotor networks after experimental injury to the neonatal rat spinal cord in vitro. Neuroscience 165(3): 996-1010
Pfeiffer, N.; Lamparter, J.; Gericke, A.; Grus, F.H.; Hoffmann, E.M.; Wahl, J. 2013: Neuroprotection of medical IOP-lowering therapy. Cell and Tissue Research 353(2): 245-251
Wang, C.; Ji, B.; Cheng, B.; Chen, J.; Bai, B. 2014: Neuroprotection of microRNA in neurological disorders (Review). Biomedical Reports 2(5): 611-619
Eleuteri, S.; Polazzi, E.; Contestabile, A. 2008: Neuroprotection of microglia conditioned media from apoptotic death induced by staurosporine and glutamate in cultures of rat cerebellar granule cells. Neuroscience Letters 448(1): 74-78
Polazzi, E.; Altamira, L.E.P.ña.; Eleuteri, S.; Barbaro, R.; Casadio, C.; Contestabile, A.; Monti, B. 2009: Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2. Journal of Neurochemistry 110(2): 545-556
Shaw, V.E.; Spana, S.; Ashkan, K.; Benabid, A.-L.; Stone, J.; Baker, G.E.; Mitrofanis, J. 2010: Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment. Journal of Comparative Neurology 518(1): 25-40
Zheng, J.; Li, H.; Guo, R.; Chen, R.; Lin, S.; Liu, M.; You, C. 2015: Neuroprotection of nalmefene for postoperative patients with spontaneous intracerebral hemorrhage. International Journal of Neuroscience 125(12): 918-923
Qi, S.-H.; Zhao, H.; Gong, J.-J.; Sun, F.-M.; Yue, J.; Guan, Q.-H.; Wang, M. 2011: Neuroprotection of paclitaxel against cerebral ischemia/reperfusion-induced brain injury through JNK3 signaling pathway. Journal of Receptor and Signal Transduction Research 31(6): 402-407
Rex, T.S.; Wong, Y.; Kodali, K.; Merry, S. 2009: Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Experimental Eye Research 89(5): 735-740
Yan, B.C.; Park, J.H.; Ahn, J.H.; Kim, I.H.; Park, O.K.; Lee, J.-C.; Yoo, K.-Y.; Choi, J.H.; Lee, C.H.; Hwang, I.K.; Park, J.H.; Her, S.; Kim, J.S.; Shin, H.-C.; Cho, J.H.; Kim, Y.-M.; Kwon, S.-H.; Won, M.-H. 2014: Neuroprotection of posttreatment with risperidone, an atypical antipsychotic drug, in rat and gerbil models of ischemic stroke and the maintenance of antioxidants in a gerbil model of ischemic stroke. Journal of Neuroscience Research 92(6): 795-807
Li, C.; Guo, Y.; Xie, W.; Li, X.; Janokovic, J.; Le, W. 2010: Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease. Neurochemical Research 35(10): 1546-1556
Du, Y.; Li, C.; Hu, W.-W.; Song, Y.-J.; Zhang, G.-Y. 2009: Neuroprotection of preconditioning against ischemic brain injury in rat hippocampus through inhibition of the assembly of GluR6-PSD95-mixed lineage kinase 3 signaling module via nuclear and non-nuclear pathways. Neuroscience 161(2): 370-380
Chen, R.; Li, G.-l. 2011: Neuroprotection of retinal degenerative disease by ciliary neurotrophic factor. Chinese Journal of Ophthalmology 47(6): 568-572
Xiao, J.-H.; Zhang, M.-N. 2010: Neuroprotection of retinal ganglion cells with GDNF-Loaded biodegradable microspheres in experimental glaucoma. International Journal of Ophthalmology 3(3): 189-191
Zhang, H.-j.; Wang, Z.-p.; Hu, S.-q.; Xu, M.; Jiang, S. 2008: Neuroprotection of sevoflurane against the ischemia injury in hippocampal slices of rat. Zhongguo Ying Yong Sheng Li Xue Za Zhi 24(4): 426-429
Liu, M.; Kelley, M.H.; Herson, P.S.; Hurn, P.D. 2010: Neuroprotection of sex steroids. Minerva Endocrinologica 35(2): 127-143
Ma, W.-w.; Xiang, L.; Yu, H.-L.; Yuan, L.-H.; Guo, A.-M.; Xiao, Y.-X.; Li, L.; Xiao, R. 2009: Neuroprotection of soyabean isoflavone co-administration with folic acid against beta-amyloid 1-40-induced neurotoxicity in rats. British Journal of Nutrition 102(4): 502-505
Chen, Y.; Wu, X.; Yu, S.; Lin, X.; Wu, J.; Li, L.; Zhao, J.; Zhao, Y. 2012: Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats. Plos one 7(6): E40165
Gao, X.; Yang, X.; Zhang, B. 2011: Neuroprotection of taurine against bilirubin-induced elevation of apoptosis and intracellular free calcium ion in vivo. Toxicology Mechanisms and Methods 21(5): 383-387
Saliba, E.; Favrais, G.ér.; Gressens, P. 2007: Neuroprotection of the newborn: from bench to cribside. Seminars in Fetal and Neonatal Medicine 12(4): 239-240
Liu, Y.; Li, Z.; Shi, X.; Liu, Y.; Li, W.; Duan, G.; Li, H.; Yang, X.; Zhang, C.; Zou, L. 2014: Neuroprotection of up-regulated carbon monoxide by electrical acupuncture on perinatal hypoxic-ischemic brain damage in rats. Neurochemical Research 39(9): 1724-1732
Choong, C.-J.; Say, Y.-H. 2011: Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K. Neurotoxicology 32(6): 857-863
Blanco, M.; Campos, F.; Rodríguez-Yáñez, M.; Arias, S.; Fernández-Ferro, J.é; Gómez-Sánchez, J.é C.; Castillo, J.é 2012: Neuroprotection or increased brain damage mediated by temperature in stroke is time dependent. Plos one 7(2): E30700
Zhang, S-nan.; Li, X-zhao.; wang, Y.; zhang, N.; Yang, Z-ming.; Liu, S-min.; Lu, F. 2014: Neuroprotection or neurotoxicity? new insights into the effects of Acanthopanax senticosus harms on nervous system through cerebral metabolomics analysis. Journal of Ethnopharmacology 15(6): 290-300
Cho, K.-i.; Yi, H.; Tserentsoodol, N.; Searle, K.; Ferreira, P.A. 2010: Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress. Disease Models and Mechanisms 3(9-10): 595-604
Ahn, J.-Y. 2014: Neuroprotection signaling of nuclear akt in neuronal cells. Experimental Neurobiology 23(3): 200-206
Nguyen, T.L.X.; Kim, C.K.; Cho, J.-H.; Lee, K.-H.; Ahn, J.-Y. 2010: Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR [corrected. Experimental and Molecular Medicine 42(8): 583-595
Liu, R.; Yuan, H.; Yuan, F.; Yang, S.-H. 2012: Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke. Neurological Research 34(4): 331-337
Saxena, S.; Roselli, F.; Singh, K.; Leptien, K.; Julien, J.-P.; Gros-Louis, F.; Caroni, P. 2013: Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 80(1): 80-96
Greco, T.; Fiskum, G. 2010: Neuroprotection through stimulation of mitochondrial antioxidant protein expression. Journal of Alzheimer's Disease: Jad 20(Suppl 2): S427-S437
Hart, R.G.; Pearce, L.A.; Ravina, B.M.; Yaltho, T.C.; Marler, J.R. 2009: Neuroprotection trials in Parkinson's disease: systematic review. Movement Disorders: Official Journal of the Movement Disorder Society 24(5): 647-654
Groenendaal, F.; Hukkelhoven, C.W.P.M.; de Vries, L.S.; van Bel, F. 2008: Neuroprotection using hypothermia after perinatal asphyxia in full-term neonates. Nederlands Tijdschrift Voor Geneeskunde 152(41): 2210-2212
Park, J.H.; Park, O.K.; Yan, B.; Ahn, J.H.; Kim, I.H.; Lee, J.-C.; Kwon, S.-H.; Yoo, K.-Y.; Lee, C.H.; Hwang, I.K.; Choi, J.H.; Won, M.-H.; Kim, J.-D. 2014: Neuroprotection via maintenance or increase of antioxidants and neurotrophic factors in ischemic gerbil hippocampus treated with tanshinone i. Chinese Medical Journal 127(19): 3396-3405
Picciotto, M.R.; Zoli, M. 2008: Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Frontiers in Bioscience: a Journal and Virtual Library 13: 492-504
Tanabe, M.; Nitta, A.; Ono, H. 2010: Neuroprotection via strychnine-sensitive glycine receptors during post-ischemic recovery of excitatory synaptic transmission in the hippocampus. Journal of Pharmacological Sciences 113(4): 378-386
Robertson, C.S.; Cherian, L.; Shah, M.; Garcia, R.; Navarro, J.C.; Grill, R.J.; Hand, C.C.; Tian, T.S.; Hannay, H.J. 2012: Neuroprotection with an erythropoietin mimetic peptide (pHBSP) in a model of mild traumatic brain injury complicated by hemorrhagic shock. Journal of Neurotrauma 29(6): 1156-1166
Frederick, J.R.; Chen, Z.; Bevers, M.B.; Ingleton, L.P.; Ma, M.; Neumar, R.W. 2008: Neuroprotection with delayed calpain inhibition after transient forebrain ischemia. Critical Care Medicine 36(11 Suppl): S481-S485
Zhang, J.; Wang, Q.; Xiang, H.; Xin, Y.; Chang, M.; Lu, H. 2014: Neuroprotection with erythropoietin in preterm and/or low birth weight infants. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 21(8): 1283-1287
Debillon, T.; Cantagrel, S.; Zupan-Simunek, V.; Gressens, P. 2008: Neuroprotection with hypothermia for hypoxic ischemic encephalopathy in term newborn: review of the learning. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 15(2): 157-161
Blanco, D.; García-Alix, A.; Valverde, E.; Tenorio, V.; Vento, M.; Cabañas, F.; Luna, M.Sánchez.; Botet, F.; Castro, J.R.; Echaniz, I.; Pallás, C.R.; Narbona, E. 2011: Neuroprotection with hypothermia in the newborn with hypoxic-ischaemic encephalopathy. Standard guidelines for its clinical application. Anales de Pediatria 75(5): 341.E1
Takeshima, Y.; Nakamura, M.; Miyake, H.; Tamaki, R.; Inui, T.; Horiuchi, K.; Wajima, D.; Nakase, H. 2011: Neuroprotection with intraventricular brain-derived neurotrophic factor in rat venous occlusion model. Neurosurgery 68(5): 1334-1341
Vavilala, M.S.; Sharma, D. 2012: Neuroprotection with phenylephrine in traumatic brain injury: cerebral perfusion or beyond?. Critical Care Medicine 40(8): 2515-2517
Hasseldam, H.; Johansen, F.F. 2010: Neuroprotection without immunomodulation is not sufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis. Neuroimmunomodulation 17(4): 252-264
Aktas, O.; Kieseier, B.; Hartung, H.-P. 2010: Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Trends in Neurosciences 33(3): 140-152
Bordet, R.ég.; Lestage, P.; Onteniente, B.; Bouhours, P.; Marlangue, C.C.; Chollet, F.ço.; Fouchard, M.; Goni, S.; Hommel, C.M.; Lacomblez, L.; Marquet, T.; Nieoullon, A.é; Pruss, R.; Quintin, P.; Rascol, O.; Stankoff, B.; Vray, M. 2007: Neuroprotection: Present and future. Therapie 62(6): 473-476
Pucci, S.; Mazzarelli, P.; Missiroli, F.; Regine, F.; Ricci, F. 2008: Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon. Progress in Brain Research 173: 555-573
Perkins, D.O. 2007: Neuroprotection: a new strategy in the treatment of schizophrenia. Early detection and intervention. Cns Spectrums 12(10 Suppl 18: 10-13
Lieberman, J.A. 2007: Neuroprotection: a new strategy in the treatment of schizophrenia. Neurobiological basis of neurodegeneration and neuroprotection. Cns Spectrums 12(10 Suppl 18: 4-6
Buckley, P.F. 2007: Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis. Cns Spectrums 12(10 Suppl 18: 7-10
Refinetti, R.; Kenagy, G.J. 2018: Circadian rhythms of body temperature and locomotor activity in the antelope ground squirrel, Ammospermophilus leucurus. Journal of Thermal Biology 72: 67-72
Lyden, P.D. 1997: Neuroprotection: before and after thrombolysis. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 6(4): 198-199
Danesh-Meyer, H.V.; Levin, L.A. 2009: Neuroprotection: extrapolating from neurologic diseases to the eye. American Journal of Ophthalmology 148(2): 186-191.E2
Traystman, R.J. 2010: Neuroprotection: introduction. Stroke 41(10 Suppl): S63
Bron, A. 2009: Neuroprotection: is it close to us?. Journal Francais d'Ophtalmologie 32(3): 217-220
Galpern, W.R.; Singhal, A.B. 2006: Neuroprotection: lessons from a spectrum of neurological disorders. International Journal of Stroke: Official Journal of the International Stroke Society 1(2): 97-99
Donnan, G.A.; Davis, S.M. 2008: Neuroprotection: still achievable in humans. Stroke 39(2): 525
Carletti, B.; Piemonte, F.; Rossi, F. 2011: Neuroprotection: the emerging concept of restorative neural stem cell biology for the treatment of neurodegenerative diseases. Current Neuropharmacology 9(2): 313-317
Yu, Q.; Wang, H.; Chen, J.; Gao, Y.; Liang, W. 2010: Neuroprotections and mechanisms of inhalational anesthetics against brain ischemia. Frontiers in Bioscience 2(4): 1275-1298
Basha, M.P.; Begum, S.; Mir, B.A. 2013: Neuroprotective Actions of Clinoptilolite and Ethylenediaminetetraacetic Acid Against Lead-induced Toxicity in Mice Mus musculus. Toxicology International 20(3): 201-207
Swamy, A.H.M.V.; Patel, N.L.; Gadad, P.C.; Koti, B.C.; Patel, U.M.; Thippeswamy, A.H.M.; Manjula, D.V. 2013: Neuroprotective Activity of Pongamia pinnata in Monosodium Glutamate-induced Neurotoxicity in Rats. Indian Journal of Pharmaceutical Sciences 75(6): 657-663
Yim, H.Ju.; Lim, J.Hwa.; Kim, M.Hee.; Namgung, U.; Lee, S.Ryong.; Jung, I.Chul. 2012: Neuroprotective Activity of Sibjeondaebo-tang on Aβ Peptide-Induced Damages. Evidence-Based Complementary and Alternative Medicine: Ecam 2012: 459894
Kim, H.J.; Kim, J.; Kang, K.S.; Lee, K.T.; Yang, H.O. 2014: Neuroprotective Effect of Chebulagic Acid via Autophagy Induction in SH-SY5Y Cells. Biomolecules and Therapeutics 22(4): 275-281
Park, H.-J.; Shim, H.S.; Choi, W.K.; Kim, K.S.; Bae, H.; Shim, I. 2011: Neuroprotective Effect of Lucium chinense Fruit on Trimethyltin-Induced Learning and Memory Deficits in the Rats. Experimental Neurobiology 20(3): 137-143
Weon, J.B.; Yun, B.-R.; Lee, J.; Eom, M.R.; Ko, H.-J.; Lee, H.Y.; Park, D.-S.; Chung, H.-C.; Chung, J.Y.; Ma, C.J. 2014: Neuroprotective Effect of Steamed and Fermented Codonopsis lanceolata. Biomolecules and Therapeutics 22(3): 246-253
Salavati, P.; Ramezani, M.; Monsef-Esfahani, H.R.; Hajiagha, R.; Parsa, M.; Tavajohi, S.; Ostad, S.N. 2013: Neuroprotective Effect of Total and Sequential Extract of Scrophularia striata Boiss. in Rat Cerebellar Granule Neurons Following Glutamate- Induced Neurotoxicity: An In-vitro Study. Iranian Journal of Pharmaceutical Research: Ijpr 12(2): 389-394
Hoveizi, E.; Tavakol, S.; Ebrahimi-Barough, S. 2015: Neuroprotective Effect of Transplanted Neural Precursors Embedded on PLA/CS Scaffold in an Animal Model of Multiple Sclerosis. Molecular Neurobiology 51(3): 1334-1342
Liu, C-Hsiang.; Lin, Y-Wen.; Tang, N-Ying.; Liu, H-Jan.; Hsieh, C-Liang. 2012: Neuroprotective Effect of Uncaria rhynchophylla in Kainic Acid-Induced Epileptic Seizures by Modulating Hippocampal Mossy Fiber Sprouting, Neuron Survival, Astrocyte Proliferation, and S100B Expression. Evidence-BasedComplementaryandAlternativeMedicine:Ecam 2012: 194790
Kwon, M.-S.; Lee, J.-K.; Park, S.-H.; Sim, Y.-B.; Jung, J.-S.; Won, M.-H.; Kim, S.-M.; Suh, H.-W. 2010: Neuroprotective Effect of Visnagin on Kainic Acid-induced Neuronal Cell Death in the Mice Hippocampus. Korean Journal of Physiology and Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology 14(5): 257-263
Kim, S.-J.; Lee, J.-H.; Chung, H.-S.; Song, J.-H.; Ha, J.; Bae, H. 2013: Neuroprotective Effects of AMP-Activated Protein Kinase on Scopolamine Induced Memory Impairment. Korean Journal of Physiology and Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology 17(4): 331-338
Lee, D.-H.; Lee, Y.J.; Kwon, K.H. 2010: Neuroprotective Effects of Astaxanthin in Oxygen-Glucose Deprivation in SH-SY5Y Cells and Global Cerebral Ischemia in Rat. Journal of Clinical Biochemistry and Nutrition 47(2): 121-129
Kumar, A.; Dogra, S.; Prakash, A. 2009: Neuroprotective Effects of Centella asiatica against Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress. International Journal of Alzheimer's Disease 2009
Cordaro, M.; Impellizzeri, D.; Paterniti, I.; Bruschetta, G.; Siracusa, R.; De Stefano, D.; Cuzzocrea, S.; Esposito, E. 2016: Neuroprotective Effects of Co-UltraPEALut on Secondary Inflammatory Process and Autophagy Involved in Traumatic Brain Injury. Journal of Neurotrauma 33(1): 132-146
Liu, J.; Gao, J.; Tu, S.; Xu, S.; Liu, Y.; Shang, W.; Gu, C.; Huang, Y.; Han, M. 2014: Neuroprotective Effects of Jitai Tablet, a Traditional Chinese Medicine, on the MPTP-Induced Acute Model of Parkinson's Disease: Involvement of the Dopamine System. Evidence-Based Complementary and Alternative Medicine: Ecam 2014: 542383
Lo, Y-Ching.; Shih, Y-Tzu.; Tseng, Y-Ting.; Hsu, H-Te. 2012: Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In Vivo. Evidence-Based Complementary and Alternative Medicine: Ecam 2012: 501032
Yang, G.; Park, D.; Lee, S.H.; Bae, D.-K.; Yang, Y.-H.; Kyung, J.; Kim, D.; Choi, E.-K.; Hong, J.T.; Jeong, H.-S.; Kim, H.J.; Jang, S.K.; Joo, S.S.; Kim, Y.-B. 2013: Neuroprotective Effects of a Butanol Fraction of Rosa hybrida Petals in a Middle Cerebral Artery Occlusion Model. Biomolecules and Therapeutics 21(6): 454-461
Zhang, S.; Gui, X.-H.; Huang, L.-P.; Deng, M.-Z.; Fang, R.-M.; Ke, X.-H.; He, Y.-P.; Li, L.; Fang, Y.-Q. 2016: Neuroprotective Effects of β-Asarone Against 6-Hydroxy Dopamine-Induced Parkinsonism via JNK/Bcl-2/Beclin-1 Pathway. Molecular Neurobiology 53(1): 83-94
Xu, J.; Guo, P.; Liu, C.; Sun, Z.; Gui, L.; Guo, Y.; Yamakuni, T.; Ohizumi, Y. 2011: Neuroprotective Kaurane Diterpenes from Fritillaria ebeiensis. Bioscience Biotechnology and Biochemistry 75(7): 1386-1388
Zhao, S.-T.; Zhao, L.; Li, J.-H. 2013: Neuroprotective Peptide humanin inhibits inflammatory response in astrocytes induced by lipopolysaccharide. Neurochemical Research 38(3): 581-588
Uppalapati, D.; Das, N.R.; Gangwal, R.P.; Damre, M.V.; Sangamwar, A.T.; Sharma, S.S. 2014: Neuroprotective Potential of Peroxisome Proliferator Activated Receptor- α Agonist in Cognitive Impairment in Parkinson's Disease: Behavioral, Biochemical, and PBPK Profile. Ppar Research 2014: 753587
Gómez del Rio, M.A.; Sánchez-Reus, M.I.; Iglesias, I.; Pozo, M.A.; García-Arencibia, M.; Fernández-Ruiz, J.; García-García, L.; Delgado, M.; Benedí, J. 2013: Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease. Cns and Neurological Disorders Drug Targets 12(5): 665-679
Swanson, C.R.; Du, E.; Johnson, D.A.; Johnson, J.A.; Emborg, M.E. 2013: Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTP. PPAR research 2013: 582809
Calou, I.; Bandeira, M.A.; Aguiar-Galvão, W.; Cerqueira, G.; Siqueira, R.; Neves, K.R.; Brito, G.A.; Viana, G. 2014: Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson's Disease Model in Rats. Parkinson's Disease 2014: 519615
Sinha, A.; Tamboli, R.S.; Seth, B.; Kanhed, A.M.; Tiwari, S.Kant.; Agarwal, S.; Nair, S.; Giridhar, R.; Chaturvedi, R.Kumar.; Yadav, M.Ram. 2015: Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease. Molecular Neurobiology 52(1): 638-652
Singh, S.K.; Sinha, P.; Mishra, L.; Srikrishna, S. 2013: Neuroprotective Role of a Novel Copper Chelator against Aβ 42 Induced Neurotoxicity. International Journal of Alzheimer's Disease 2013: 567128
Theendakara, V.; Patent, A.; Peters Libeu, C.A.; Philpot, B.; Flores, S.; Descamps, O.; Poksay, K.S.; Zhang, Q.; Cailing, G.; Hart, M.; John, V.; Rao, R.V.; Bredesen, D.E. 2013: Neuroprotective Sirtuin ratio reversed by ApoE4. Proceedings of the National Academy of Sciences of the United States of America 110(45): 18303-18308
Darras, F.H.; Kling, B.; Heilmann, J.ör.; Decker, M. 2012: Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer. Acs Medicinal Chemistry Letters 3(11): 914-919
Kwon, J.; Hiep, N.T.; Kim, D.-W.; Hwang, B.Y.; Lee, H.J.; Mar, W.; Lee, D. 2014: Neuroprotective Xanthones from the Root Bark of Cudrania tricuspidata. Journal of Natural Products 77(8): 1893-1901
Chwiej, J.; Janeczko, K.; Marciszko, M.; Czyzycki, M.; Rickers, K.; Setkowicz, Z. 2010: Neuroprotective action of FK-506 (tacrolimus) after seizures induced with pilocarpine: quantitative and topographic elemental analysis of brain tissue. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 15(2): 283-289
Da Silva, G.G.P.; Zanoni, J.N.; Buttow, N.C. 2011: Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World Journal of Gastroenterology 17(7): 898-905
Kim, C.R.; Jeon, H.L.; Shin, S.K.; Kim, H.J.; Ahn, C.-W.; Jung, S.U.; Park, S.-H.; Kim, M.R. 2014: Neuroprotective action of deer bone extract against glutamate or Aβ₁₋₄₂-induced oxidative stress in mouse hippocampal cells. Journal of Medicinal Food 17(2): 226-235
Tanaka, M.; Yamazaki, M.; Chiba, K. 2009: Neuroprotective action of genipin on tunicamycin-induced cytotoxicity in neuro2a cells. Biological and Pharmaceutical Bulletin 32(7): 1220-1223
Chiu, C.-T.; Chuang, D.-M. 2011: Neuroprotective action of lithium in disorders of the central nervous system. Zhong Nan da Xue Xue Bao. Yi Xue Ban 36(6): 461-476
Rzemieniec, J.; Litwa, E.; Wnuk, A.; Lason, W.; Gołas, A.; Krzeptowski, W.; Kajta, M. 2015: Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling. Journal of Steroid Biochemistry and Molecular Biology 146: 26-37
Bastianetto, S.ép.; Ménard, C.; Quirion, R.ém. 2015: Neuroprotective action of resveratrol. Biochimica et Biophysica Acta 1852(6): 1195-1201
Rey, M.; Kruse, M.ía.S.; Alvarez, L.D.; Ghini, A.A.; Veleiro, A.S.; Burton, G.; Coirini, H.éc. 2013: Neuroprotective action of synthetic steroids with oxygen bridge. Activity on GABAA receptor. Experimental Neurology 249: 49-58
Sun, M.; Zhao, Y.; Gu, Y.; Xu, C. 2010: Neuroprotective actions of aminoguanidine involve reduced the activation of calpain and caspase-3 in a rat model of stroke. Neurochemistry International 56(4): 634-641
Fargo, K.N.; Foecking, E.M.; Jones, K.J.; Sengelaub, D.R. 2009: Neuroprotective actions of androgens on motoneurons. Frontiers in Neuroendocrinology 30(2): 130-141
Saldanha, C.J.; Duncan, K.A.; Walters, B.J. 2009: Neuroprotective actions of brain aromatase. Frontiers in Neuroendocrinology 30(2): 106-118
Etgen, A.M.; Jover-Mengual, T.; Zukin, R.Suzanne. 2011: Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications. Frontiers in Neuroendocrinology 32(3): 336-352
Azcoitia, I.ñi.; Arevalo, M.-A.; De Nicola, A.F.; Garcia-Segura, L.M. 2011: Neuroprotective actions of estradiol revisited. Trends in Endocrinology and Metabolism: Tem 22(12): 467-473
Gutierrez-Merino, C.; Lopez-Sanchez, C.; Lagoa, R.; Samhan-Arias, A.K.; Bueno, C.; Garcia-Martinez, V. 2011: Neuroprotective actions of flavonoids. Current Medicinal Chemistry 18(8): 1195-1212
Frago, L.M.; Baquedano, E.; Argente, J.ús.; Chowen, J.A. 2011: Neuroprotective actions of ghrelin and growth hormone secretagogues. Frontiers in Molecular Neuroscience 4: 23
Doherty, G.H.; Oldreive, C.; Harvey, J. 2008: Neuroprotective actions of leptin on central and peripheral neurons in vitro. Neuroscience 154(4): 1297-1307
Catania, A. 2008: Neuroprotective actions of melanocortins: a therapeutic opportunity. Trends in Neurosciences 31(7): 353-360
Poteet, E.; Winters, A.; Yan, L.-J.; Shufelt, K.; Green, K.N.; Simpkins, J.W.; Wen, Y.; Yang, S.-H. 2012: Neuroprotective actions of methylene blue and its derivatives. Plos one 7(10): E48279
Borowicz, K.K.; Piskorska, B.; Banach, M.; Czuczwar, S.J. 2011: Neuroprotective actions of neurosteroids. Frontiers in Endocrinology 2: 50
Tokuyama, Y.; Reddy, A.P.; Bethea, C.L. 2008: Neuroprotective actions of ovarian hormones without insult in the raphe region of rhesus macaques. Neuroscience 154(2): 720-731
Blusztajn, J.K.; Mellott, T.J. 2013: Neuroprotective actions of perinatal choline nutrition. Clinical Chemistry and Laboratory Medicine 51(3): 591-599
DonCarlos, L.L.; Azcoitia, I.ñi.; Garcia-Segura, L.M. 2009: Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology 34(Suppl 1): S113-S122
Bourque, M.él.; Dluzen, D.E.; Di Paolo, T.ér.ès. 2009: Neuroprotective actions of sex steroids in Parkinson's disease. Frontiers in Neuroendocrinology 30(2): 142-157
Picazo, O.; Becerril-Montes, A.; Huidobro-Perez, D.; Garcia-Segura, L.M. 2010: Neuroprotective actions of the synthetic estrogen 17alpha-ethynylestradiol in the hippocampus. Cellular and Molecular Neurobiology 30(5): 675-682
Eggert, D.; Dash, P.K.; Gorantla, S.; Dou, H.; Schifitto, G.; Maggirwar, S.B.; Dewhurst, S.; Poluektova, L.; Gelbard, H.A.; Gendelman, H.E. 2010: Neuroprotective activities of CEP-1347 in models of neuroAIDS. Journal of Immunology 184(2): 746-756
Chen, W.; Li, X.; Jia, L.-Q.; Wang, J.; Zhang, L.; Hou, D.; Wang, J.; Ren, L. 2013: Neuroprotective activities of catalpol against CaMKII-dependent apoptosis induced by LPS in PC12 cells. British Journal of Pharmacology 169(5): 1140-1152
Jiang, B.; Zhang, H.; Bi, J.; Zhang, X.L. 2008: Neuroprotective activities of catalpol on MPP+/MPTP-induced neurotoxicity. Neurological Research 30(6): 639-644
Wang, S.; Wang, D.-S.; Wang, R. 2008: Neuroprotective activities of enzymatically hydrolyzed peptides from porcine hide gelatin. International Journal of Clinical and Experimental Medicine 1(3): 283-293
Esposito, E.; Impellizzeri, D.; Mazzon, E.; Paterniti, I.; Cuzzocrea, S. 2012: Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease. Plos one 7(8): E41880
Gendelman, H.E.; Appel, S.H. 2011: Neuroprotective activities of regulatory T cells. Trends in Molecular Medicine 17(12): 687-688
Juszczak, M.łg.; Walczak, K.; Langner, E.; Karpińska, M.; Matysiak, J.; Rzeski, W. 2013: Neuroprotective activity of 2-amino-1,3,4-thiadiazole derivative 4BrABT--an in vitro study. Annals of Agricultural and Environmental Medicine: Aaem 20(3): 575-579
Thangarajan, S.; Deivasigamani, A.; Natarajan, S.S.; Krishnan, P.; Mohanan, S.K. 2014: Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. International Journal of Neuroscience 124(9): 673-684
Chandrashekhar, V.M.; Ranpariya, V.L.; Ganapaty, S.; Parashar, A.; Muchandi, A.A. 2010: Neuroprotective activity of Matricaria recutita Linn against global model of ischemia in rats. Journal of Ethnopharmacology 127(3): 645-651
Ranpariya, V.L.; Parmar, S.K.; Sheth, N.R.; Chandrashekhar, V.M. 2011: Neuroprotective activity of Matricaria recutita against fluoride-induced stress in rats. Pharmaceutical Biology 49(7): 696-701
Shalavadi, M.H.; Chandrashekhar, V.M.; Avinash, S.P.; Sowmya, C.; Ramkishan, A. 2012: Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson's disease model. Indian Journal of Pharmacology 44(6): 737-743
Shalavadi, M.H.; Chandrashekhar, V.M.; Ramkishan, A.; Nidavani, R.B.; Biradar, B.S. 2013: Neuroprotective activity of Stereospermum suaveolens against global cerebral ischemia rat model. Pharmaceutical Biology 51(8): 955-960
Jeon, G.-I.; Yoon, M.-Y.; Park, H.-R.; Lee, S.-C.; Park, E. 2009: Neuroprotective activity of Viola mandshurica extracts on hydrogen peroxide-induced DNA damage and cell death in PC12 cells. Annals of the new York Academy of Sciences 1171: 576-582
Prakash, T.; Kotresha, D.; Nedendla, R.Rao. 2011: Neuroprotective activity of Wedelia calendulacea on cerebral ischemia/reperfusion induced oxidative stress in rats. Indian Journal of Pharmacology 43(6): 676-682
Etcheverrigaray, M.; Ceaglio, N.; Mattio, M.ón.; Oggero, M.; Amadeo, I.; Forno, G.; Perotti, N.; Kratje, R. 2011: Neuroprotective activity of a new erythropoietin formulation with increased penetration in the central nervous system. Bmc Proceedings 5(Suppl 8): P3
Tan, H.P.; Wong, D.Z.H.; Ling, S.K.; Chuah, C.H.; Kadir, H.A. 2012: Neuroprotective activity of galloylated cyanogenic glucosides and hydrolysable tannins isolated from leaves of Phyllagathis rotundifolia. Fitoterapia 83(1): 223-229
Chandrashekhar, V.M.; Ganapaty, S.; Ramkishan, A.; Narsu, M.Laxmi. 2013: Neuroprotective activity of gossypin from Hibiscus vitifolius against global cerebral ischemia model in rats. Indian Journal of Pharmacology 45(6): 575-580
Wang, D.; Yuan, X.; Liu, T.; Liu, L.; Hu, Y.; Wang, Z.; Zheng, Q. 2012: Neuroprotective activity of lavender oil on transient focal cerebral ischemia in mice. Molecules 17(8): 9803-9817
Inchina, V.I.; Bukina, S.J. 2008: Neuroprotective activity of mexidole and 3-hydroxypyridine acetylcysteinate against the background of cerebral ischemia in the complex of experimental diabetes mellitus and exogenous hypercholesterolemia. Bulletin of Experimental Biology and Medicine 145(6): 738-740
Ferrari, D.; Cysneiros, R.M.; Scorza, C.A.; Arida, R.M.; Cavalheiro, E.A.; de Almeida, A.-C.G.; Scorza, F.A. 2008: Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium-binding proteins. Epilepsy and Behavior: E&b 13(1): 36-42
Darbinian, N.; Khalili, K.; Amini, S. 2014: Neuroprotective activity of pDING in response to HIV-1 Tat. Journal of Cellular Physiology 229(2): 153-161
Gonzalo-Gobernado, R.; Calatrava-Ferreras, L.ía.; Reimers, D.; Herranz, A.S.án.; Rodríguez-Serrano, M.; Miranda, C.; Jiménez-Escrig, A.; Díaz-Gil, J.J.é; Bazán, E. 2013: Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease. Plos one 8(7): E67771
Weon, J.B.; Yang, H.J.; Lee, B.; Yun, B.-R.; Ahn, J.H.; Lee, H.Y.; Ma, C.J. 2011: Neuroprotective activity of the methanolic extract of Lonicera japonica in glutamate-injured primary rat cortical cells. Pharmacognosy Magazine 7(28): 284-288
Tomassoni, D.; Amenta, F.; Di Cesare Mannelli, L.; Ghelardini, C.; Nwankwo, I.E.; Pacini, A.; Tayebati, S.K. 2013: Neuroprotective activity of thioctic acid in central nervous system lesions consequent to peripheral nerve injury. Biomed Research International 2013: 985093
Son, I.H.; Park, Y.H.; Lee, S.I.; Yang, H.D.; Moon, H.-I. 2007: Neuroprotective activity of triterpenoid saponins from Platycodi radix against glutamate-induced toxicity in primary cultured rat cortical cells. Molecules 12(5): 1147-1152
Buch, P.; Patel, V.; Ranpariya, V.; Sheth, N.; Parmar, S. 2012: Neuroprotective activityof Cymbopogon martinii against cerebral ischemia/reperfusion-induced oxidative stress in rats. Journal of Ethnopharmacology 142(1): 35-40
Barreto, G.E.; Gonzalez, J.; Capani, F.; Morales, L. 2012: Neuroprotective agents in brain injury: a partial failure?. International Journal of Neuroscience 122(5): 223-226
Zhu, Y.; Fotinos, A.; Mao, L.L.J.; Atassi, N.; Zhou, E.W.; Ahmad, S.; Guan, Y.; Berry, J.D.; Cudkowicz, M.E.; Wang, X. 2015: Neuroprotective agents target molecular mechanisms of disease in ALS. Drug Discovery Today 20(1): 65-75
Sánchez, A.J.; García-Merino, A. 2012: Neuroprotective agents: cannabinoids. Clinical Immunology 142(1): 57-67
De la Vega, M.D.C.; Delsouc, M.ía.B.; Ponce, I.; Ragusa, V.; Vallcaneras, S.; Anzulovich, A.C.; Casais, M. 2018: Circadian rhythms of factors involved in luteal regression are modified in p55 tumour necrosis factor receptor (TNFRp55)-deficient mice. Reproduction Fertility and Development 30(12): 1651-1665
Hashimoto, M.; Hossain, S. 2011: Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. Journal of Pharmacological Sciences 116(2): 150-162
Boneva, N.B.; Kikuchi, M.; Minabe, Y.; Yamashima, T. 2011: Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: implication of fatty acid-binding proteins (FABP) and G protein-coupled receptor 40 (GPR40) in adult neurogenesis. Journal of Pharmacological Sciences 116(2): 163-172
Briyal, S.; Shah, S.; Gulati, A. 2014: Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia. Neuroscience 281: 269-281
Sharma, M.K.; Jalewa, J.; Hölscher, C. 2014: Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress. Journal of Neurochemistry 128(3): 459-471
Zhang, C.; Zhu, J.; Zhang, J.; Li, H.; Zhao, Z.; Liao, Y.; Wang, X.; Su, J.; Sang, S.; Yuan, X.; Liu, Q. 2014: Neuroprotective and anti-apoptotic effects of valproic acid on adult rat cerebral cortex through ERK and Akt signaling pathway at acute phase of traumatic brain injury. Brain Research 1555: 1-9
Pandareesh, M.D.; Anand, T. 2014: Neuroprotective and anti-apoptotic propensity of Bacopa monniera extract against sodium nitroprusside induced activation of iNOS, heat shock proteins and apoptotic markers in PC12 cells. Neurochemical Research 39(5): 800-814
Chu, L.W.; Chen, J.Y.; Yu, K.L.; Cheng, K.I.; Wu, P.C.; Wu, B.N. 2012: Neuroprotective and anti-inflammatory activities of atorvastatin in a rat chronic constriction injury model. International Journal of Immunopathology and Pharmacology 25(1): 219-230
Yang, X.; Cheng, B. 2010: Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. Journal of Molecular Neuroscience: Mn 42(2): 145-153
Tiwari-Woodruff, S.; Voskuhl, R.R. 2009: Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. Journal of the Neurological Sciences 286(1-2): 81-85
Cho, N.; Choi, J.H.; Yang, H.; Jeong, E.J.; Lee, K.Y.; Kim, Y.C.; Sung, S.H. 2012: Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 50(6): 1940-1945
Jeong, G.-S.; Lee, D.-S.; Kim, D.-C.; Jahng, Y.; Son, J.-K.; Lee, S.-H.; Kim, Y.-C. 2011: Neuroprotective and anti-inflammatory effects of mollugin via up-regulation of heme oxygenase-1 in mouse hippocampal and microglial cells. European Journal of Pharmacology 654(3): 226-234
Frau, L.; Borsini, F.; Wardas, J.; Khairnar, A.S.; Schintu, N.; Morelli, M. 2011: Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease. Synapse 65(3): 181-188
Keddy, P.G.W.; Dunlop, K.; Warford, J.; Samson, M.L.; Jones, Q.R.D.; Rupasinghe, H.P.V.; Robertson, G.S. 2012: Neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction AF4 in a mouse model of hypoxic-ischemic brain injury. Plos one 7(12): E51324
Rasheed, N.; Ahmad, A.; Al-Sheeha, M.; Alghasham, A.; Palit, G. 2011: Neuroprotective and anti-stress effect of A68930 in acute and chronic unpredictable stress model in rats. Neuroscience Letters 504(2): 151-155
Fujiki, M.; Kubo, T.; Kamida, T.; Sugita, K.; Hikawa, T.; Abe, T.; Ishii, K.; Kobayashi, H. 2008: Neuroprotective and antiamnesic effect of donepezil, a nicotinic acetylcholine-receptor activator, on rats with concussive mild traumatic brain injury. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 15(7): 791-796
Gudasheva, T.A.; Romanova, G.A.; Shakova, F.M.; Kotel'nikova, S.O.; Barskov, I.V.; Stel'mashuk, E.V.; Seredenin, S.B. 2012: Neuroprotective and antiamnesic effects of GK-2h dipeptide HNGF mimetic on a model of experimental ischemic stroke of brain cortex prefrontal areas. Eksperimental'naia i Klinicheskaia Farmakologiia 75(10): 12-15
Romanova, G.A.; Silachev, D.N.; Shakova, F.M.; Kvashennikova, Y.N.; Viktorov, I.V.; Shram, S.I.; Myasoedov, N.F. 2006: Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex. Bulletin of Experimental Biology and Medicine 142(6): 663-666
Seredenin, S.B.; Romanova, G.A.; Gudasheva, T.A.; Shakova, F.M.; Barskov, I.V.; Stelmashuk, E.V.; Antipova, T.A. 2011: Neuroprotective and antiamnestic effect of nerve growth factor dipeptide mimetic GK-2 in experimental ischemic infarction of brain cortex. Bulletin of Experimental Biology and Medicine 150(4): 432-435
Rodrigues, A.Dalpicolli.; Scheffel, T.Becker.; Scola, G.; Santos, Mê.Telles.Dos.; Fank, B.; de Freitas, S.Cesa.Vieira.; Dani, C.; Vanderlinde, R.; Henriques, Jão.Antonio.Pegas.; Coitinho, A.Simon.; Salvador, M. 2012: Neuroprotective and anticonvulsant effects of organic and conventional purple grape juices on seizures in Wistar rats induced by pentylenetetrazole. Neurochemistry International 60(8): 799-805
Bassani, T.B.; Gradowski, R.W.; Zaminelli, T.; Barbiero, J.ín.K.; Santiago, R.M.; Boschen, S.L.; da Cunha, C.; Lima, M.M.S.; Andreatini, R.; Vital, M.A.B.F. 2014: Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats. Brain Research 1593: 95-105
Khanna, S.; Park, H.-A.; Sen, C.K.; Golakoti, T.; Sengupta, K.; Venkateswarlu, S.; Roy, S. 2009: Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid. Antioxidants and Redox Signaling 11(3): 449-468
Gazal, M.; Valente, M.R.; Acosta, B.A.; Kaufmann, F.N.; Braganhol, E.; Lencina, C.L.; Stefanello, F.M.; Ghisleni, G.; Kaster, M.P. 2014: Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats. European Journal of Pharmacology 724: 132-139
Kanhere, R.; Anjana, A.; Anbu, J.; Sumithra, M.; K F H, N.A. 2013: Neuroprotective and antioxidant potential of terpenoid fraction from Hygrophila auriculata against transient global cerebral ischemia in rats. Pharmaceutical Biology 51(2): 181-189
Huang, X.; Li, Q.; Li, H.; Guo, L. 2009: Neuroprotective and antioxidative effect of cactus polysaccharides in vivo and in vitro. Cellular and Molecular Neurobiology 29(8): 1211-1221
Leibinger, M.; Müller, A.; Andreadaki, A.; Hauk, T.G.; Kirsch, M.; Fischer, D. 2009: Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 29(45): 14334-14341
Twede, V.D.; Miljanich, G.; Olivera, B.M.; Bulaj, G. 2009: Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads. Current Opinion in Drug Discovery and Development 12(2): 231-239
Maslov, L.N.; Khaliulin, I.G.; Podoksenov, I.K. 2012: Neuroprotective and cardioprotective effects of hypothermic preconditioning. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 67-72
Arce, M.P.; Rodríguez-Franco, M.ía.I.; González-Muñoz, G.C.; Pérez, C.ón.; López, B.; Villarroya, M.; López, M.G.; García, A.G.; Conde, S. 2009: Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease. Journal of Medicinal Chemistry 52(22): 7249-7257
Weon, J.B.; Lee, B.; Yun, B.-R.; Lee, J.; Ma, J.Y.; Ma, C.J. 2014: Neuroprotective and cognitive enhancing activity of the fermented Bozhougyiqi-Tang. Pharmacognosy Magazine 10(Suppl 2): S249-S255
Borre, Y.E.; Panagaki, T.; Koelink, P.J.; Morgan, M.E.; Hendriksen, H.; Garssen, J.; Kraneveld, A.D.; Olivier, B.; Oosting, R.S. 2014: Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration and depression. Neuropharmacology 79: 738-749
Onose, G.; Mureşanu, D.F.; Ciurea, A.V.; Daia Chendreanu, C.; Mihaescu, A.S.; Mardare, D.C.; Andone, I.; Spânu, A.; Popescu, C.; Dumitrescu, A.; Popescu, M.; Grigorean, V.; Ungur, B.; Marinescu, F.; Colibbeanu, I.; Onose, L.; Haras, M.; Sandu, A.; Spircu, T. 2009: Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin. Journal of Medicine and Life 2(4): 350-360
Novikova, L.N.; Brohlin, M.; Kingham, P.J.; Novikov, L.N.; Wiberg, M. 2011: Neuroprotective and growth-promoting effects of bone marrow stromal cells after cervical spinal cord injury in adult rats. CytoTherapy 13(7): 873-887
Abdel-Salam, O.M.E.; Youness, E.R.; Mohammed, N.A.; Abd-Elmoniem, M.; Omara, E.; Sleem, A.A. 2012: Neuroprotective and hepatoprotective effects of micronized purified flavonoid fraction (Daflon®) in lipopolysaccharide-treated rats. Drug Discoveries and Therapeutics 6(6): 306-314
Hong, S.; Iizuka, Y.; Lee, T.; Kim, C.Y.; Seong, G.J. 2014: Neuroprotective and neurite outgrowth effects of maltol on retinal ganglion cells under oxidative stress. Molecular Vision 20: 1456-1462
Kupershmidt, L.; Weinreb, O.; Amit, T.; Mandel, S.; Carri, M.Teresa.; Youdim, M.B.H. 2009: Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 23(11): 3766-3779
López, V.íc.; Martín, S.; Gómez-Serranillos, M.P.; Carretero, M.E.; Jäger, A.K.; Calvo, M.I. 2010: Neuroprotective and neurochemical properties of mint extracts. PhytoTherapy Research: Ptr 24(6): 869-874
Chertoff, M.; Di Paolo, N.; Schoeneberg, A.; Depino, A.; Ferrari, C.; Wurst, W.; Pfizenmaier, K.; Eisel, U.; Pitossi, F. 2011: Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult mice. Experimental Neurology 227(2): 237-251
López, V.íc.; Martín, S.; Gómez-Serranillos, M.P.; Carretero, M.E.; Jäger, A.K.; Calvo, M.I. 2009: Neuroprotective and neurological properties of Melissa officinalis. Neurochemical Research 34(11): 1955-1961
Heurteaux, C.; Gandin, C.; Borsotto, M.; Widmann, C.; Brau, F.; Lhuillier, M.; Onteniente, B.; Lazdunski, M. 2010: Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo. Neuropharmacology 58(7): 987-1001
Ray, B.; Bisht, S.; Maitra, A.; Maitra, A.; Lahiri, D.K. 2011: Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease. Journal of Alzheimer's Disease: Jad 23(1): 61-77
Xiong, Y.; Mahmood, A.; Meng, Y.; Zhang, Y.; Zhang, Z.G.; Morris, D.C.; Chopp, M. 2012: Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury. Annals of the new York Academy of Sciences 1270: 51-58
Xiong, Y.; Zhang, Y.; Mahmood, A.; Meng, Y.; Zhang, Z.G.; Morris, D.C.; Chopp, M. 2012: Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats. Journal of Neurosurgery 116(5): 1081-1092
Sawada, H.; Suzuki, H.; Nagatsu, T.; Sawada, M. 2010: Neuroprotective and neurotoxic phenotypes of activated microglia in neonatal mice with respective MPTP- and ethanol-induced brain injury. Neuro-Degenerative Diseases 7(1-3): 64-67
Resenberger, U.K.; Winklhofer, K.F.; Tatzelt, J.ör. 2011: Neuroprotective and neurotoxic signaling by the prion protein. Topics in Current Chemistry 305: 101-119
Lapchak, P.A. 2011: Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective. Expert Opinion on Investigational Drugs 20(1): 13-22
Patil, S.P.; Jain, P.D.; Sancheti, J.S.; Ghumatkar, P.J.; Tambe, R.; Sathaye, S. 2014: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice. Neuropharmacology 86: 192-202
Park, S.-Y. 2009: Neuroprotective and neurotrophic effects of isorosmanol. Zeitschrift für Naturforschung. C Journal of Biosciences 64(5-6): 395-398
Riadh, N.; Allagui, M.S.; Bourogaa, E.; Vincent, C.; Croute, F.ço.; Elfeki, A. 2011: Neuroprotective and neurotrophic effects of long term lithium treatment in mouse brain. Biometals: An International Journal on the Role of Metal Ions in Biology Biochemistry and Medicine 24(4): 747-757
Talpate, K.A.; Bhosale, U.A.; Zambare, M.R.; Somani, R.S. 2014: Neuroprotective and nootropic activity of Clitorea ternatea Linn.(Fabaceae) leaves on diabetes induced cognitive decline in experimental animals. Journal of Pharmacy and Bioallied Sciences 6(1): 48-55
Williams, C.J.; Dexter, D.T. 2014: Neuroprotective and symptomatic effects of targeting group IIi mGlu receptors in neurodegenerative disease. Journal of Neurochemistry 129(1): 4-20
Sawada, M. 2009: Neuroprotective and toxic changes in microglia in neurodegenerative disease. Parkinsonism and Related Disorders 15(Suppl 1): S39-S41
Shahrokhi, N.; Haddad, M.K.; Joukar, S.; Shabani, M.; Keshavarzi, Z.; Shahozehi, B. 2012: Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury. Pakistan Journal of Pharmaceutical Sciences 25(1): 219-225
Thaler, S.; Haritoglou, C.; Schuettauf, F. 2013: Neuroprotective approaches. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 110(10): 941-947
Xu, J.; Yang, B.; Guo, Y.; Jin, D.-q.; Guo, P.; Liu, C.; Hou, W.; Zhang, T.; Gui, L.; Sun, Z. 2011: Neuroprotective bakkenolides from the roots of Valeriana jatamansi. Fitoterapia 82(6): 849-853
Cho, N.; Yang, H.; Lee, M.; Huh, J.; Kim, H.-W.; Kim, H.-P.; Sung, S.-H. 2013: Neuroprotective benzyl benzoate glycosides from Disporum viridescens roots in HT22 hippocampal neuronal cells. Journal of Natural Products 76(12): 2291-2297
Jeong, E.J.; Hwang, L.; Lee, M.; Lee, K.Y.; Ahn, M.-J.; Sung, S.H. 2014: Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 64: 397-402
Magalhães, M.; Rodrigues, F.Paulo.Martins.; Chopard, M.Renata.Tollio.; Melo, V.Catarina.de.Albuquerque.; Melhado, A.; Oliveira, I.; Gallacci, C.Bernardi.; Pachi, P.Roberto.; Lima Neto, T.Barbosa. 2015: Neuroprotective body hypothermia among newborns with hypoxic ischemic encephalopathy: three-year experience in a tertiary university hospital. A retrospective observational study. Sao Paulo Medical Journal 133(4): 314-319
Xu, J.; Guo, Y.; Zhao, P.; Xie, C.; Jin, D.-q.; Hou, W.; Zhang, T. 2011: Neuroprotective cadinane sesquiterpenes from the resinous exudates of Commiphora myrrha. Fitoterapia 82(8): 1198-1201
Ma, X.-H.; Gao, Q.; Jia, Z.; Zhang, Z.-W. 2015: Neuroprotective capabilities of TSA against cerebral ischemia/reperfusion injury via PI3K/Akt signaling pathway in rats. International Journal of Neuroscience 125(2): 140-146
Chen, Y.; Wu, X.; Yu, S.; Fauzee, N.J.S.; Wu, J.; Li, L.; Zhao, J.; Zhao, Y. 2012: Neuroprotective capabilities of Tanshinone IIA against cerebral ischemia/reperfusion injury via anti-apoptotic pathway in rats. Biological and Pharmaceutical Bulletin 35(2): 164-170
Choi, Y.-G.; Yeo, S.; Hong, Y.-M.; Lim, S. 2011: Neuroprotective changes of striatal degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis. Cellular and Molecular Neurobiology 31(3): 377-391
Rezazadeh, H.; Hoseini Kahnuee, M.; Roohbakhsh, A.; Shamsizadeh, A.; Rahmani, M.R.; Bidaki, R.; Amin, F.; Kamali, B.; Bakhshi, H.; Allahtavakoli, M. 2013: Neuroprotective consequences of postconditioning on embolic model of cerebral ischemia in rat. Iranian Journal of Basic Medical Sciences 16(2): 144-149
Bica, L.; Liddell, J.R.; Donnelly, P.S.; Duncan, C.; Caragounis, A.; Volitakis, I.; Paterson, B.M.; Cappai, R.; Grubman, A.; Camakaris, J.; Crouch, P.J.; White, A.R. 2014: Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation. Plos one 9(2): E90070
Reick, C.; Ellrichmann, G.; Thöne, J.; Scannevin, R.H.; Saft, C.; Linker, R.A.; Gold, R. 2014: Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation. Experimental Neurology 257: 50-56
Pardue, M.T.; Kim, M.K.; Walker, T.A.; Faulkner, A.E.; Chow, A.Y.; Ciavatta, V.T. 2012: Neuroprotective dose response in RCS rats implanted with microphotodiode arrays. Advances in Experimental Medicine and Biology 723: 115-120
Liu, A.Y.C.; Mathur, R.; Mei, N.; Langhammer, C.G.; Babiarz, B.; Firestein, B.L. 2011: Neuroprotective drug riluzole amplifies the heat shock factor 1 (HSF1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survival. Journal of Biological Chemistry 286(4): 2785-2794
Omodaka, K.; Nishiguchi, K.M.; Yasuda, M.; Tanaka, Y.; Sato, K.; Nakamura, O.; Maruyama, K.; Nakazawa, T. 2014: Neuroprotective effect against axonal damage-induced retinal ganglion cell death in apolipoprotein E-deficient mice through the suppression of kainate receptor signaling. Brain Research 1586: 203-212
Zhu, Z.-F.; Wang, Q.-G.; Han, B.-J.; William, C.P. 2010: Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice. Brain Research Bulletin 83(5): 272-277
Langmeier, M.; Folbergrová, J.; Haugvicová, R.; Riljak, V. 2006: Neuroprotective effect of (R, S)-4-phosphonophenylglycine against neuronal damage associated with homocysteic acid-induced seizures in immature rats. Prague Medical Report 107(4): 421-432
Ahn, S.Min.; Kim, H.Neui.; Kim, Y.Ri.; Oh, E.Young.; Choi, Y.Whan.; Shin, H.Kyoung.; Choi, B.Tae. 2014: Neuroprotective effect of 1-methoxyoctadecan-1-ol from Uncaria sinensis on glutamate-induced hippocampal neuronal cell death. Journal of Ethnopharmacology 155(1): 293-299
Chen, X.; Deng, A.; Zhou, H.; Gu, J. 2013: Neuroprotective effect of 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-D-pyranoside against sodium nitroprusside-induced neurotoxicity in HT22 cells. Molecular and Cellular Biochemistry 383(1-2): 149-159
He, B.; Chen, P.; Yang, J.; Yun, Y.; Zhang, X.; Yang, R.; Shen, Z. 2012: Neuroprotective effect of 20(R)-ginsenoside Rg(3) against transient focal cerebral ischemia in rats. Neuroscience Letters 526(2): 106-111
Han, J.; Miyamae, Y.; Shigemori, H.; Isoda, H. 2010: Neuroprotective effect of 3,5-di-O-caffeoylquinic acid on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1. Neuroscience 169(3): 1039-1045
Ma, Y.; Li, Y.; Zhang, C.; Zhou, X.; Wu, Y. 2014: Neuroprotective effect of 4-methylcyclopentadecanone on focal cerebral ischemia/reperfusion injury in rats. Journal of Pharmacological Sciences 125(3): 320-328
ArunaDevi, R.; Lata, S.; Bhadoria, B.K.; Ramteke, V.D.; Kumar, S.; Sankar, P.; Kumar, D.; Tandan, S.K. 2010: Neuroprotective effect of 5,7,3',4',5'-pentahydroxy dihydroflavanol-3-O-(2''-O-galloyl)-beta-D-glucopyranoside, a polyphenolic compound in focal cerebral ischemia in rat. European Journal of Pharmacology 626(2-3): 205-212
Sengul, G.; Coskun, S.; Cakir, M.; Coban, M.K.; Saruhan, F.; Hacimuftuoglu, A. 2011: Neuroprotective effect of ACE inhibitors in glutamate - induced neurotoxicity: rat neuron culture study. Turkish Neurosurgery 21(3): 367-371
Du, A.-l.; Ji, T.-l.; Yang, B.; Cao, J.-f.; Zhang, X.-g.; Li, Y.; Pan, S.; Zhang, B.; Hu, Z.-b.; Zeng, X.-w. 2013: Neuroprotective effect of AG490 in experimental traumatic brain injury of rats. Chinese Medical Journal 126(15): 2934-2937
Hanish Singh, J.C.; Alagarsamy, V.; Diwan, P.V.; Sathesh Kumar, S.; Nisha, J.C.; Narsimha Reddy, Y. 2011: Neuroprotective effect of Alpinia galanga (L.) fractions on Aβ(25-35) induced amnesia in mice. Journal of Ethnopharmacology 138(1): 85-91
Bora, K.Singh.; Sharma, A. 2010: Neuroprotective effect of Artemisia absinthium L. on focal ischemia and reperfusion-induced cerebral injury. Journal of Ethnopharmacology 129(3): 403-409
Hu, W.-X.; Xiang, Q.; Wen, Z.; He, D.; Wu, X.-M.; Hu, G.-Z. 2014: Neuroprotective effect of Atractylodes macrocephalaon polysaccharides in vitro on neuronal apoptosis induced by hypoxia. Molecular Medicine Reports 9(6): 2573-2581
Jiang, H.; Wang, J.; Xie, J.-x. 2004: Neuroprotective effect of BFP Abeta(1-40) and C31 induced PC12 cell damage. Zhongguo Ying Yong Sheng Li Xue Za Zhi 20(2): 134-135
Saraf, M.K.; Prabhakar, S.; Anand, A. 2010: Neuroprotective effect of Bacopa monniera on ischemia induced brain injury. Pharmacology Biochemistry and Behavior 97(2): 192-197
Wang, X.; Han, W.; Du, X.; Zhu, C.; Carlsson, Y.; Mallard, C.; Jacotot, E.; Hagberg, H. 2010: Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury. Stroke 41(9): 2050-2055
Ayyathan, D.Manikoth.; Chandrasekaran, R.; Thiagarajan, K. 2015: Neuroprotective effect of Brahmi, an ayurvedic drug against oxidative stress induced by methyl mercury toxicity in rat brain mitochondrial-enriched fractions. Natural Product Research 29(11): 1046-1051
Pérez-Barrón, G.; Avila-Acevedo, J.é G.; García-Bores, A.M.ía.; Montes, S.; García-Jiménez, S.; León-Rivera, I.; Rubio-Osornio, M.és.; Monroy-Noyola, A. 2015: Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson's disease rat model. Journal of Natural Medicines 69(1): 86-93
Wang, L.; Jiang, D.-M. 2013: Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5. Bmc Complementary and Alternative Medicine 13: 309
Wang, L.; Jiang, D-Ming. 2009: Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia/reperfusion injury in rats. Journal of Ethnopharmacology 124(2): 219-223
Zhao, L-Dong.; Wang, J-Hua.; Jin, G-Rong.; Zhao, Y.; Zhang, H-Jun. 2012: Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats--time window and mechanism. Journal of Ethnopharmacology 140(2): 339-344
Longhi, L.; Perego, C.; Zanier, E.R.; Ortolano, F.; Bianchi, P.; Stocchetti, N.; De Simoni, M.G. 2008: Neuroprotective effect of C1-inhibitor following traumatic brain injury in mice. Acta Neurochirurgica. Suppl 102: 381-384
Jayaraj, R.L.; Tamilselvam, K.; Manivasagam, T.; Elangovan, N. 2013: Neuroprotective effect of CNB-001, a novel pyrazole derivative of curcumin on biochemical and apoptotic markers against rotenone-induced SK-N-SH cellular model of Parkinson's disease. Journal of Molecular Neuroscience: Mn 51(3): 863-870
Liu, X.-Y.; Li, C.-Y.; Bu, H.; Li, Z.; Li, B.; Sun, M.-M.; Zhang, L.; Tian, M.; Fan, Z.-L.; Ren, W.-B. 2010: Neuroprotective effect of CPDT on THA-induced cortical motor neuron death in an organotypic culture model. Brain Research Bulletin 83(6): 345-350
Haleagrahara, N.; Ponnusamy, K. 2010: Neuroprotective effect of Centella asiatica extract (CAE) on experimentally induced parkinsonism in aged Sprague-Dawley rats. Journal of Toxicological Sciences 35(1): 41-47
Ko, C.-N.; Park, I.-S.; Park, S.-U.; Jung, W.-S.; Moon, S.-K.; Park, J.-M.; Kang, C.; Cho, K.-H. 2013: Neuroprotective effect of Chunghyuldan (Qing Xue Dan) on hypoxia-reoxygenation induced damage of neuroblastoma 2a cell lines. Chinese Journal of Integrative Medicine 19(12): 940-944
Kim, H.G.; Kim, J.-Y.; Whang, W.-W.; Oh, M.S. 2014: Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo. Canadian Journal of Physiology and Pharmacology 92(6): 429-437
Díaz-Ruíz, A.; Ríos, C.; Carvajal-Sotelo, J.; Ortiz-Plata, A.; Espino-Solis, G.P.; Méndez-Armenta, M.; Montes, S.; Monroy-Noyola, A. 2010: Neuroprotective effect of DAHK peptide in an occlusive model of permanent focal ischemia in rats. Neurochemical Research 35(2): 343-347
Seetapun, S.; Yaoling, J.; Wang, Y.; Zhu, Y.Z. 2013: Neuroprotective effect of Danshensu derivatives as anti-ischaemia agents on SH-SY5Y cells and rat brain. Bioscience Reports 33(4)
Jahromi, S.R.; Haddadi, M.; Shivanandappa, T.; Ramesh, S.R. 2013: Neuroprotective effect of Decalepis hamiltonii in paraquat-induced neurotoxicity in Drosophila melanogaster: biochemical and behavioral evidences. Neurochemical Research 38(12): 2616-2624
El-Ghazaly, M.A.; Sadik, N.A.H.; Rashed, E.R.; Abd-El-Fattah, A.A. 2015: Neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson's disease. Toxicology and Industrial Health 31(12): 1128-1143
Frauenknecht, K.; Bargiotas, P.; Bauer, H.; von Landenberg, P.; Schwaninger, M.; Sommer, C. 2010: Neuroprotective effect of Fn14 deficiency is associated with induction of the granulocyte-colony stimulating factor (G-CSF) pathway in experimental stroke and enhanced by a pathogenic human antiphospholipid antibody. Journal of Neuroimmunology 227(1-2): 1-9
Seredenin, S.B.; Silachev, D.N.; Gudasheva, T.A.; Pirogov, Y.A.; Isaev, N.K. 2011: Neuroprotective effect of GK-2, a dipeptide mimetic of nerve growth factor, during experimental focal ischemia in middle cerebral artery basin. Bulletin of Experimental Biology and Medicine 151(5): 584-587
Ma, S.; Liu, X.; Xun, Q.; Zhang, X. 2014: Neuroprotective effect of Ginkgolide K against H2O2-induced PC12 cell cytotoxicity by ameliorating mitochondrial dysfunction and oxidative stress. Biological and Pharmaceutical Bulletin 37(2): 217-225
Bu, Y.; Kwon, S.; Kim, Y.T.; Kim, M.-Y.; Choi, H.; Kim, J.G.; Jamarkattel-Pandit, N.; Doré, S.; Kim, S.-H.; Kim, H. 2010: Neuroprotective effect of HT008-1, a prescription of traditional Korean medicine, on transient focal cerebral ischemia model in rats. PhytoTherapy Research: Ptr 24(8): 1207-1212
Nade, V.S.; Kawale, L.A.; Dwivedi, S.; Yadav, A.V. 2010: Neuroprotective effect of Hibiscus rosa sinensis in an oxidative stress model of cerebral post-ischemic reperfusion injury in rats. Pharmaceutical Biology 48(7): 822-827
Storozhevykh, T.P.; Senilova, Y.E.; Brustovetsky, T.; Pinelis, V.G.; Brustovetsky, N. 2010: Neuroprotective effect of KB-R7943 against glutamate excitotoxicity is related to mild mitochondrial depolarization. Neurochemical Research 35(2): 323-335
Shin, J.Y.; Park, H.-J.; Ahn, Y.H.; Lee, P.H. 2009: Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Journal of Neurochemistry 111(4): 1042-1050
Wang, G.-H.; Jiang, Z.-L.; Chen, Z.-Q.; Li, X.; Peng, L.-L. 2010: Neuroprotective effect of L-serine against temporary cerebral ischemia in rats. Journal of Neuroscience Research 88(9): 2035-2045
Liu, J-ping.; Feng, L.; Zhang, M-hua.; Ma, D-ying.; Wang, S-yuan.; Gu, J.; Fu, Q.; Qu, R.; Ma, S-ping. 2013: Neuroprotective effect of Liuwei Dihuang decoction on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat. Journal of Ethnopharmacology 150(1): 371-381
Ni, T.; Wei, G.; Yin, X.; Liu, X.; Liu, D. 2013: Neuroprotective effect of Lycium barbarum on retina of Royal College of Surgeons (RCS) rats: a preliminary study. Folia neuropathologica 51(2): 158-163
Kalonia, H.; Kumar, P.; Nehru, B.; Kumar, A. 2009: Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats. Indian Journal of Experimental Biology 47(11): 880-892
Thirunavukkarasu, S.V.; Venkataraman, S.; Raja, S.; Upadhyay, L. 2012: Neuroprotective effect of Manasamitra vatakam against aluminium induced cognitive impairment and oxidative damage in the cortex and hippocampus of rat brain. Drug and Chemical Toxicology 35(1): 104-115
Malik, Z.Ahmad.; Singh, M.; Sharma, P.L. 2011: Neuroprotective effect of Momordica charantia in global cerebral ischemia and reperfusion induced neuronal damage in diabetic mice. Journal of Ethnopharmacology 133(2): 729-734
Prakash, A.; Kalra, J.K.; Kumar, A. 2015: Neuroprotective effect of N-acetyl cysteine against streptozotocin-induced memory dysfunction and oxidative damage in rats. Journal of Basic and Clinical Physiology and Pharmacology 26(1): 13-23
Pawlas, N.; Małecki, A. 2009: Neuroprotective effect of N-acetylcysteine in neurons exposed to arachidonic acid during simulated ischemia in vitro. Pharmacological Reports: Pr 61(4): 743-750
Kamboj, S.S.; Chopra, K.; Sandhir, R. 2008: Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes. Metabolic Brain Disease 23(4): 427-443
Jin, M.C.; Yoo, J.-M.; Sok, D.-E.; Kim, M.R. 2014: Neuroprotective effect of N-acyl 5-hydroxytryptamines on glutamate-induced cytotoxicity in HT-22 cells. Neurochemical Research 39(12): 2440-2451
Neymotin, A.; Calingasan, N.Y.; Wille, E.; Naseri, N.; Petri, S.; Damiano, M.; Liby, K.T.; Risingsong, R.; Sporn, M.; Beal, M.F.; Kiaei, M. 2011: Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radical Biology and Medicine 51(1): 88-96
Endo, K.; Nakamachi, T.; Seki, T.; Kagami, N.; Wada, Y.; Nakamura, K.; Kishimoto, K.; Hori, M.; Tsuchikawa, D.; Shinntani, N.; Hashimoto, H.; Baba, A.; Koide, R.; Shioda, S. 2011: Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse. Journal of Molecular Neuroscience: Mn 43(1): 22-29
Deguil, J.; Chavant, Fçois.; Lafay-Chebassier, C.; Pérault-Pochat, M-Christine.; Fauconneau, B.; Pain, Séphanie. 2010: Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice. Neurotoxicity Research 17(2): 142-155
Jeong, H.J.; Yoo, D.Y.; Kim, D.W.; Yeo, H.J.; Cho, S.B.; Hyeon, J.; Park, J.H.; Park, J.; Eum, W.S.; Hwang, H.S.; Won, M.-H.; Hwang, I.K.; Choi, S.Y. 2014: Neuroprotective effect of PEP-1-peroxiredoxin2 on CA1 regions in the hippocampus against ischemic insult. Biochimica et Biophysica Acta 1840(7): 2321-2330
Jia, D.; Deng, Y.; Gao, J.; Liu, X.; Chu, J.; Shu, Y. 2014: Neuroprotective effect of Panax notoginseng plysaccharides against focal cerebral ischemia reperfusion injury in rats. International Journal of Biological Macromolecules 63: 177-180
Sharma, V.; Bala, A.; Deshmukh, R.; Bedi, K.L.; Sharma, P.L. 2012: Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats. Pharmacology Biochemistry and Behavior 101(2): 239-245
Han, X.-S.; Huang, Y.; Jing, H.-J.; Zhang, A.-W.; Jiang, T.; Xu, Y.-M. 2014: Neuroprotective effect of RYGB in Zucker fatty diabetic rats. International Journal of Clinical and Experimental Medicine 7(10): 3297-3304
Jacob, R.; Nalini, G.; Chidambaranathan, N. 2013: Neuroprotective effect of Rhodiola rosea Linn against MPTP induced cognitive impairment and oxidative stress. Annals of Neurosciences 20(2): 47-51
Park, S.-E.; Kim, S.; Sapkota, K.; Kim, S.-J. 2010: Neuroprotective effect of Rosmarinus officinalis extract on human dopaminergic cell line, SH-SY5Y. Cellular and Molecular Neurobiology 30(5): 759-767
Yune, T.Y.; Lee, J.Y.; Cui, C.M.; Kim, H.C.; Oh, T.H. 2009: Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats. Journal of Neurochemistry 110(4): 1276-1287
Zhang, Y.; Li, C.-S.; Wu, C.-J.; Yang, J.; Hang, C.-C. 2014: Neuroprotective effect of Shenfu Injection () following cardiac arrest in pig correlates with improved mitochondrial function and cerebral glucose uptake. Chinese Journal of Integrative Medicine 20(11): 835-843
Thaakur, S.; Sravanthi, R. 2010: Neuroprotective effect of Spirulina in cerebral ischemia-reperfusion injury in rats. Journal of Neural Transmission 117(9): 1083-1091
Hong, Y.Ki.; Park, S.Hwan.; Lee, S.; Hwang, S.; Lee, M.Jung.; Kim, D.; Lee, J.Ho.; Han, S.Yeop.; Kim, S.Tae.; Kim, Y-Kyoon.; Jeon, S.; Koo, B-Soo.; Cho, K.Sang. 2011: Neuroprotective effect of SuHeXiang Wan in Drosophila models of Alzheimer's disease. Journal of Ethnopharmacology 134(3): 1028-1032
Zhu, Y.; Bu, Q.; Liu, X.; Hu, W.; Wang, Y. 2014: Neuroprotective effect of TAT-14-3-3ε fusion protein against cerebral ischemia/reperfusion injury in rats. Plos one 9(3): E93334
Kosaraju, J.; Chinni, S.; Roy, P.Deb.; Kannan, E.; Antony, A.Shanish.; Kumar, M.N.Satish. 2014: Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism. Indian Journal of Pharmacology 46(2): 176-180
Hu, B.; Wang, Q.; Chen, Y.; Du, J.; Zhu, X.; Lu, Y.; Xiong, L.; Chen, S. 2010: Neuroprotective effect of WIN 55,212-2 pretreatment against focal cerebral ischemia through activation of extracellular signal-regulated kinases in rats. European Journal of Pharmacology 645(1-3): 102-107
Fu, W.; Du, G.; Liu, D.; Ruan, J.-L. 2013: Neuroprotective effect of a caffeic acid derivative from Abacopteris penangiana. Pharmaceutical Biology 51(3): 376-382
Xia, X-Hua.; Li, Q.; Liu, M. 2014: Neuroprotective effect of a formula, moschus combined with borneolum synthcticum, from traditional chinese medicine on ischemia stroke in rats. Evidence-Based Complementary and Alternative Medicine: Ecam 2014: 157938
Yan, B.C.; Park, J.H.; Shin, B.N.; Ahn, J.H.; Kim, I.H.; Lee, J.-C.; Yoo, K.-Y.; Hwang, I.K.; Choi, J.H.; Park, J.H.; Lee, Y.L.; Suh, H.-W.; Jun, J.-G.; Kwon, Y.-G.; Kim, Y.-M.; Kwon, S.-H.; Her, S.; Kim, J.S.; Hyun, B.-H.; Kim, C.-K.; Cho, J.H.; Lee, C.H.; Won, M.-H. 2013: Neuroprotective effect of a new synthetic aspirin-decursinol adduct in experimental animal models of ischemic stroke. Plos one 8(9): E74886
Koneri, R.B.; Samaddar, S.; Simi, S.M.; Rao, S.T. 2014: Neuroprotective effect of a triterpenoid saponin isolated from Momordica cymbalaria Fenzl in diabetic peripheral neuropathy. Indian Journal of Pharmacology 46(1): 76-81
Wang, F.; Wang, Y.; Geng, X.; Asmaro, K.; Peng, C.; Sullivan, J.M.; Ding, J.Y.; Ji, X.; Ding, Y. 2012: Neuroprotective effect of acute ethanol administration in a rat with transient cerebral ischemia. Stroke 43(1): 205-210
Sengul, G.; Coban, M.K.; Cakir, M.; Coskun, S.; Aksoy, H.; Hacimuftuoglu, A.; Saruhan, F.; Calik, M. 2013: Neuroprotective effect of acute interferon-beta 1B treatment after spinal cord injury. Turkish Neurosurgery 23(1): 45-49
Gáspár, T.ás.; Domoki, F.; Lenti, L.; Institoris, A.ám.; Snipes, J.A.; Bari, F.; Busija, D.W. 2009: Neuroprotective effect of adenoviral catalase gene transfer in cortical neuronal cultures. Brain Research 1270: 1-9
Seredenin, S.B.; Romanova, G.A.; Shakova, F.M. 2008: Neuroprotective effect of afobazole on rats with bilateral local photothrombosis of vessels in the prefrontal cortex. Bulletin of Experimental Biology and Medicine 145(2): 207-209
Guerrero, A.; De la Cruz, J.P.; Muñoz-Marín, J.; López-Villodres, J.A.; Madrona, A.; Espartero, J.L.; González-Correa, J.A. 2012: Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model. Food Chemistry 134(4): 2176-2183
Chen, W.; Qi, J.; Feng, F.; Wang, M.-d.; Bao, G.; Wang, T.; Xiang, M.; Xie, W.-F. 2014: Neuroprotective effect of allicin against traumatic brain injury via Akt/endothelial nitric oxide synthase pathway-mediated anti-inflammatory and anti-oxidative activities. Neurochemistry International 68: 28-37
Ansari, M.A.; Hussain, S.K.; Mudagal, M.P.; Goli, D. 2013: Neuroprotective effect of allopurinol and nimesulide against cerebral ischemic reperfusion injury in diabetic rats. European Review for Medical and Pharmacological Sciences 17(2): 170-178
Limón, I.D.; Mendieta, L.; Díaz, A.; Chamorro, G.án.; Espinosa, B.; Zenteno, E.; Guevara, J. 2009: Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-beta((25-35)). Neuroscience Letters 453(2): 98-103
Boyaci, M.G.; Eser, O.; Kocogullari, C.U.; Karavelioglu, E.; Tokyol, C.; Can, Y. 2015: Neuroprotective effect of alpha-lipoic acid and methylprednisolone on the spinal cord ischemia/reperfusion injury in rabbits. British Journal of Neurosurgery 29(1): 46-51
Sasaki, M.; Ozawa, Y.; Kurihara, T.; Noda, K.; Imamura, Y.; Kobayashi, S.; Ishida, S.; Tsubota, K. 2009: Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Investigative Ophthalmology and Visual Science 50(3): 1433-1439
Kim, K.-T.; Nam, T.-K.; Park, Y.-S.; Kim, Y.-B.; Park, S.-W. 2011: Neuroprotective effect of anthocyanin on experimental traumatic spinal cord injury. Journal of Korean Neurosurgical Society 49(4): 205-211
Gutierres, J.é M.; Carvalho, F.B.; Schetinger, M.R.C.; Agostinho, P.; Marisco, P.C.; Vieira, J.M.; Rosa, M.M.; Bohnert, C.; Rubin, M.A.; Morsch, V.M.; Spanevello, R.; Mazzanti, C.M. 2014: Neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia in rats. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 33: 88-97
Zhang, F.; Li, F.; Chen, G. 2014: Neuroprotective effect of apigenin in rats after contusive spinal cord injury. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 35(4): 583-588
Do Carmo, S.; Jacomy, H.él.èn.; Talbot, P.J.; Rassart, E. 2008: Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 28(41): 10330-10338
Akdemir, G.ök.; Ratelade, J.; Asavapanumas, N.; Verkman, A.S. 2014: Neuroprotective effect of aquaporin-4 deficiency in a mouse model of severe global cerebral ischemia produced by transient 4-vessel occlusion. Neuroscience Letters 574: 70-75
Zhang, N.; Wen, Q.; Ren, L.; Liang, W.; Xia, Y.; Zhang, X.; Zhao, D.; Sun, D.; Hu, Y.; Hao, H.; Yan, Y.; Zhang, G.; Yang, J.; Kang, T. 2013: Neuroprotective effect of arctigenin via upregulation of P-CREB in mouse primary neurons and human SH-SY5Y neuroblastoma cells. International Journal of Molecular Sciences 14(9): 18657-18669
Lee, K.Y.; Bae, O.-N.; Weinstock, S.; Kassab, M.; Majid, A. 2014: Neuroprotective effect of asiatic acid in rat model of focal embolic stroke. Biological and Pharmaceutical Bulletin 37(8): 1397-1401
Lu, Y.-P.; Liu, S.-Y.; Sun, H.; Wu, X.-M.; Li, J.-J.; Zhu, L. 2010: Neuroprotective effect of astaxanthin on H(2)O(2)-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo. Brain Research 1360: 40-48
Tang, X.-Q.; Li, Y.-J.; Zhao, J.; Shen, X.-T.; Yang, C.-T.; Fan, L.-L.; Hu, B.; Li, Y.-J.; Liao, D.-F. 2010: Neuroprotective effect of asymmetric dimethylarginine against 1-methyl-4-phenylpyridinium ion-induced damage in PC12 cells. Clinical and Experimental Pharmacology and Physiology 37(5-6): 530-535
Pan, H.-C.; Yang, D.-Y.; Ou, Y.-C.; Ho, S.-P.; Cheng, F.-C.; Chen, C.-J. 2010: Neuroprotective effect of atorvastatin in an experimental model of nerve crush injury. Neurosurgery 67(2): 376-388; Discussion: 388-389
He, J.; Kong, J.; Tan, Q.-R.; Li, X.-M. 2009: Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models. Cell Adhesion and Migration 3(1): 129-137
Cheng, Y.; He, G.; Mu, X.; Zhang, T.; Li, X.; Hu, J.; Xu, B.; Du, G. 2008: Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neuroscience Letters 441(1): 16-20
Yu, X.; He, G.; Du, G. 2012: Neuroprotective effect of baicalein in patients with Parkinson's disease. Zhongguo Zhong Yao Za Zhi 37(4): 421-425
Tu, X.-K.; Yang, W.-Z.; Shi, S.-S.; Wang, C.-H.; Chen, C.-M. 2009: Neuroprotective effect of baicalin in a rat model of permanent focal cerebral ischemia. Neurochemical Research 34(9): 1626-1634
Cao, Y.; Li, G.; Wang, Y.-f.; Fan, Z.-k.; Yu, D.-s.; Wang, Z.-d.; Bi, Y.-l. 2010: Neuroprotective effect of baicalin on compression spinal cord injury in rats. Brain Research 1357: 115-123
Qi, L.; Dong, Z.; Ma, J. 2009: Neuroprotective effect of batroxobin on experimental intracerebral hemorrhage in rats. Yao Xue Xue Bao 44(4): 338-343
Kang, J.M.; Jung, J.-C.; Kim, H.; Lim, H.; Jang, S.; Oh, S. 2008: Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice. Archives of Pharmacal Research 31(9): 1098-1107
Ji, Z.-H.; Liu, C.; Zhao, H.; Yu, X.-Y. 2015: Neuroprotective effect of biatractylenolide against memory impairment in D-galactose-induced aging mice. Journal of Molecular Neuroscience: Mn 55(3): 678-683
Zhang, J.; Fu, B.; Zhang, X.; Chen, L.; Zhang, L.; Zhao, X.; Bai, X.; Zhu, C.; Cui, L.; Wang, L. 2013: Neuroprotective effect of bicyclol in rat ischemic stroke: down-regulates TLR4, TLR9, TRAF6, NF-κB, MMP-9 and up-regulates claudin-5 expression. Brain Research 1528: 80-88
Haleagrahara, N.; Siew, C.J.; Mitra, N.K.; Kumari, M. 2011: Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum. Neuroscience Letters 500(2): 139-143
Chen, A.; Xiong, L.-J.; Tong, Y.; Mao, M. 2013: Neuroprotective effect of brain-derived neurotrophic factor mediated by autophagy through the PI3K/Akt/mTOR pathway. Molecular Medicine Reports 8(4): 1011-1016
Kong, X.; Su, X.; Zhu, J.; Wang, J.; Wan, H.; Zhong, M.; Li, L.; Lin, N. 2014: Neuroprotective effect of buyang huanwu decoction on rat ischemic/reperfusion brain damage by promoting migration of neural precursor cells. Rejuvenation Research 17(3): 264-275
Lee, S.G.; Lee, H.; Nam, T.G.; Eom, S.H.; Heo, H.J.; Lee, C.Y.; Kim, D.-O. 2011: Neuroprotective effect of caffeoylquinic acids from Artemisia princeps Pampanini against oxidative stress-induced toxicity in PC-12 cells. Journal of Food Science 76(2): C250-C256
Fu, J.; Xue, R.; Gu, J.; Xiao, Y.; Zhong, H.; Pan, X.; Ran, R. 2013: Neuroprotective effect of calcitriol on ischemic/reperfusion injury through the NR3A/CREB pathways in the rat hippocampus. Molecular Medicine Reports 8(6): 1708-1714
Guo, C.; Tong, L.; Xi, M.; Yang, H.; Dong, H.; Wen, A. 2012: Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats. Journal of Ethnopharmacology 144(3): 768-774
Kumar, A.; Prakash, A.; Dogra, S. 2011: Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats. Pharmacological Reports: Pr 63(4): 915-923
Tasset, I.; Espínola, C.; Medina, F.J.; Feijóo, M.; Ruiz, C.; Moreno, E.; Gómez, M.M.; Collado, J.A.; Muñoz, C.; Muntané, J.; Montilla, P.; Túnez, I. 2009: Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma. Journal of Physiology and Biochemistry 65(3): 291-296
Notturno, F.; Pace, M.; Zappasodi, F.; Cam, E.; Bassetti, C.L.; Uncini, A. 2014: Neuroprotective effect of cathodal transcranial direct current stimulation in a rat stroke model. Journal of the Neurological Sciences 342(1-2): 146-151
Cui, C.; Cui, Y.; Gao, J.; Sun, L.; Wang, Y.; Wang, K.; Li, R.; Tian, Y.; Song, S.; Cui, J. 2014: Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 35(5): 695-700
Belenichev, I.F.; Pavlov, S.V.; Dunaev, V.V. 2010: Neuroprotective effect of cerebrocurin in a model of acute cerebral stroke. Eksperimental'naia i Klinicheskaia Farmakologiia 73(2): 6-9
Chen, X.-r.; Liao, S.-j.; Ye, L.-x.; Gong, Q.; Ding, Q.; Zeng, J.-s.; Yu, J. 2014: Neuroprotective effect of chondroitinase ABC on primary and secondary brain injury after stroke in hypertensive rats. Brain Research 1543: 324-333
Omata, N.; Murata, T.; Takamatsu, S.; Maruoka, N.; Mitsuya, H.; Yonekura, Y.; Fujibayashi, Y.; Wada, Y. 2008: Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium treatment. Bipolar Disorders 10(3): 360-368
Iwama, D.; Miyamoto, K.; Miyahara, S.; Tamura, H.; Tsujikawa, A.; Yamashiro, K.; Kiryu, J.; Yoshimura, N. 2007: Neuroprotective effect of cilostazol against retinal ischemic damage via inhibition of leukocyte-endothelial cell interactions. Journal of Thrombosis and Haemostasis: Jth 5(4): 818-825
Ramiro-Puig, E.; Casadesús, G.; Lee, H.-g.; Zhu, X.; McShea, A.; Perry, G.; Pérez-Cano, F.J.; Smith, M.A.; Castell, M. 2009: Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress. European Journal of Nutrition 48(1): 54-61
Herges, K.; Millward, J.M.; Hentschel, N.; Infante-Duarte, C.; Aktas, O.; Zipp, F. 2011: Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation. Plos one 6(10): E25456
An, S.S.; Jin, H.L.; Kim, K.N.; Kim, D.S.; Cho, J.; Liu, M.-L.; Oh, J.S.; Yoon, D.H.; Lee, M.H.; Ha, Y. 2010: Neuroprotective effect of combined hypoxia-induced VEGF and bone marrow-derived mesenchymal stem cell treatment. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 26(3): 323-331
Yue, Y-Kun.; Mo, B.; Zhao, J.; Yu, Y-Jie.; Liu, L.; Yue, C-Li.; Liu, W. 2014: Neuroprotective effect of curcumin against oxidative damage in BV-2 microglia and high intraocular pressure animal model. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 30(8): 657-664
Kuo, C.-P.; Lu, C.-H.; Wen, L.-L.; Cherng, C.-H.; Wong, C.-S.; Borel, C.O.; Ju, D.-T.; Chen, C.-M.; Wu, C.-T. 2011: Neuroprotective effect of curcumin in an experimental rat model of subarachnoid hemorrhage. Anesthesiology 115(6): 1229-1238
Yadav, R.S.; Shukla, R.K.; Sankhwar, M.L.; Patel, D.K.; Ansari, R.W.; Pant, A.B.; Islam, F.; Khanna, V.K. 2010: Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats. Neurotoxicology 31(5): 533-539
Lee, H.S.; Jung, K.K.; Cho, J.Y.; Rhee, M.H.; Hong, S.; Kwon, M.; Kim, S.H.; Kang, S.Y. 2007: Neuroprotective effect of curcumin is mainly mediated by blockade of microglial cell activation. Die Pharmazie 62(12): 937-942
Yang, J.; Song, S.; Li, J.; Liang, T. 2014: Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat. Pathology Research and Practice 210(6): 357-362
Liu, Z.-Q.; Xing, S.-S.; Zhang, W. 2013: Neuroprotective effect of curcumin on spinal cord in rabbit model with ischemia/reperfusion. Journal of Spinal Cord Medicine 36(2): 147-152
Zhao, J.; Zhao, Y.; Zheng, W.; Lu, Y.; Feng, G.; Yu, S. 2008: Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Research 1229: 224-232
Yang, X.-Y.; Liu, Q.-N.; Zhang, L.; Jiang, S.-Q.; Gong, P.-L. 2010: Neuroprotective effect of dauricine after transient middle cerebral artery occlusion in rats: involvement of Bcl-2 family proteins. American Journal of Chinese Medicine 38(2): 307-318
Morelli, S.; Piscioneri, A.; Salerno, S.; Al-Fageeh, M.B.; Drioli, E.; De Bartolo, L. 2014: Neuroprotective effect of didymin on hydrogen peroxide-induced injury in the neuronal membrane system. Cells Tissues Organs 199(2-3): 184-200
Egea, J.; Romero, A.; Parada, E.; León, R.; Dal-Cim, T.; López, M.G. 2014: Neuroprotective effect of dimebon against ischemic neuronal damage. Neuroscience 267: 11-21
Zenina, T.A.; Gudasheva, T.A.; Bukreyev, Y.S.; Seredenin, S.B. 2007: Neuroprotective effect of dipeptide AVP(4-5)-NH2 is associated with nerve growth factor and heat shock protein HSP70. Bulletin of Experimental Biology and Medicine 144(4): 543-545
Dobrachinski, F.; da Silva, M.H.; Tassi, C.ín.L.íc.C.; de Carvalho, N.él.R.; Dias, G.R.M.; Golombieski, R.M.; da Silva Loreto, E.L.úc.; da Rocha, J.ão.B.T.; Fighera, M.R.; Soares, F.él.A.A. 2014: Neuroprotective effect of diphenyl diselenide in a experimental stroke model: maintenance of redox system in mitochondria of brain regions. Neurotoxicity Research 26(4): 317-330
Szczudlik, A.; Rudzińska, M. 2007: Neuroprotective effect of dopamine agonists. Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S22-S28
Liu, Z.; He, D.; Zhang, X.; Li, Y.; Zhu, C.; Dong, L.; Zhang, X.; Xing, Y.; Wang, C.; Qiao, H.; Chen, L. 2012: Neuroprotective effect of early and short-time applying sophoridine in pMCAO rat brain: down-regulated TRAF6 and up-regulated p-ERK1/2 expression, ameliorated brain infaction and edema. Brain Research Bulletin 88(4): 379-384
Unsal, C.; Oran, M.; Albayrak, Y.; Aktas, C.; Erboga, M.; Topcu, B.; Uygur, R.; Tulubas, F.; Yanartas, O.; Ates, O.; Ozen, O.A. 2016: Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats. Toxicology and Industrial Health 32(4): 730-740
Ahn, B.R.; Moon, H.E.; Kim, H.R.; Jung, H.A.; Choi, J.S. 2012: Neuroprotective effect of edible brown alga Eisenia bicyclis on amyloid beta peptide-induced toxicity in PC12 cells. Archives of Pharmacal Research 35(11): 1989-1998
Barbosa, M.O.; Cristante, A.F.ça.; Santos, G.B.D.; Ferreira, R.; Marcon, R.M.; Barros Filho, T.E.P.d. 2014: Neuroprotective effect of epidural hypothermia after spinal cord lesion in rats. Clinics 69(8): 559-564
Fan, B.; Li, G.-y.; Li, Y.-p.; Cui, J.-z. 2008: Neuroprotective effect of epigallocatechin gallate on oxidative-stress-injured retinal cells. Zhonghua Yi Xue Za Zhi 88(24): 1711-1714
Kim, C.-Y.; Lee, C.; Park, G.H.; Jang, J.-H. 2009: Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity. Archives of Pharmacal Research 32(6): 869-881
Okutan, O.; Turkoglu, O.F.; Gok, H.B.; Beskonakli, E. 2008: Neuroprotective effect of erythropoietin after experimental cold injury-induced vasogenic brain edema in rats. Surgical Neurology 70(5): 498-502
Danigo, A.; Magy, L.; Richard, L.; Desmoulière, A.; Bourthoumieu, S.; Funalot, Bît.; Demiot, C. 2014: Neuroprotective effect of erythropoietin against pressure ulcer in a mouse model of small fiber neuropathy. Plos one 9(11): E113454
Grasso, G.; Graziano, F.; Sfacteria, A.; Carletti, F.; Meli, F.; Maugeri, R.; Passalacqua, M.; Certo, F.; Fazio, M.; Buemi, M.; Iacopino, D.G. 2009: Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage. Neurosurgery 65(4): 763-769; Discussion: 769-770
Nagańska, E.; Taraszewska, A.; Matyja, E.; Grieb, P.ł; Rafałowska, J. 2010: Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study. Folia Neuropathologica 48(1): 35-44
Tugyan, K.ım.; Ozbal, S.; Cilaker, S.; Kiray, M.; Pekcetin, C.; Ergur, B.U.; Kumral, A. 2013: Neuroprotective effect of erythropoietin on nandrolone decanoate-induced brain injury in rats. Neuroscience Letters 533: 28-33
Wakida, K.; Shimazawa, M.; Hozumi, I.; Satoh, M.; Nagase, H.; Inuzuka, T.; Hara, H. 2007: Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Neuroscience 148(1): 105-114
Mourão, F.áv.A.G.ça.; Leite, H.ér.R.; de Carvalho, L.E.D.; Ferreira E Vieira, T.H.él.; Pinto, M.C.X.; de Castro Medeiros, D.; Andrade, I.L.L.; Gonçalves, D.F.; Pereira, G.S.; Dutra Moraes, M.ár.F.áv.; Massensini, A.é R. 2014: Neuroprotective effect of exercise in rat hippocampal slices submitted to in vitro ischemia is promoted by decrease of glutamate release and pro-apoptotic markers. Journal of Neurochemistry 131(1): 65-73
Mehraein, F.; Talebi, R.; Jameie, B.; Joghataie, M.T.; Madjd, Z. 2011: Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats. Iranian Biomedical Journal 15(1-2): 44-50
Xu, J.; Sun, C.; Ma, H.; Wang, L.; Zhang, J.; Zhang, Y.; Wu, L. 2010: Neuroprotective effect of extract of Ginkgo biloba against excitotoxicty compared with ginkgolide B in neuron cell of rat. Zhongguo Zhong Yao Za Zhi 35(1): 114-117
Luo, L.; Sun, Y. 2011: Neuroprotective effect of ferulic acid in vitro. Zhong Yao Cai 34(11): 1750-1753
Mishra, V.; Verma, R.; Raghubir, R. 2010: Neuroprotective effect of flurbiprofen in focal cerebral ischemia: the possible role of ASIC1a. Neuropharmacology 59(7-8): 582-588
Kim, J.M.; Kim, S.; Kim, D.H.; Lee, C.H.; Park, S.J.; Jung, J.W.; Ko, K.H.; Cheong, J.H.; Lee, S.H.; Ryu, J.H. 2011: Neuroprotective effect of forsythiaside against transient cerebral global ischemia in gerbil. European Journal of Pharmacology 660(2-3): 326-333
Baluchnejadmojarad, T.; Roghani, M.; Nadoushan, M.R.J.; Bagheri, M. 2009: Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model. PhytoTherapy Research: Ptr 23(1): 132-135
Prasad, S.N.; Muralidhara 2014: Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: relevance to neuropathy. Journal of Insect Physiology 60: 7-16
Moon, M.; Kim, H.G.; Hwang, L.; Seo, J.-H.; Kim, S.; Hwang, S.; Kim, S.; Lee, D.; Chung, H.; Oh, M.S.; Lee, K.-T.; Park, S. 2009: Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotoxicity Research 15(4): 332-347
Hwang, S.; Moon, M.; Kim, S.; Hwang, L.; Ahn, K.J.; Park, S. 2009: Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4. Endocrine Journal 56(4): 609-617
El-Akabawy, G.; El-Kholy, W. 2014: Neuroprotective effect of ginger in the brain of streptozotocin-induced diabetic rats. Annals of Anatomy 196(2-3): 119-128
Shanmugam, K.R.; Mallikarjuna, K.; Kesireddy, N.; Sathyavelu Reddy, K. 2011: Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 49(4): 893-897
Li, L.; Zhang, Q.-g.; Lai, L.-y.; Wen, X.-j.; Zheng, T.; Cheung, C.-w.; Zhou, S.-q.; Xu, S.-y. 2013: Neuroprotective effect of ginkgolide B on bupivacaine-induced apoptosis in SH-SY5Y cells. Oxidative Medicine and Cellular Longevity 2013: 159864
Ma, S.; Liu, H.; Jiao, H.; Wang, L.; Chen, L.; Liang, J.; Zhao, M.; Zhang, X. 2012: Neuroprotective effect of ginkgolide K on glutamate-induced cytotoxicity in PC 12 cells via inhibition of ROS generation and Ca(2+) influx. Neurotoxicology 33(1): 59-69
Maskey, D.; Lee, J.-K.; Kim, H.R.; Kim, H.-G. 2013: Neuroprotective effect of ginseng against alteration of calcium binding proteins immunoreactivity in the mice hippocampus after radiofrequency exposure. Biomed Research International 2013: 812641
Chen, Z.; Lu, T.; Yue, X.; Wei, N.; Jiang, Y.; Chen, M.; Ni, G.; Liu, X.; Xu, G. 2010: Neuroprotective effect of ginsenoside Rb1 on glutamate-induced neurotoxicity: with emphasis on autophagy. Neuroscience Letters 482(3): 264-268
Silachev, D.N.; Khailova, L.S.; Babenko, V.A.; Gulyaev, M.V.; Kovalchuk, S.I.; Zorova, L.D.; Plotnikov, E.Y.; Antonenko, Y.N.; Zorov, D.B. 2014: Neuroprotective effect of glutamate-substituted analog of gramicidin a is mediated by the uncoupling of mitochondria. Biochimica et Biophysica Acta 1840(12): 3434-3442
Chen, B.; Gao, X.-Q.; Yang, C.-X.; Tan, S.-K.; Sun, Z.-L.; Yan, N.-H.; Pang, Y.-G.; Yuan, M.; Chen, G.-J.; Xu, G.-T.; Zhang, K.; Yuan, Q.L. 2009: Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Research 1284: 1-11
Hong, Y.; Deng, C.; Zhang, J.; Zhu, J.; Li, Q. 2012: Neuroprotective effect of granulocyte colony-stimulating factor in a focal cerebral ischemic rat model with hyperlipidemia. Journal of Huazhong University of Science and Technology. Medical Sciences 32(6): 872-878
Molz, S.; Dal-Cim, T.; Budni, J.; Martín-de-Saavedra, M.D.; Egea, J.; Romero, A.; del Barrio, L.; Rodrigues, A.L.S.; López, M.G.; Tasca, C.I. 2011: Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition. Journal of Neuroscience Research 89(9): 1400-1408
Ahmad, M.A.; Najmi, A.K.; Mujeeb, M.; Akhtar, M. 2014: Neuroprotective effect of guggulipid alone and in combination with aspirin on middle cerebral artery occlusion (MCAO) model of focal cerebral ischemia in rats. Toxicology Mechanisms and Methods 24(6): 438-447
Wang, P.; Niu, L.; Gao, L.; Li, W.-X.; Jia, D.; Wang, X.-L.; Gao, G.-D. 2010: Neuroprotective effect of gypenosides against oxidative injury in the substantia nigra of a mouse model of Parkinson's disease. Journal of International Medical Research 38(3): 1084-1092
Chen-Roetling, J.; Cai, Y.; Regan, R.F. 2014: Neuroprotective effect of heme oxygenase-2 knockout in the blood injection model of intracerebral hemorrhage. Bmc Research Notes 7: 561
Hoi, C.P.; Ho, Y.P.; Baum, L.; Chow, A.H.L. 2010: Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. PhytoTherapy Research: Ptr 24(10): 1538-1542
Park, H.-J.; Bang, G.; Lee, B.R.; Kim, H.O.; Lee, P.H. 2011: Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism. Cell Transplantation 20(6): 827-835
Chen, J.; Shehadah, A.; Pal, A.; Zacharek, A.; Cui, X.; Cui, Y.; Roberts, C.; Lu, M.; Zeitlin, A.; Hariri, R.; Chopp, M. 2013: Neuroprotective effect of human placenta-derived cell treatment of stroke in rats. Cell Transplantation 22(5): 871-879
Xu, X.; Chua, C.C.; Gao, J.; Chua, K.-W.; Wang, H.; Hamdy, R.C.; Chua, B.H.L. 2008: Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway. Brain Research 1227: 12-18
Ozkan, A.; Sen, H.M.; Sehitoglu, I.; Alacam, H.; Guven, M.; Aras, A.B.; Akman, T.; Silan, C.şk.; Cosar, M.; Karaman, H.I.O. 2015: Neuroprotective effect of humic Acid on focal cerebral ischemia injury: an experimental study in rats. Inflammation 38(1): 32-39
Ambikar, D.B.; Harle, U.N.; Khandare, R.A.; Bore, V.V.; Vyawahare, N.S. 2010: Neuroprotective effect of hydroalcoholic extract of dried fruits of Trapa bispinosa Roxb on lipofuscinogenesis and fluorescence product in brain of D-galactose induced ageing accelerated mice. Indian Journal of Experimental Biology 48(4): 378-382
Hong, Y.; Shao, A.; Wang, J.; Chen, S.; Wu, H.; McBride, D.W.; Wu, Q.; Sun, X.; Zhang, J. 2014: Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible role of the Akt/GSK3β signaling pathway. Plos one 9(4): E96212
Shen, M.-H.; Cai, J.-M.; Sun, Q.; Zhang, D.-W.; Huo, Z.L.; He, J.; Sun, X.J. 2013: Neuroprotective effect of hydrogen-rich saline in acute carbon monoxide poisoning. Cns Neuroscience and Therapeutics 19(5): 361-363
Rivers, J.R.; Maggo, S.D.S.; Ashton, J.C. 2012: Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemia. Neuroreport 23(3): 134-138
Palzur, E.; Zaaroor, M.; Vlodavsky, E.; Milman, F.; Soustiel, J.F. 2008: Neuroprotective effect of hyperbaric oxygen therapy in brain injury is mediated by preservation of mitochondrial membrane properties. Brain Research 1221: 126-133
Avraham-Lubin, B.-C.R.; Dratviman-Storobinsky, O.; El, S.D.-B.; Hasanreisoglu, M.; Goldenberg-Cohen, N. 2011: Neuroprotective effect of hyperbaric oxygen therapy on anterior ischemic optic neuropathy. Frontiers in Neurology 2: 23
Pansiot, J.; Loron, G.; Olivier, P.; Fontaine, R.; Charriaut-Marlangue, C.; Mercier, J.-C.; Gressens, P.; Baud, O. 2010: Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat. Plos one 5(6): E10916
Zhang, R.; Zhang, H.; Xu, L.; Ma, K.; Wallrapp, C.; Jonas, J.B. 2011: Neuroprotective effect of intravitreal cell-based glucagon-like peptide-1 production in the optic nerve crush model. Acta Ophthalmologica 89(4): E320-E326
Maslov, L.N.; Lishmanov, I.B. 2012: Neuroprotective effect of ischemic postconditioning and remote preconditioning. Prospective of clinical use. Angiologiia i Sosudistaia Khirurgiia 18(2): 27-34
Liu, Y.; Zhu, S.; Wang, Y.; Hu, J.; Xu, L.; Ding, L.; Liu, G. 2014: Neuroprotective effect of ischemic preconditioning in focal cerebral infarction: relationship with upregulation of vascular endothelial growth factor. Neural Regeneration Research 9(11): 1117-1121
Tsuda, K. 2010: Neuroprotective effect of isoflurane and N-methyl-D-aspartate receptors in ischemic brain injury. Stroke 41(10): E578; Author Reply E579
Li, S.; Pu, X.-P. 2011: Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. Biological and Pharmaceutical Bulletin 34(8): 1291-1296
Yu, L.; Chen, C.; Wang, L.-F.; Kuang, X.; Liu, K.; Zhang, H.; Du, J.-R. 2013: Neuroprotective effect of kaempferol glycosides against brain injury and neuroinflammation by inhibiting the activation of NF-κB and STAT3 in transient focal stroke. Plos one 8(2): E55839
Sugata, S.; Hanaya, R.; Kumafuji, K.; Tokudome, M.; Serikawa, T.; Kurisu, K.; Arita, K.; Sasa, M. 2011: Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneously epileptic rats. Brain Research Bulletin 86(1-2): 36-41
Komur, M.; Okuyaz, C.; Celik, Y.; Resitoglu, B.; Polat, A.; Balci, S.; Tamer, L.; Erdogan, S.; Beydagi, H. 2014: Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 30(6): 1001-1009
Wu, X.-m.; Qian, Z.-m.; Zhu, L.; Du, F.; Yung, W.-h.; Gong, Q.; Ke, Y. 2011: Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801. British Journal of Pharmacology 164(2): 332-343
Wu, Y.; Ye, X.-H.; Guo, P.-P.; Xu, S.-P.; Wang, J.; Yuan, S.-Y.; Yao, S.-L.; Shang, Y. 2010: Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia. Journal of Molecular Neuroscience: Mn 42(2): 226-234
Sun, Y-Xuan.; Tang, Y.; Wu, A-Li.; Liu, T.; Dai, X-Ling.; Zheng, Q-Sheng.; Wang, Z-Bin. 2010: Neuroprotective effect of liquiritin against focal cerebral ischemia/reperfusion in mice via its antioxidant and antiapoptosis properties. Journal of Asian Natural Products Research 12(12): 1051-1060
Hajek, T.; Bauer, M.; Simhandl, C.; Rybakowski, J.; O'Donovan, C.; Pfennig, A.; König, B.; Suwalska, A.; Yucel, K.; Uher, R.; Young, L.T.; MacQueen, G.; Alda, M. 2014: Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychological Medicine 44(3): 507-517
Spandou, E.; Soubasi, V.; Papoutsopoulou, S.; Augoustides-Savvopoulou, P.; Loizidis, T.; Pazaiti, A.; Karkavelas, G.; Guiba-Tziampiri, O. 2007: Neuroprotective effect of long-term MgSO4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage. Reproductive Sciences 14(7): 667-677
Barber-Singh, J.; Seo, B.B.; Nakamaru-Ogiso, E.; Lau, Y.-S.; Matsuno-Yagi, A.; Yagi, T. 2009: Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder. Rejuvenation Research 12(4): 259-267
Jiang, B.-P.; Yang, R.-W.; Liu, X.-M.; Liu, Y.-M.; Chang, Q.; Si, J.-Y.; Pan, R.-L. 2012: Neuroprotective effect of longistyline a against corticosterone-induced neurotoxicity in PC12 cells. Yao Xue Xue Bao 47(5): 600-603
Yan, J.-Q.; Ma, Y.-J.; Sun, J.-C.; Bai, S.-F.; Huang, L.-N. 2014: Neuroprotective effect of lovastatin by inhibiting NMDA receptor1 in 6-hydroxydopamine treated PC12 cells. International Journal of Clinical and Experimental Medicine 7(10): 3313-3319
Antipova, T.A. 2010: Neuroprotective effect of low-molecular peptide mimetic (GK-2) of nerve growth factor is related to activated synthesis of heat shock proteins (hsp32 and hsp70) and increased phosphorylation of TrkA receptor. Eksperimental'naia i Klinicheskaia Farmakologiia 73(12): 6-8
Binawade, Y.; Jagtap, A. 2013: Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations. Journal of Medicinal Food 16(10): 934-943
Cheng, H.-Y.; Hsieh, M.-T.; Tsai, F.-S.; Wu, C.-R.; Chiu, C.-S.; Lee, M.-M.; Xu, H.-X.; Zhao, Z.-Z.; Peng, W.-H. 2010: Neuroprotective effect of luteolin on amyloid beta protein (25-35)-induced toxicity in cultured rat cortical neurons. PhytoTherapy Research: Ptr 24(Suppl 1): S102-S108
Hasturk, A.E.; Harman, F.; Arca, T.; Sargon, M.; Kilinc, K.; Kaptanoglu, E. 2013: Neuroprotective effect of magnesium sulfate and dexamethasone on intrauterine ischemia in the fetal rat brain: ultrastructural evaluation. Turkish Neurosurgery 23(5): 666-671
Solaroglu, A.; Suat Dede, F.; Gelisen, O.; Secilmis, O.; Dede, H. 2011: Neuroprotective effect of magnesium sulfate treatment on fetal brain in experimental intrauterine ischemia reperfusion injury. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 24(10): 1259-1261
Kocic, I.; Kowianski, P.; Rusiecka, I.; Lietzau, G.; Mansfield, C.; Moussy, A.; Hermine, O.; Dubreuil, P. 2015: Neuroprotective effect of masitinib in rats with postischemic stroke. Naunyn-Schmiedeberg's Archives of Pharmacology 388(1): 79-86
Parada, E.; Buendia, I.; León, R.; Negredo, P.; Romero, A.; Cuadrado, A.; López, M.G.; Egea, J. 2014: Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression. Journal of Pineal Research 56(2): 204-212
Kim, H.A.; Lee, K.H.; Lee, B.H. 2014: Neuroprotective effect of melatonin against kainic acid-induced oxidative injury in hippocampal slice culture of rats. International Journal of Molecular Sciences 15(4): 5940-5951
Vornicescu, C.; Boşca, B.; Crişan, D.ţa.; Yacoob, S.; Stan, N.; Filip, A.; Şovrea, A. 2013: Neuroprotective effect of melatonin in experimentally induced hypobaric hypoxia. Romanian Journal of Morphology and Embryology 54(4): 1097-1106
Alonso-Alconada, D.; Alvarez, A.; Arteaga, O.; Martínez-Ibargüen, A.ín.; Hilario, E. 2013: Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia. International Journal of Molecular Sciences 14(5): 9379-9395
Liu, C.; Lin, N.; Wu, B.; Qiu, Y. 2009: Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. Brain Research 1282: 173-182
Cabuk, B.; Etus, V.; Bozkurt, S.U.; Sav, A.; Ceylan, S. 2011: Neuroprotective effect of memantine on hippocampal neurons in infantile rat hydrocephalus. Turkish Neurosurgery 21(3): 352-358
Dolgun, H.; Sekerci, Z.; Turkoglu, E.; Kertmen, H.; Yilmaz, E.R.; Anlar, M.; Erguder, I.B.; Tuna, H. 2010: Neuroprotective effect of mesna (2-mercaptoethane sulfonate) against spinal cord ischemia/reperfusion injury in rabbits. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 17(4): 486-489
Patil, S.P.; Jain, P.D.; Ghumatkar, P.J.; Tambe, R.; Sathaye, S. 2014: Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice. Neuroscience 277: 747-754
Jung, H.W.; Jin, G.-Z.; Kim, S.Y.; Kim, Y.S.; Park, Y.-K. 2009: Neuroprotective effect of methanol extract of Phellodendri Cortex against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells. Cell Biology International 33(9): 957-963
Nathan, H.J.; Rodriguez, R.; Wozny, D.; Dupuis, J.-Y.; Rubens, F.D.; Bryson, G.L.; Wells, G. 2007: Neuroprotective effect of mild hypothermia in patients undergoing coronary artery surgery with cardiopulmonary bypass: five-year follow-up of a randomized trial. Journal of Thoracic and Cardiovascular Surgery 133(5): 1206-1211
Nakano, H.; Colli, B.O.; Lopes, L.d.S. 2007: Neuroprotective effect of mild hypothermia in the temporary brain ischemia in cats. Arquivos de Neuro-Psiquiatria 65(3b): 810-815
Ha, K.-Y.; Kim, Y.-H. 2008: Neuroprotective effect of moderate epidural hypothermia after spinal cord injury in rats. Spine 33(19): 2059-2065
Zeng, K-Wu.; Wang, X-Mei.; Ko, H.; Yang, H.Ok. 2010: Neuroprotective effect of modified Wu-Zi-Yan-Zong granule, a traditional Chinese herbal medicine, on CoCl2-induced PC12 cells. Journal of Ethnopharmacology 130(1): 13-18
Wang, W.; Xu, J.; Li, L.; Wang, P.; Ji, X.; Ai, H.; Zhang, L.; Li, L. 2010: Neuroprotective effect of morroniside on focal cerebral ischemia in rats. Brain Research Bulletin 83(5): 196-201
Yu, L.; Wang, N.; Zhang, Y.; Wang, Y.; Li, J.; Wu, Q.; Liu, Y. 2014: Neuroprotective effect of muscone on glutamate-induced apoptosis in PC12 cells via antioxidant and Ca(2+) antagonism. Neurochemistry International 70: 10-21
Azam, F.; Barodia, S.Kumar.; Anwer, T.; Alam, M.M. 2009: Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease. Journal of Enzyme Inhibition and Medicinal Chemistry 24(3): 808-817
Kandhare, A.D.; Raygude, K.S.; Ghosh, P.; Ghule, A.E.; Bodhankar, S.L. 2012: Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia 83(4): 650-659
Tiurenkov, I.N.; Volotova, E.V.; Kurkin, D.V.; Bakulin, D.A.; Logvinov, I.O.; Antipova, T.A. 2014: Neuroprotective effect of neuroglutam under conditions of activated free radical oxidation. Eksperimental'naia i Klinicheskaia Farmakologiia 77(8): 16-19
Croce, N.; Dinallo, V.; Ricci, V.; Federici, G.; Caltagirone, C.; Bernardini, S.; Angelucci, F. 2011: Neuroprotective effect of neuropeptide y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production. Neuro-Degenerative Diseases 8(5): 300-309
Rodríguez-González, R.; Agulla, J.ús.; Pérez-Mato, M.ía.; Sobrino, T.ás.; Castillo, J.é 2011: Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA. Neurochemistry International 58(3): 337-343
Riljak, V.ír.; Benes, J.; Pokorný, J.; Myslivecek, J. 2011: Neuroprotective effect of nicotine against kainic acid excitotoxicity is associated with alpha-bungarotoxin insensitive receptors subtype of nAChRs. Neuro Endocrinology Letters 32(6): 816-820
Dhir, A.; Naidu, P.S.; Kulkarni, S.K. 2007: Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice. Seizure 16(8): 691-697
Karim, M.Z.; Sawada, A.; Mizuno, K.; Kawakami, H.; Ishida, K.; Yamamoto, T. 2009: Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration. Journal of Glaucoma 18(1): 26-31
Greco, R.; Amantea, D.; Blandini, F.; Nappi, G.; Bagetta, G.; Corasaniti, M.T.; Tassorelli, C. 2007: Neuroprotective effect of nitroglycerin in a rodent model of ischemic stroke: evaluation of Bcl-2 expression. International Review of Neurobiology 82: 423-435
Yasuda, N.; Ishii, T.; Oyama, D.; Fukuta, T.; Agato, Y.; Sato, A.; Shimizu, K.; Asai, T.; Asakawa, T.; Kan, T.; Yamada, S.; Ohizumi, Y.; Oku, N. 2014: Neuroprotective effect of nobiletin on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats. Brain Research 1559: 46-54
Kalemenev, S.V.; Zubareva, O.E.; Lukomskaya, N.Y.; Magazanik, L.G. 2012: Neuroprotective effect of noncompetitive NMDA receptor antagonists IEM-1957 and memantine in experimental focal cerebral ischemia. Doklady Biological Sciences: Proceedings of the Academy of Sciences of the Ussr Biological Sciences Sections 443: 78-80
Ostrovskaya, R.U.; Vakhitova, Y.V.; Kuzmina, U.S.; Salimgareeva, M.K.; Zainullina, L.F.; Gudasheva, T.A.; Vakhitov, V.A.; Seredenin, S.B. 2014: Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation. Journal of Biomedical Science 21: 74
Khalatbary, A.R.; Ahmadvand, H. 2012: Neuroprotective effect of oleuropein following spinal cord injury in rats. Neurological Research 34(1): 44-51
Webber, D.J.; van Blitterswijk, M.; Chandran, S. 2009: Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia. American Journal of Pathology 175(6): 2332-2342
Zamani, M.; Hassanshahi, J.; Soleimani, M.; Zamani, F. 2013: Neuroprotective effect of olive oil in the hippocampus CA1 neurons following ischemia: Reperfusion in mice. Journal of Neurosciences in Rural Practice 4(2): 164-170
Lin, A.M.Y.; Ping, Y.H.; Chang, G.F.; Wang, J.Y.; Chiu, J.H.; Kuo, C.D.; Chi, C.W. 2011: Neuroprotective effect of oral S/B remedy (Scutellaria baicalensis Georgi and Bupleurum scorzonerifolfium Willd) on iron-induced neurodegeneration in the nigrostriatal dopaminergic system of rat brain. Journal of Ethnopharmacology 134(3): 884-891
Borges, A.A.él.; El-Batah, P.N.; Yamashita, L.F.; Santana, A.d.S.; Lopes, A.C.; Freymuller-Haapalainen, E.; Coimbra, C.G.; Sinigaglia-Coimbra, R. 2015: Neuroprotective effect of oral choline administration after global brain ischemia in rats. Nutritional Neuroscience 18(6): 265-274
Yuan, L.-B.; Dong, H.-L.; Zhang, H.-P.; Zhao, R.-N.; Gong, G.; Chen, X.-M.; Zhang, L.-N.; Xiong, L. 2011: Neuroprotective effect of orexin-A is mediated by an increase of hypoxia-inducible factor-1 activity in rat. Anesthesiology 114(2): 340-354
Chao, X.; Zhou, J.; Chen, T.; Liu, W.; Dong, W.; Qu, Y.; Jiang, X.; Ji, X.; Zhen, H.; Fei, Z. 2010: Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats. Brain Research 1363: 206-211
Chen, T.; Liu, W.; Chao, X.; Qu, Y.; Zhang, L.; Luo, P.; Xie, K.; Huo, J.; Fei, Z. 2011: Neuroprotective effect of osthole against oxygen and glucose deprivation in rat cortical neurons: involvement of mitogen-activated protein kinase pathway. Neuroscience 183: 203-211
Liu, W.-B.; Zhou, J.; Qu, Y.; Li, X.; Lu, C.-T.; Xie, K.-L.; Sun, X.-L.; Fei, Z. 2010: Neuroprotective effect of osthole on MPP+-induced cytotoxicity in PC12 cells via inhibition of mitochondrial dysfunction and ROS production. Neurochemistry International 57(3): 206-215
Antonov, S.M.; Krivoi, I.I.; Drabkina, T.M.; Mironova, E.V.; Evstratova, A.A. 2009: Neuroprotective effect of ouabain and Bcl-2 peptide expression during hyperactivation of NMDA receptors in rat brain cortical neurons in vitro. Doklady Biological Sciences: Proceedings of the Academy of Sciences of the Ussr Biological Sciences Sections 426: 207-209
Kong, L.; Zhou, X.; Li, F.; Yodoi, J.; McGinnis, J.; Cao, W. 2010: Neuroprotective effect of overexpression of thioredoxin on photoreceptor degeneration in Tubby mice. Neurobiology of Disease 38(3): 446-455
Knapp, L.; Gellért, L.; Kocsis, K.; Kis, Z.; Farkas, T.; Vécsei, L.; Toldi, J. 2015: Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat. Cellular and Molecular Neurobiology 35(1): 17-22
Liu, B.-N.; Han, B.-X.; Liu, F. 2014: Neuroprotective effect of pAkt and HIF-1 α on ischemia rats. Asian Pacific Journal of Tropical Medicine 7(3): 221-225
Liu, J.; Feng, L.; Ma, D.; Zhang, M.; Gu, J.; Wang, S.; Fu, Q.; Song, Y.; Lan, Z.; Qu, R.; Ma, S. 2013: Neuroprotective effect of paeonol on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat. Neuroscience Letters 549: 63-68
He, S.; Yang, J.; Wu, B.; Pan, Y.; Wan, H.; Wang, Y.; Du, Y.; Wang, S. 2010: Neuroprotective effect of parthenocissin A, a natural antioxidant and free radical scavenger, in focal cerebral ischemia of rats. PhytoTherapy Research: Ptr 24(Suppl 1): S63-S70
Yu, C.; Wang, J. 2013: Neuroprotective effect of penehyclidine hydrochloride on focal cerebral ischemia-reperfusion injury. Neural Regeneration Research 8(7): 622-632
Tulsawani, R.; Kelly, L.S.; Fatma, N.; Chhunchha, B.; Kubo, E.; Kumar, A.; Singh, D.P. 2010: Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage. Bmc Neuroscience 11: 125
Heo, S-Jin.; Cha, S-Heui.; Kim, K-Nam.; Lee, S-Hong.; Ahn, G.; Kang, D-Hyung.; Oh, C.; Choi, Y-Ung.; Affan, A.; Kim, D.; Jeon, Y-Jin. 2012: Neuroprotective effect of phlorotannin isolated from Ishige okamurae against H₂O₂ -induced oxidative stress in murine hippocampal neuronal cells, HT22. Applied Biochemistry and Biotechnology 166(6): 1520-1532
Li, T.; Wang, N.; Zhao, M. 2012: Neuroprotective effect of phosphocreatine on focal cerebral ischemia-reperfusion injury. Journal of Biomedicine and Biotechnology 2012: 168756
Souza, L.C.; Filho, C.B.; Goes, A.é T.R.; Fabbro, L.D.; de Gomes, M.G.; Savegnago, L.; Oliveira, M.S.; Jesse, C.R. 2013: Neuroprotective effect of physical exercise in a mouse model of Alzheimer's disease induced by β-amyloid₁₋₄₀ peptide. Neurotoxicity Research 24(2): 148-163
Medhi, B.; Aggarwal, R.; Chakrabarti, A. 2010: Neuroprotective effect of pioglitazone on acute phase changes induced by partial global cerebral ischemia in mice. Indian Journal of Experimental Biology 48(8): 793-799
Fu, M.; Sun, Z.-H.; Zuo, H.-C. 2010: Neuroprotective effect of piperine on primarily cultured hippocampal neurons. Biological and Pharmaceutical Bulletin 33(4): 598-603
Shurygina, L.V.; Kravtsov, A.A.; Zlishcheva, E.I.; Nemchinova, E.A.; Bukin, D.Y. 2014: Neuroprotective effect of potassium comenate against glutamate toxicity on the model of cultured rat cerebellar neurons. Bulletin of Experimental Biology and Medicine 158(1): 49-52
Zhou, Y.; Qu, Z.-q.; Zeng, Y.-s.; Lin, Y.-k.; Li, Y.; Chung, P.; Wong, R.; Hägg, U. 2012: Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 64(7-8): 673-680
Chen, Y.; Chen, S.-y.; Wang, Q.; Sun, J.; Zhu, Z.-h.; Hou, L.-c.; Xiong, L.-z. 2008: Neuroprotective effect of preconditioning with cannabinoid receptor agonist WIN 55, 212 - 2 on focal cerebral ischemia: experiment with rats. Zhonghua Yi Xue Za Zhi 88(31): 2219-2222
Yokobori, S.; Gajavelli, S.; Mondello, S.; Mo-Seaney, J.; Bramlett, H.M.; Dietrich, W.D.; Bullock, M.R. 2013: Neuroprotective effect of preoperatively induced mild hypothermia as determined by biomarkers and histopathological estimation in a rat subdural hematoma decompression model. Journal of Neurosurgery 118(2): 370-380
Rabiei, Z.; Rafieian-Kopaei, M. 2014: Neuroprotective effect of pretreatment with Lavandula officinalis ethanolic extract on blood-brain barrier permeability in a rat stroke model. Asian Pacific Journal of Tropical Medicine 7s1: S421-S426
Zhang, W.; Zhang, Q.; Deng, W.; Li, Y.; Xing, G.; Shi, X.; Du, Y. 2014: Neuroprotective effect of pretreatment with ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus. Neural Regeneration Research 9(15): 1446-1452
Wang, J.Yu.; Yang, J.Yu.; Wang, F.; Fu, S.Yuan.; Hou, Y.; Jiang, B.; Ma, J.; Song, C.; Wu, C.Fu. 2013: Neuroprotective effect of pseudoginsenoside-f11 on a rat model of Parkinson's disease induced by 6-hydroxydopamine. Evidence-Based Complementary and Alternative Medicine: Ecam 2013: 152798
Yaidikar, L.; Byna, B.; Thakur, S.R. 2014: Neuroprotective effect of punicalagin against cerebral ischemia reperfusion-induced oxidative brain injury in rats. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 23(10): 2869-2878
Carvalho, A.S.R.; Torres, L.B.; Persike, D.S.; Fernandes, M.J.é S.; Amado, D.; Naffah-Mazzacoratti, M.d.G.ça.; Cavalheiro, E.A.ão.; da Silva, A.V. 2011: Neuroprotective effect of pyruvate and oxaloacetate during pilocarpine induced status epilepticus in rats. Neurochemistry International 58(3): 385-390
Kanter, M.; Unsal, C.; Aktas, C.; Erboga, M. 2016: Neuroprotective effect of quercetin against oxidative damage and neuronal apoptosis caused by cadmium in hippocampus. Toxicology and Industrial Health 32(3): 541-550
Abdalla, F.át.H.; Cardoso, A.éi.M.; Pereira, L.B.; Schmatz, R.; Gonçalves, J.F.; Stefanello, N.; Fiorenza, A.M.; Gutierres, J.é M.; Serres, J.D.d.S.; Zanini, D.; Pimentel, V.C.; Vieira, J.M.; Schetinger, M.R.C.; Morsch, V.M.; Mazzanti, C.M. 2013: Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats. Molecular and Cellular Biochemistry 381(1-2): 1-8
Wang, J-ming.; Sun, N-xue.; Hui, N.; Fan, Y-zhi.; Feng, H-xiao.; Zhao, S-ping. 2009: Neuroprotective effect of rAAV-mediated rhBDNF gene transfection on rabbit retina against acute high intraocular pressure. Nan Fang Yi Ke da Xue Xue Bao 29(9): 1770-1774
Wang, H.; Liu, Z.-l.; Zhuang, X.-t.; Wang, M.-f.; Xu, L. 2009: Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats. Chinese Medical Journal 122(17): 2008-2012
Elizarova, O.S.; Litvinova, S.A.; Balaban'ian, V.Iu.; Barskov, I.V.; Novikova, S.V.; Stel'mashuk, E.V.; Garibova, T.L.; Voronina, T.A. 2012: Neuroprotective effect of recombinant human erythropoietin-loaded poly(lactic-co-glycolic) acid nanoparticles in rats with intracerebral posttraumatic hematoma. Eksperimental'naia i Klinicheskaia Farmakologiia 75(8): 7-10
Mohamed, H.E.; El-Swefy, S.E.; Hasan, R.A.; Hasan, A.A. 2014: Neuroprotective effect of resveratrol in diabetic cerebral ischemic-reperfused rats through regulation of inflammatory and apoptotic events. Diabetology and Metabolic Syndrome 6(1): 88
Jin, F.; Wu, Q.; Lu, Y.-F.; Gong, Q.-H.; Shi, J.-S. 2008: Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. European Journal of Pharmacology 600(1-3): 78-82
Cheng, Y.; Xue, J.; Jiang, H.; Wang, M.; Gao, L.; Ma, D.; Zhang, Z. 2014: Neuroprotective effect of resveratrol on arsenic trioxide-induced oxidative stress in feline brain. Human and Experimental Toxicology 33(7): 737-747
Radad, K.; Scheller, D.; Rausch, W.-D.; Reichmann, H.; Gille, G. 2014: Neuroprotective effect of rotigotine against complex i inhibitors, MPP⁺ and rotenone, in primary mesencephalic cell culture. Folia Neuropathologica 52(2): 179-186
ArunaDevi, R.; Ramteke, V.D.; Kumar, S.; Shukla, M.K.; Jaganathan, S.; Kumar, D.; Sharma, A.K.; Tandan, S.K. 2010: Neuroprotective effect of s-methylisothiourea in transient focal cerebral ischemia in rat. Nitric Oxide: Biology and Chemistry 22(1): 1-10
Muthuraman, A.; Singh, N. 2012: Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain. Journal of Ethnopharmacology 142(3): 723-731
Wang, C.-P.; Li, G.-C.; Shi, Y.-W.; Zhang, X.-C.; Li, J.-L.; Wang, Z.-W.; Ding, F.; Liang, X.-M. 2014: Neuroprotective effect of schizandrin a on oxygen and glucose deprivation/reperfusion-induced cell injury in primary culture of rat cortical neurons. Journal of Physiology and Biochemistry 70(3): 735-747
Suganthy, N.; Karutha Pandian, S.; Pandima Devi, K. 2010: Neuroprotective effect of seaweeds inhabiting South Indian coastal area (Hare Island, Gulf of Mannar Marine Biosphere Reserve): Cholinesterase inhibitory effect of Hypnea valentiae and Ulva reticulata. Neuroscience Letters 468(3): 216-219
Baluchnejadmojarad, T.; Roghani, M.; Mafakheri, M. 2010: Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neuroscience Letters 480(3): 206-210
Pérez-H, J.ús.; Carrillo-S, C.; García, E.; Ruiz-Mar, G.; Pérez-Tamayo, R.; Chavarría, A.í 2014: Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Toxicology 319: 38-43
Toth, M.E.; Gonda, S.; Vigh, L.; Santha, M. 2010: Neuroprotective effect of small heat shock protein, Hsp27, after acute and chronic alcohol administration. Cell Stress and Chaperones 15(6): 807-817
Ishikawa, S.; Hirata, A.; Nakabayashi, J.; Iwakiri, R.; Okinami, S. 2012: Neuroprotective effect of small interfering RNA targeted to caspase-3 on rat retinal ganglion cell loss induced by ischemia and reperfusion injury. Current Eye Research 37(10): 907-913
Jin, Y.; Yan, E.-z.; Li, X.-m.; Fan, Y.; Zhao, Y.-j.; Liu, Z.; Liu, W.-z. 2008: Neuroprotective effect of sodium ferulate and signal transduction mechanisms in the aged rat hippocampus. Acta Pharmacologica Sinica 29(12): 1399-1408
Yifeng, M.; Bin, W.; Weiqiao, Z.; Yongming, Q.; Bing, L.; Xiaojie, L. 2011: Neuroprotective effect of sophocarpine against transient focal cerebral ischemia via down-regulation of the acid-sensing ion channel 1 in rats. Brain Research 1382: 245-251
Taveira, M.; Sousa, C.; Valentão, P.íc.; Ferreres, F.; Teixeira, J.ão.P.; Andrade, P.B. 2014: Neuroprotective effect of steroidal alkaloids on glutamate-induced toxicity by preserving mitochondrial membrane potential and reducing oxidative stress. Journal of Steroid Biochemistry and Molecular Biology 140: 106-115
Mies, G. 1998: Neuroprotective effect of sumatriptan, a 5-HT(1D) receptor agonist, in focal cerebral ischemia of rat brain. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 7(4): 242-249
Gulati, P.; Singh, N. 2014: Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia-reperfusion injury. Journal of Surgical Research 186(1): 475-483
Mo, H.; Chen, Y.; Huang, L.; Zhang, H.; Li, J.; Zhou, W. 2013: Neuroprotective effect of tea polyphenols on oxyhemoglobin induced subarachnoid hemorrhage in mice. Oxidative Medicine and Cellular Longevity 2013: 743938
Chiarotto, G.Bortolança.; Drummond, L.; Cavarretto, G.; Bombeiro, Aé.Luis.; de Oliveira, A.Leite.Rodrigues. 2014: Neuroprotective effect of tempol (4 hydroxy-tempo) on neuronal death induced by sciatic nerve transection in neonatal rats. Brain Research Bulletin 106: 1-8
Fargo, K.N.; Foster, A.M.; Sengelaub, D.R. 2009: Neuroprotective effect of testosterone treatment on motoneuron recruitment following the death of nearby motoneurons. Developmental Neurobiology 69(12): 825-835
Kleteckova, L.; Tsenov, G.; Kubova, H.; Stuchlik, A.; Vales, K. 2014: Neuroprotective effect of the 3α5β-pregnanolone glutamate treatment in the model of focal cerebral ischemia in immature rats. Neuroscience Letters 564: 11-15
Limón, D.; Díaz, A.; Hernandez, M.; Fernandez-G, J.M.; Torres-Martínez, A.C.; Pérez-Severiano, F.; Rendón-Huerta, E.P.; Montaño, L.F.; Guevara, J. 2012: Neuroprotective effect of the aminoestrogen prolame against impairment of learning and memory skills in rats injected with amyloid-β-25-35 into the hippocampus. European Journal of Pharmacology 685(1-3): 74-80
Inden, M.; Kitamura, Y.; Tamaki, A.; Yanagida, T.; Shibaike, T.; Yamamoto, A.; Takata, K.; Yasui, H.; Taira, T.; Ariga, H.; Taniguchi, T. 2009: Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice. Neurochemistry International 55(8): 760-767
Sarkar, S.; Chigurupati, S.; Raymick, J.; Mann, D.; Bowyer, J.F.; Schmitt, T.; Beger, R.D.; Hanig, J.P.; Schmued, L.C.; Paule, M.G. 2014: Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model. Neurotoxicology 44: 250-262
Zeng, X.J.; Yu, S.P.; Zhang, L.; Wei, L. 2010: Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. Experimental Cell Research 316(11): 1773-1783
Yun, B.-R.; Weon, J.B.; Lee, J.; Eom, M.R.; Ma, C.J. 2014: Neuroprotective effect of the fermented Gumiganghwal-tang. Journal of Bioscience and Bioengineering 118(2): 235-238
Houkin, K.; Nakayama, N.; Kamada, K.; Noujou, T.; Abe, H.; Kashiwaba, T. 1998: Neuroprotective effect of the free radical scavenger MCI-186 in patients with cerebral infarction: clinical evaluation using magnetic resonance imaging and spectroscopy. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 7(5): 315-322
Liu, W.J.; Jin, H.Y.; Lee, K.A.; Xie, S.H.; Baek, H.S.; Park, T.S. 2011: Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats. British Journal of Pharmacology 164(5): 1410-1420
Rosa, A.O.; Egea, J.; Martínez, A.; García, A.G.; López, M.G. 2008: Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors. Experimental Neurology 212(1): 93-99
Assis, L.C.; Hort, M.A.; de Souza, G.V.; Martini, A.C.; Forner, S.ân.; Martins, D.F.; Silva, J.C.; Horst, H.; dos Santos, A.R. S.; Pizzolatti, M.G.; Rae, G.A.; Koepp, J.; de Bem, A.F.; do Valle, R.M.R. 2014: Neuroprotective effect of the proanthocyanidin-rich fraction in experimental model of spinal cord injury. Journal of Pharmacy and Pharmacology 66(5): 694-704
Cheng, X.; Luo, H.; Zhou, L.; Wang, L.; Sun, J.; Huang, Y.; Luo, E.; Cai, Y. 2014: Neuroprotective effect of the traditional Chinese herbal formula Tongxinluo: a PET imaging study in rats. Neural Regeneration Research 9(13): 1267-1274
Sedaghat, R.; Roghani, M.; Khalili, M. 2014: Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model. Iranian Journal of Pharmaceutical Research: Ijpr 13(1): 227-234
Aktaş, Z.; Gürelik, G.ök.; Akyürek, N.; Onol, M.; Hasanreisoğlu, B. 2007: Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model. Clinical and Experimental Ophthalmology 35(6): 527-534
Pyo, J.-H.; Jeong, Y.-K.; Yeo, S.; Lee, J.-H.; Jeong, M.-Y.; Kim, S.-H.; Choi, Y.-G.; Lim, S. 2013: Neuroprotective effect of trans-cinnamaldehyde on the 6-hydroxydopamine-induced dopaminergic injury. Biological and Pharmaceutical Bulletin 36(12): 1928-1935
Ni, Y.-q.; Gan, D.-k.; Xu, H.-d.; Xu, G.-z.; Da, C.-d. 2009: Neuroprotective effect of transcorneal electrical stimulation on light-induced photoreceptor degeneration. Experimental Neurology 219(2): 439-452
Béjot, Y.; Aboa-Eboulé, C.; Marie, C.; Giroud, M. 2011: Neuroprotective effect of transient ischemic attack. Presse Medicale 40(2): 167-172
Aharonowiz, M.; Einstein, O.; Fainstein, N.; Lassmann, H.; Reubinoff, B.; Ben-Hur, T. 2008: Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. Plos one 3(9): E3145
Schmid, H.; Herrmann, T.; Kohler, K.; Stett, A. 2009: Neuroprotective effect of transretinal electrical stimulation on neurons in the inner nuclear layer of the degenerated retina. Brain Research Bulletin 79(1): 15-25
Pankova, T.M.; Starostina, M.V.; Shtark, M.B.; Epstein, O.I. 2007: Neuroprotective effect of ultra-low doses of antibodies against S100 protein in neuroblastoma culture during oxygen and glucose deprivation. Bulletin of Experimental Biology and Medicine 144(3): 288-290
Lee, E.; Eom, J.-E.; Kim, H.-L.; Kang, D.-H.; Jun, K.-Y.; Jung, D.S.; Kwon, Y. 2012: Neuroprotective effect of undecylenic acid extracted from Ricinus communis L. through inhibition of μ-calpain. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 46(1-2): 17-25
Wu, J.; Zhang, S.; Sun, X. 2010: Neuroprotective effect of upregulated sonic Hedgehog in retinal ganglion cells following chronic ocular hypertension. Investigative Ophthalmology and Visual Science 51(6): 2986-2992
Naseer, M.I.; Ullah, I.; Ullah, N.; Lee, H.Y.; Cheon, E.W.; Chung, J.; Kim, M.O. 2011: Neuroprotective effect of vitamin C against PTZ induced apoptotic neurodegeneration in adult rat brain. Pakistan Journal of Pharmaceutical Sciences 24(3): 263-268
Naseer, M.I.; Lee, H.Y.; Kim, M.O. 2010: Neuroprotective effect of vitamin C against the ethanol and nicotine modulation of GABA(B) receptor and PKA-alpha expression in prenatal rat brain. Synapse 64(6): 467-477
Rahangadale, S.; Kurkure, N.; Prajapati, B.; Hedaoo, V.; Bhandarkar, A.G. 2012: Neuroprotective effect of vitamin e supplementation in wistar rat treated with acrylamide. Toxicology International 19(1): 1-8
Matchett, G.A.; Allard, M.W.; Martin, R.D.; Zhang, J.H. 2009: Neuroprotective effect of volatile anesthetic agents: molecular mechanisms. Neurological Research 31(2): 128-134
Ben Yakir-Blumkin, M.; Loboda, Y.; Schächter, L.; Finberg, J.P.M. 2014: Neuroprotective effect of weak static magnetic fields in primary neuronal cultures. Neuroscience 278: 313-326
Kharoubi, O.; Slimani, M.; Aoues, A. 2011: Neuroprotective effect of wormwood against lead exposure. Journal of Emergencies Trauma and Shock 4(1): 82-88
Nakatani, Y.; Tsuji, M.; Amano, T.; Miyagawa, K.; Miyagishi, H.; Saito, A.; Imai, T.; Takeda, K.; Ishii, D.; Takeda, H. 2014: Neuroprotective effect of yokukansan against cytotoxicity induced by corticosterone on mouse hippocampal neurons. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 21(11): 1458-1465
Yu, X.; Li, Y.V. 2013: Neuroprotective effect of zinc chelator DEDTC in a zebrafish (Danio rerio) Model of Hypoxic Brain Injury. Zebrafish 10(1): 30-35
Reyes-Fermín, L.M.ía.; González-Reyes, S.; Tarco-Álvarez, N.G.; Hernández-Nava, M.; Orozco-Ibarra, M.; Pedraza-Chaverri, J.é 2012: Neuroprotective effect of α-mangostin and curcumin against iodoacetate-induced cell death. Nutritional Neuroscience 15(5): 34-41
Ma, J.; Jiang, L.; Zhong, Y.; Li, Z.; Xie, J.; Zhao, C.; Dong, F. 2010: Neuroprotective effect on retinal ganglion cells by transpupillary laser irradiation of the optic nerve head. Neuroscience Letters 476(1): 3-8
Harada, S.; Yamazaki, Y.; Nishioka, H.; Tokuyama, S. 2013: Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemia. Brain Research 1541: 61-68
Keowkase, R.; Aboukhatwa, M.; Adam, B.-L.; Beach, J.W.; Terry, A.V.; Buccafussco, J.J.; Luo, Y. 2010: Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans. Molecular Neurodegeneration 5: 59
Shu, D.; He, J.; Chen, J. 2009: Neuroprotective effects and mechanisms of Chuanxiong Chatiao pulvis against MPTP-induced dopaminergic neurotoxicity in mice model of Parkinson's disease. Zhongguo Zhong Yao Za Zhi 34(19): 2494-2497
Lau, Y.-S.; Patki, G.; Das-Panja, K.; Le, W.-D.; Ahmad, S.O. 2011: Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration. European Journal of Neuroscience 33(7): 1264-1274
Goyagi, T.; Nishikawa, T.; Tobe, Y. 2011: Neuroprotective effects and suppression of ischemia-induced glutamate elevation by β1-adrenoreceptor antagonists administered before transient focal ischemia in rats. Journal of Neurosurgical Anesthesiology 23(2): 131-137
Choi, S.K.; Lee, G.-J.; Choi, S.; Kim, Y.J.; Park, H.-K.; Park, B.J. 2011: Neuroprotective effects by nimodipine treatment in the experimental global ischemic rat model : real time estimation of glutamate. Journal of Korean Neurosurgical Society 49(1): 1-7
Ruan, H.; Yang, Y.; Zhu, X.; Wang, X.; Chen, R. 2009: Neuroprotective effects of (+/-)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice. Neuroscience Letters 450(2): 152-157
Hou, R.-R.; Chen, J.-Z.; Chen, H.; Kang, X.-G.; Li, M.-G.; Wang, B.-R. 2008: Neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells. Cell Biology International 32(1): 22-30
He, M.; Zhao, L.; Wei, M.-J.; Yao, W.-F.; Zhao, H.-S.; Chen, F.-J. 2009: Neuroprotective effects of (-)-epigallocatechin-3-gallate on aging mice induced by D-galactose. Biological and Pharmaceutical Bulletin 32(1): 55-60
Shibata, S.; Maeda, M.; Furuta, K.; Suzuki, M.; Oh-Hashi, K.; Kiuchi, K.; Hirata, Y. 2009: Neuroprotective effects of (arylthio)cyclopentenone derivatives on manganese-induced apoptosis in PC12 cells. Brain Research 1294: 218-225
Semenas, E.; Sharma, H.S.; Nozari, A.; Basu, S.; Wiklund, L. 2011: Neuroprotective effects of 17β-estradiol after hypovolemic cardiac arrest in immature piglets: the role of nitric oxide and peroxidation. Shock 36(1): 30-37
Zhang, D.; Xia, H.; Xu, L.; Zhang, C.; Yao, W.; Wang, Y.; Ren, J.; Wu, J.; Tian, Y.; Liu, W.; Wang, X. 2012: Neuroprotective effects of 17β-estradiol associate with KATP in rat brain. Neuroreport 23(16): 952-957
Fiocchetti, M.; Ascenzi, P.; Marino, M. 2012: Neuroprotective effects of 17β-estradiol rely on estrogen receptor membrane initiated signals. Frontiers in Physiology 3: 73
Han, J.; Isoda, H. 2011: Neuroprotective effects of 3,5-di-o-caffeoylquinic acid in vitro and in vivo. Bmc Proceedings 5(Suppl 8): P20
Hu, Y.; Liu, M.-Y.; Liu, P.; Dong, X.; Boran, A.D.W. 2014: Neuroprotective effects of 3,6'-disinapoyl sucrose through increased BDNF levels and CREB phosphorylation via the CaMKIi and ERK1/2 pathway. Journal of Molecular Neuroscience: Mn 53(4): 600-607
Weon, J.B.; Lee, B.; Yun, B.-R.; Lee, J.; Ma, C.J. 2014: Neuroprotective effects of 4,5-dimethoxypyrocatechol isolated from Cynanchum paniculatum on HT22 cells. Pharmacognosy Magazine 10(38): 161-164
Koriyama, Y.; Ohno, M.; Kimura, T.; Kato, S. 2009: Neuroprotective effects of 5-S-GAD against oxidative stress-induced apoptosis in RGC-5 cells. Brain Research 1296: 187-195
Lei, Y.; Fu, W.; Chen, J.; Xiong, C.; Wu, G.; Wei, H.; Ruan, J. 2011: Neuroprotective effects of Abacopterin E from Abacopteris penangiana against oxidative stress-induced neurotoxicity. Journal of Ethnopharmacology 134(2): 275-280
Li, H.; Park, J.H.; Lee, J.-C.; Yoo, K.-Y.; Hwang, I.K.; Lee, C.H.; Choi, J.H.; Kim, J.-D.; Kang, I.-J.; Won, M.-H. 2013: Neuroprotective effects of Alpinia katsumadai against experimental ischemic damage via control of oxidative stress. Pharmaceutical Biology 51(2): 197-205
Li, H.; Yoo, K.-Y.; Lee, C.H.; Choi, J.H.; Hwang, I.K.; Kim, J.-D.; Kim, Y.-M.; Kang, I.-J.; Won, M.-H. 2011: Neuroprotective effects of Alpinia katsumadai against neuronal damage in the gerbil hippocampus induced by transient cerebral ischemia. International Journal of Neuroscience 121(9): 490-496
Tian, X.; Sui, S.; Huang, J.; Bai, J.-P.; Ren, T.-S.; Zhao, Q.-C. 2014: Neuroprotective effects of Arctium lappa L. roots against glutamate-induced oxidative stress by inhibiting phosphorylation of p38, JNK and ERK 1/2 MAPKs in PC12 cells. Environmental Toxicology and Pharmacology 38(1): 189-198
Qi, F.-Y.; Yang, L.; Tian, Z.; Zhao, M.-G.; Liu, S.-B.; An, J.-Z. 2014: Neuroprotective effects of Asiaticoside. Neural Regeneration Research 9(13): 1275-1282
Chan, W.-S.; Durairajan, S.S.K.; Lu, J.-H.; Wang, Y.; Xie, L.-X.; Kum, W.-F.; Koo, I.; Yung, K.K.L.; Li, M. 2009: Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. Neurochemistry International 55(6): 414-422
Nannepaga, J.S.; Korivi, M.; Tirumanyam, M.; Bommavaram, M.; Kuo, C.-H. 2014: Neuroprotective effects of Bacopa monniera whole-plant extract against aluminum-induced hippocampus damage in rats: evidence from electron microscopic images. Chinese Journal of Physiology 57(5): 279-285
Nakajima, Y.; Shimazawa, M.; Mishima, S.; Hara, H. 2009: Neuroprotective effects of Brazilian green propolis and its main constituents against oxygen-glucose deprivation stress, with a gene-expression analysis. PhytoTherapy Research: Ptr 23(10): 1431-1438
Mu, Q.; Liu, P.; Hu, X.; Gao, H.; Zheng, X.; Huang, H. 2014: Neuroprotective effects of Buyang Huanwu decoction on cerebral ischemia-induced neuronal damage. Neural Regeneration Research 9(17): 1621-1627
Ma, J.; Yu, W.; Wang, Y.; Cao, G.; Cai, S.; Chen, X.; Yan, N.; Yuan, Y.; Zeng, H.; Fleenor, D.L.; Liu, X.; Pang, I.-H. 2010: Neuroprotective effects of C-type natriuretic peptide on rat retinal ganglion cells. Investigative Ophthalmology and Visual Science 51(7): 3544-3553
Wang, Y.; Wang, Y.; Yang, Q.; Guo, L.; Yin, Y.; Fan, N.; Zhou, X.; Cai, S.-P.; Kaufman, P.L.; Liu, X. 2014: Neuroprotective effects of C3 exoenzyme in excitotoxic retinopathy. Experimental Eye Research 125: 128-134
El-Khadragy, M.F.; Al-Olayan, E.M.; Abdel Moneim, A.E. 2014: Neuroprotective effects of Citrus reticulata in scopolamine-induced dementia oxidative stress in rats. Cns and Neurological Disorders Drug Targets 13(4): 684-690
Wang, Q.; Gong, Q.; Wu, Q.; Shi, J. 2010: Neuroprotective effects of Dendrobium alkaloids on rat cortical neurons injured by oxygen-glucose deprivation and reperfusion. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 17(2): 108-115
Yang, M.Hye.; Yoon, K.Dong.; Chin, Y-Won.; Park, J.Hyun.; Kim, S.Hyun.; Kim, Y.Choong.; Kim, J. 2009: Neuroprotective effects of Dioscorea opposita on scopolamine-induced memory impairment in in vivo behavioral tests and in vitro assays. Journal of Ethnopharmacology 121(1): 130-134
Lee, D.; Park, J.; Yoon, J.; Kim, M-Yeon.; Choi, H-Young.; Kim, H. 2012: Neuroprotective effects of Eleutherococcus senticosus bark on transient global cerebral ischemia in rats. Journal of Ethnopharmacology 139(1): 6-11
Xie, J.; Jiang, L.; Zhang, T.; Jin, Y.; Yang, D.; Chen, F. 2010: Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats. Neuroscience Letters 479(1): 26-30
Kim, M.-J.; Lee, J.; Seong, A.-R.; Lee, Y.-H.; Kim, Y.-J.; Baek, H.-Y.; Kim, Y.J.; Jun, W.J.; Yoon, H.-G. 2011: Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 49(4): 780-784
Kwon, S.-H.; Lee, H.-K.; Kim, J.-A.; Hong, S.-I.; Kim, S.-Y.; Jo, T.-H.; Park, Y.-I.; Lee, C.-K.; Kim, Y.-B.; Lee, S.-Y.; Jang, C.-G. 2011: Neuroprotective effects of Eucommia ulmoides Oliv. Bark on amyloid beta(25-35)-induced learning and memory impairments in mice. Neuroscience Letters 487(1): 123-127
Lee, K.H.; Won, R.; Kim, U.J.; Kim, G.M.; Chung, M.-A.; Sohn, J.-H.; Lee, B.H. 2010: Neuroprotective effects of FK506 against excitotoxicity in organotypic hippocampal slice culture. Neuroscience Letters 474(3): 126-130
Gaire, B.P.; Kim, H. 2014: Neuroprotective effects of Fructus Chebulae extracts on experimental models of cerebral ischemia. Journal of Traditional Chinese Medicine 34(1): 69-75
Jezierski, A.; Rennie, K.; Zurakowski, B.; Ribecco-Lutkiewicz, M.; Haukenfrers, J.; Ajji, A.; Gruslin, A.ée.; Sikorska, M.; Bani-Yaghoub, M. 2014: Neuroprotective effects of GDNF-expressing human amniotic fluid cells. Stem Cell Reviews and Reports 10(2): 251-268
Li, Z.; Hu, H.; Lin, R.; Mao, J.; Zhu, X.; Hong, Z.; Tao, J.; Zhang, Y.; Chen, L. 2014: Neuroprotective effects of Gua Lou Gui Zhi decoction against glutamate-induced apoptosis in BV-2 cells. International Journal of Molecular Medicine 33(3): 597-604
Yang, Y-H.; Hsieh, T-J.; Tsai, M-L.; Chen, C-H.; Lin, H-T.; Wu, S-J. 2014: Neuroprotective effects of Hu-Yi-Neng, a diet supplement, on SH-SY5Y human neuroblastoma cells. Journal of Nutrition Health and Aging 18(2): 184-190
Wang, P.-R.; Wang, J.-S.; Yang, M.-H.; Kong, L.-Y. 2014: Neuroprotective effects of Huang-Lian-Jie-Du-Decoction on ischemic stroke rats revealed by (1)H NMR metabolomics approach. Journal of Pharmaceutical and Biomedical Analysis 88: 106-116
Miltiadous, P.; Stamatakis, A.; Stylianopoulou, F. 2010: Neuroprotective effects of IGF-i following kainic acid-induced hippocampal degeneration in the rat. Cellular and Molecular Neurobiology 30(3): 347-360
Park, S.J.; Jung, H.-J.; Son, M.-S.; Jung, J.M.; Kim, D.H.; Jung, I.H.; Cho, Y.-B.; Lee, E.H.; Ryu, J.H. 2012: Neuroprotective effects of INM-176 against lipopolysaccharide-induced neuronal injury. Pharmacology Biochemistry and Behavior 101(3): 427-433
Ahn, S.-W.; Jeon, G.S.; Kim, M.-J.; Shon, J.-H.; Kim, J.-E.; Shin, J.-Y.; Kim, S.-M.; Kim, S.H.; Ye, I.-H.; Lee, K.-W.; Hong, Y.-H.; Sung, J.-J. 2014: Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis. Journal of the Neurological Sciences 340(1-2): 112-116
Kim, K.Young.; Cho, H.Sill.; Lee, S.Hee.; Ahn, J.Hee.; Cheon, H.Gyeong. 2011: Neuroprotective effects of KR-62980, a new PPARγ agonist, against chemical ischemia-reperfusion in SK-N-SH cells. Brain research 1372: 103-114
Pu, F.; Motohashi, K.; Kaneko, T.; Tanaka, Y.; Manome, N.; Irie, K.; Takata, J.; Egashira, N.; Oishi, R.; Okamoto, T.; Sei, Y.; Yokozawa, T.; Mishima, K.; Iwasaki, K.; Fujiwara, M. 2009: Neuroprotective effects of Kangen-karyu on spatial memory impairment in an 8-arm radial maze and neuronal death in the hippocampal CA1 region induced by repeated cerebral ischemia in rats. Journal of Pharmacological Sciences 109(3): 424-430
Kim, Y.J.; Kim, S.Y.; Sung, D.K.; Chang, Y.S.; Park, W.S. 2012: Neuroprotective effects of L-carnitine against oxygen-glucose deprivation in rat primary cortical neurons. Korean Journal of Pediatrics 55(7): 238-248
Vamos, E.; Voros, K.; Vecsei, L.; Klivenyi, P. 2010: Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease. Biomedicine and PharmacoTherapy 64(4): 282-286
Wang, H.-B.; Li, Y.-X.; Hao, Y.-J.; Wang, T.-F.; Lei, Z.; Wu, Y.; Zhao, Q.-P.; Ang, H.; Ma, L.; Liu, J.; Zhao, C.-J.; Jiang, Y.-X.; Wang, Y.-R.; Dai, X.-Y.; Zhang, W.-N.; Sun, T.; Yu, J.-Q. 2013: Neuroprotective effects of LBP on brain ischemic reperfusion neurodegeneration. European Review for Medical and Pharmacological Sciences 17(20): 2760-2765
Pino-Figueroa, A.; Nguyen, D.; Maher, T.J. 2010: Neuroprotective effects of Lepidium meyenii (Maca). Annals of the new York Academy of Sciences 1199: 77-85
Teng, P.; Li, Y.; Cheng, W.; Zhou, L.; Shen, Y.; Wang, Y. 2013: Neuroprotective effects of Lycium barbarum polysaccharides in lipopolysaccharide-induced BV2 microglial cells. Molecular Medicine Reports 7(6): 1977-1981
Im, A.-R.; Kim, Y.-H.; Uddin, M.R.; Chae, S.; Lee, H.W.; Kim, Y.S.; Lee, M.Y. 2013: Neuroprotective effects of Lycium chinense Miller against rotenone-induced neurotoxicity in PC12 cells. American Journal of Chinese Medicine 41(6): 1343-1359
Elkind, E.; Vaisid, T.; Kornspan, J.D.; Barnoy, S.; Rottem, S.; Kosower, N.S. 2011: Neuroprotective effects of Mycoplasma hyorhinis against amyloid-β-peptide toxicity in SH-SY5Y human neuroblastoma cells are mediated by calpastatin upregulation in the mycoplasma-infected cells. Neurochemistry International 58(4): 497-503
Karalija, A.; Novikova, L.N.; Kingham, P.J.; Wiberg, M.; Novikov, L.N. 2012: Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats. Plos one 7(7): E41086
Biraboneye, A.C.; Madonna, S.; Maher, P.; Kraus, J.-L. 2010: Neuroprotective effects of N-alkyl-1,2,4-oxadiazolidine-3,5-diones and their corresponding synthetic intermediates N-alkylhydroxylamines and N-1-alkyl-3-carbonyl-1-hydroxyureas against in vitro cerebral ischemia. Chemmedchem 5(1): 79-85
Zhang, Y.-B.; Kan, M.-Y.; Yang, Z.-H.; Ding, W.-L.; Yi, J.; Chen, H.-Z.; Lu, Y. 2009: Neuroprotective effects of N-stearoyltyrosine on transient global cerebral ischemia in gerbils. Brain Research 1287: 146-156
Sokolowska, P.; Passemard, S.; Mok, A.; Schwendimann, L.; Gozes, I.; Gressens, P. 2011: Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy. Neuroscience 173: 156-168
Zhu, W.W.; Ma, X.L.; Guo, A.L.; Zhao, H.Y.; Luo, H.H. 2011: Neuroprotective effects of NEP1-40 and fasudil on Nogo-A expression in neonatal rats with hypoxic-ischemic brain damage. Genetics and Molecular Research: Gmr 10(4): 2987-2995
Yang, C.; Wang, H.; Zhang, S.; Cheng, Y.; Sun, J. 2012: Neuroprotective effects of NKN on focal cerebral ischemia in rats. Turkish Neurosurgery 22(1): 1-6
Lin, Q.; Hai, J.; Yao, L.-Y.; Lu, Y. 2010: Neuroprotective effects of NSTyr on cognitive function and neuronal plasticity in rats of chronic cerebral hypoperfusion. Brain Research 1325: 183-190
Hobbenaghi, R.; Javanbakht, J.; Sadeghzadeh, S.; Kheradmand, D.; Abdi, F.S.; Jaberi, M.H.; Mohammadiyan, M.R.; Khadivar, F.; Mollaei, Y. 2014: Neuroprotective effects of Nigella sativa extract on cell death in hippocampal neurons following experimental global cerebral ischemia-reperfusion injury in rats. Journal of the Neurological Sciences 337(1-2): 74-79
Botia, B.éa.; Jolivel, V.ér.; Burel, D.; Le Joncour, V.; Roy, V.; Naassila, M.; Bénard, M.; Fournier, A.; Vaudry, H.; Vaudry, D. 2011: Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum. Neurotoxicity Research 19(3): 423-434
Wang, G.; Pan, J.; Tan, Y.-Y.; Sun, X.-K.; Zhang, Y.-F.; Zhou, H.-Y.; Ren, R.-J.; Wang, X.-J.; Chen, S.-D. 2008: Neuroprotective effects of PACAP27 in mice model of Parkinson's disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum. Neuropeptides 42(3): 267-276
Zheng, L.; Ishii, Y.; Tokunaga, A.; Hamashima, T.; Shen, J.; Zhao, Q.-L.; Ishizawa, S.; Fujimori, T.; Nabeshima, Y.-I.; Mori, H.; Kondo, T.; Sasahara, M. 2010: Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved. Journal of Neuroscience Research 88(6): 1273-1284
Kim, Y.N.; Jung, H.Y.; Eum, W.S.; Kim, D.W.; Shin, M.J.; Ahn, E.H.; Kim, S.J.; Lee, C.H.; Yong, J.I.; Ryu, E.J.; Park, J.; Choi, J.H.; Hwang, I.K.; Choi, S.Y. 2014: Neuroprotective effects of PEP-1-carbonyl reductase 1 against oxidative-stress-induced ischemic neuronal cell damage. Free Radical Biology and Medicine 69: 181-196
Kim, H.Neui.; Kim, Y.Ri.; Jang, J.Yeon.; Choi, Y.Whan.; Baek, J.Ung.; Hong, J.Woo.; Choi, Y.Hyun.; Shin, H.Kyoung.; Choi, B.Tae. 2013: Neuroprotective effects of Polygonum multiflorum extract against glutamate-induced oxidative toxicity in HT22 hippocampal cells. Journal of Ethnopharmacology 150(1): 108-115
Im, A.-R.; Chae, S.-W.; Zhang, G.J.; Lee, M.-Y. 2014: Neuroprotective effects of Psoralea corylifolia Linn seed extracts on mitochondrial dysfunction induced by 3-nitropropionic acid. Bmc Complementary and Alternative Medicine 14: 370
Xia, Y.; Xing, J.Z.; Krukoff, T.L. 2009: Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways. Neuroscience 162(2): 292-306
Shi, X.R.; Hong, Z.Y.; Liu, H.R.; Zhang, Y.C.; Zhu, Y.Z. 2011: Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells. Neurochemistry International 58(8): 851-860
Yoon, M.-Y.; Hwang, J.-H.; Park, J.-H.; Lee, M.-R.; Kim, H.-J.; Park, E.; Park, H.-R. 2011: Neuroprotective effects of SG-168 against oxidative stress-induced apoptosis in PC12 cells. Journal of Medicinal Food 14(1-2): 120-127
Shahlaie, K.; Gurkoff, G.G.; Lyeth, B.G.; Muizelaar, J.P.; Berman, R.F. 2013: Neuroprotective effects of SNX-185 in an in vitro model of TBi with a second insult. Restorative Neurology and Neuroscience 31(2): 141-153
Yousuf, S.; Atif, F.; Kesherwani, V.; Agrawal, S.K. 2011: Neuroprotective effects of Tacrolimus (FK-506) and Cyclosporin (CsA) in oxidative injury. Brain and Behavior 1(2): 87-94
Dong, K.; Xu, W.; Yang, J.; Qiao, H.; Wu, L. 2009: Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice. PhytoTherapy Research: Ptr 23(5): 608-613
Jang, J.-H.; Kim, C.-Y.; Lim, S.H.; Yang, C.H.; Song, K.-S.; Han, H.S.; Lee, H.-K.; Lee, J. 2010: Neuroprotective effects of Triticum aestivum L. against beta-amyloid-induced cell death and memory impairments. PhytoTherapy Research: Ptr 24(1): 76-84
Yang, J.; Guo, L.; Liu, R.; Liu, H. 2012: Neuroprotective effects of VEGF administration after focal cerebral ischemia/reperfusion: dose response and time window. Neurochemistry International 60(6): 592-596